var title_f41_9_42128="CT of nonmucinous minimally invasive adenocarcinoma";
var content_f41_9_42128=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53003&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53003&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT of nonmucinous minimally invasive adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial 2-mm CT section shows a peripheral, predominantly ground-glass, part-solid nodule in the right upper lobe that includes a 4 x 3 mm solid component (arrow), which corresponded to invasion by pathology.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011; 6:244. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42128=[""].join("\n");
var outline_f41_9_42128=null;
var title_f41_9_42129="Cylindrical bronchiectasis RLL";
var content_f41_9_42129=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cylindrical bronchiectasis of right lower lobe",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    HRCT shows mild dilatation of the posterobasal and laterobasal segmental bronchi in the right lower lobe (long arrow). Multiple ill-defined, peripheral right lower lobe nodules are visible and represent mucous plugs in dilated subsegmental bronchi (short arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42129=[""].join("\n");
var outline_f41_9_42129=null;
var title_f41_9_42130="Skin biopsy MCTD IF";
var content_f41_9_42130=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F80459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F80459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin lesion in mixed connective tissue disease (MCTD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Indirect immunofluorescence microscopy for Cb5-9 from a skin lesion in mixed connective tissue disease, showing granular nuclear staining in the epidermis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42130=[""].join("\n");
var outline_f41_9_42130=null;
var title_f41_9_42131="Lipoma arborescens knee MRI";
var content_f41_9_42131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F64392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F64392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lipoma arborescents of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 398px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGOAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UooooA9U8IWLWngf+0LlQsTy7Y89XyTzUepaZ9ogZoEIlIyOK3vAOmyappdmt5PvtrKLKQZ4BPNb10mN6PB5cQGS+KAPK5bGS2Qeeg3DqfWqRsd+cD5mrttUsZdRuoktM/Zozkue9Mu9JaL5gNuBQBxkdisZIHUU17FWbc68Ct+S3VBl8DYN2aroRdLu6AHGKAMT7IMHI4zxisXU4xHckDpiu1e2PLY+QDIrjtYVlujv5z0oAojvQKDSUALSsMKp9adMu1/qM0TDa+B0AFADB3q9o0ayXu1sY2MRn1xVYx7YN57niptJDfb4yvUHNAAkLGNFGcs+CKdqabGjGMcV0MUMRv2k2jy8ZI9DWHrwAuhjpigCrp67rpBWhLAQWAHBqpo4zejjOATWy6l0OOAKAM5IlBwfoaesAAwO3SrrRqojOOvJpTCDJ8nC0AUzGMjd16UjQqXyAMYq/JCNvIOfWolgAduc96AMS6TYPqarVp30IUOe3WsygCaGMujnsKmSEuCo5A5FS6Xyrgj5ScGtGxtwJiwGExgUAZ9tEcbcfNUrLjoOlXxF8zkLlu2KjERSRUc/MeSPSgCm0SyLkDnvTBbEZGeK00gXkqPqKJYcyf7AoAzFiIkJK5IqZo/Mhk+XBArR+zbYSVOc0lmhDuJB1X86AMJgWtTnqDVOt1IAyzjbzzisNgQSDwaAErSsYxJEG9OKza1dJkHlvGRk5yKAFurcIqv69ag+zv5qlhle1bNwnmIPlwFHNQRxliv8qAKqxhl+YfKKW8gMdqrqMg8fSrYAEpBH4VPFD5gMUn3eooAykjLIMjIqT7OGGOw7VPNEYWOzkGrMcau6lF4HWgCiLcMoDL04p62yrkdhWgy/MVUcVG0e8lcYB4oAz54lVPXccCr+nWHmx4ONqjLN6CpZLEiz8xjiJT94+tR/bjcoLGzUorACR/WgDPuAt1eO8C/6PHwD61oi3AVfl6gVdu7BLLQJJYByjAEd+nWpLcedawOoBygoA4OiinRrvdVHc4oA+g/hHbpp/hxjNl5pcMxHOOOBW/4gnJs1WSHEMx25x0qTwPYxaZ4Ws4xiVyAzE960NSSS9je2MSrDICd3900AYd2Lawslt44x5h+4o6msObT5508y5bYc/drW8N2NxuuLnUH86RW2RMTkAVduLQvO5HzkDODQBw11pcUkoUn5T2qjNpC252KCFz19q7i8svLYvsGPSqrQiTHmKMehFAHIyWkiRSKo3Rj5h9K8y1N/tOpS44AO0V7D4hik0rS5tSjO6NDs8v8ACvFpJfMu2lIwGfcQPrQAlzGY5MEYzUNamqzRSAhB82cg+1QWdt9pR9vDLigCqfmC+wxQ2WcDvwK1bK1FnK0t7H+6ZSEz/Ee1UbdBJexAZ2s/9aAC9OBHF/cGD9a0/DtudstwVyOFWs3Vk8vUZ17Bq3/DWXsFRTyJP8KANs2Sw6Dc55u35WuS8QRGIWqv9/Yc16NJBhFZxlidoFcN42TZdW4xj5T/ADoAz/Dylr1sDoldHHbHzAzrhR196x/CERa5mk7KuK6qXIJXqoHSgDHkh3sVTnLU42siKScZBHGa0IQm/G3bu7+lOMREjOxz2AoAoToVjAI5IphiUZI6svStOaFSw3c8VFBAANzjJ6UAc/fofJaPZzt4Nc7XcXUeXC7eOSK426XbcSAjGGPFAF7RlMgkjHVq27SLA2txtql4PVWun4+YdK23jKMd425oApoDG25RkZ70nkLJNLLJ/rDViICT2GanMI8vjr60AVEjAA9aQxhSSxytaDRKy4IwaatuGzkZzQBUSP50IBMXepri23YeDoentVmFfJHTcuelSEKt4GiHyN/DQBhQMqyMrrg8iud1KMx3kg7E5FdRNGWkfjo3X8axPEUZW4V8cEYoAye1aGjH/SCPUVn9sVd0cj7am44BoA6V1LjHRsU1YAIie56VbgA8wE0+aIL82flzyKAKSQjJY/eqwsbZX5aspbqWzjoM1NbjaxEo5J4oAzDbl1chfmWkjtpFwwBweorWMJEhVe/NSwxbYi5Xc3QCgDKEPmBtvC9M+9TWtntlUsC4XqAKtpDz8q/Kw4HoakeO4t7ItCuTuO4+lAGbqStc6hY6Yo+XzFeYDsM0DTRN4iv0tF8u2jXC/nWlounuLprrO+V3HzGtBViOsXIBw5QbgPXNAFLS7fz28u4HB+Rl/rWPdzSaPdS2bxkbWJXI7HpXY3Fo/kC5gGXU4YCr2pWWnatJDc3OFl8pUYfSgDwWp7Nd15AuM5dRj8agrQ0GCS41i0SL73mKc+gB60AfV2i25TSLJWTYDEOvbirUyLsUM+QcrxS2Fyk1pEgcMNg2/lT2KDJZciP5moA5zQIkt4dRtzJxBJkhuo4zSXHC+fFMoDdB603w9B/aZ8UazdgwLOjJAnTgLjP6VieEbbz9J826kaQJIVxn0oA1Lm7V5AoQkx/e9DVeSaCRvnUqOtbCWoEUigDnjNQNAqIQ8QZTgDigDhviPqMEHhyWEOPMnO7Z6DFeS6JpcmrSzrF95E3Y9a7T4nyQ6l4gNrZjDom3aPrVDwtZz6ayyj5XBO/6UAcQ6vHIUcEMvBB7Vp+HZ0h1JUkGYpOG9q37zSk1PX2a3Xh24A71iX1mbTxEbaJSGDAYPrigDR16+t7yDCELHbDZEP7xpfB8EUjB549wO4Z9Ca56+Rlu2g24Kttx716h4f0dNM+H2o6tKP3kYAAPv0oA878QWwtbuWNm3SByc+1aXgwhxNEeodWH58/yrBDte3JMxJkkbJau18KaSLe5WSM7hLxj6UAdJftt1qKFATC0YfPvXFfERNl3Z47o3869HlhUsHZeUbaK8/8AiggTULLb0MZ49OaAKngmF5UutvC8An0rrLi22ZHG5sYNYnw4Cm0vtwzyOPXiuhML3NyGDERqQADQBWt7L94VyGAH61IbUMjsOvpWn9ky8iRDbIBmmyQuixEoRn71AGatuNi7l5Hc02dFWEbRg1rzAFEGO/5VWlgxHnGWoA567yWVlGOMYrh9RGLyT3Oa9JnjRUcY+fqK871tAmoPgY3c0AanhIASMzHADV3iWkOoSTJxhFzn3rg/BirJqAjc8Meld/DGbJfMiPEnBoA5aKJ7W7aKQZUkgH0rQgjzKEfgk1rrbr80rqHU/oaJYoZrNZk+W4iOD7igCn5QWNlIyaRLcrDI+DgdK2bW0injEiSDdjlaasTzK8W3GOgoAzNitH0wcU23hAkG8c9jVwriVUxnB5rU+woYGfALg5AoA5C8gPnXMajnAIrC1633aRFMB8wPzV2c4EWpl2AJIwQaxtVtTJa30JGMZYCgDz5Rk4q3pJUX0e/1qmeD7ipYT5dwpPGDQB3xt2QcexJp1tazXiynlEzwTVuDc+mQeX828cmtSwVWj2McADGBQBVsoUjZUcZ4xk0jRgXR3LkL0FbMloWtiwXayfyqpMN8YlQAFeKAM6dGi/eMPlPSrFkgdsY6jpVtrVmhBYZQcircUMQTzUHzKvIoAzDGkJ+6WbPFaUKxP4e1FsjcFBI9DmohG25CCMtyK1Nas4LDwwYlP+l3jc+vrQBiaaogsg/8SxM/41JpNtFPAt3ICrysQznoK2NJ0aRbRVlAd/LPHrTbK1kl8P3trGgDhyTH3Az1FAEWmXqpIoKEjcF9jVybQ7aeRpEmXDEkjPQ1e0GygewidwsgAI/Gkm0xEkOHYA84FAHzTXX/AAt0k6x4ut7cyCOIAtIx/u8VyFdn8JrWS58X2+yQxxoN0jA44zQB73PpFppd3cz3cd00UzBodS08n7TZqFACNEcrLFnJIAzkn5SeRZvb+XTtHkvLwwXumyrth1awy1s5zjEgyWhbPUNkA8bs8VuK0Dt5eQcjiuelVdJv57rRLxrG/kz5oCh4Zh6Sxnhx2zww7EV5tbDV6c3Wwsr33jJ6P0e8X6XXl1LTTVpC+GoZ59BuoLnChImII79xWP4BUf2TcJJxidvx5q9G1vcwS2+lyweHtQuQVW0mctp10x4HkyYzAx/uEY7AHlqpeFre703zdK1m2ey1WNi5t5cBmXP31PR1/wBpSRWmGx9OvL2Uk41FvF7+q6NeauhOLWvQ6JozHMxH3WHSqd7IiRzMWAaOMsB74rQMMjr7jrWXrdtHHYXskpwY4s5+tdxJ4FPNcHxZY6hcDieUZ9+a6bxA8VpdNKDsDHlfrWbfwCazhjX/AF0YMsfrkGrGqWjajpkM8uftBQhx6bRxQBS0HUYtN8QqkvIY5QntVvxbp/mTXGrRRgzjG0r6etefzXUjTI7/AOsj4Bq7Jr2oSfKsrCMjbt7GgB1hG2pasJCP9WNzn1Ir2vxZZv8A8KdnihG3GyR/cZzivM/B2nlNYs4mH+sYGQeor2XxS6xfDyRJB+6nkEPHb5sUAfPthDHbafFfSocbioPYnNd14Ok+33ETxrhEyTWt8SPCceh/CuxEK5MdyGL45IIxWd8Koz9kVyPlbgGgDrbiMJbvISAN3Neb/F6NUv8ATto+9CT+tetarp+7RboHiTGRj1ryT4s7xcaQsow4tzn86AJfhYoaC+3KfmIUH3xXZ2kSrE8c+BMrDBFc78JoTJoV5tGWE+f/AB2uwgtFkZrhiSFIyPegBDF5Z3HBfvUMquT2xmtJIMoZX6MajeJdjeUMgHmgDLljjQlm646HvTptnkg7Oegq+0UdwAsic4wPamSxFJUQDhetAHOXuwKVdMO3evOfFybdQXAx8uK9WvofOusFR8oy30rzTxvEBcRSp9w5AoAi8JYWaNu/mYz+FemtCslpLHnDxEED1rzDwkC9xsHZg1et7QLm3eVNoZgCfWgCppjxlNpQ5PBBqlJbSQ3UjEjymyMGuiu7ZRJMIwEIIKkd+ahubRX2LKCMigDHtbdih8k/MDmrRDowkHHqaksrdrWZyeUPAq5JCZLQrjlj8p9DQBkXkIN8PIOAVyfritfSnHyMfvAYOe9QRRJJdIjcMg+b3rTtLZTExxgKflxQBzXiOxlhuTMPun5gayJSsrxSSn/WptIrttXtHuLIq5I2cgVyGoQCS0hkjXlDhsetAHl+oRGC9mjPZjULcgGtvxbb+XeJJtwXHNYWaAPUvCrpPpMORkKCK2rKNTeKo+UE1zfw2lSWxuIX5IwQK7iCONwS6bZFHHFAB5cgB/iwcEeoqAW6I8iuMIeQK0rYSHDdCCOD3p+sWjzAOq7XABwO9AGdNGzqmwbYxxTzbNbxnj7wyfpWgV3Qwoww7dR6VYW2maMo47YBPpQBg2M9rphNxco07KCQgp2lNPq9zJqF4mIs4iQ/wjtW1Dpf2SfzERJQOoI61altSt2s0OFhYDdGOxoAhlMun2U91/BbqdzenGaleIXenWGvaQQztnzkHRlxU2pRXD+DNfR1BWTjHfbtpng6JEsNOhszizWBfMU92xzQBm+EtRhub2/tFQxuj7lU+mOa6G8jQyDAP3RVKbS4rTWzdRKFZ1PzDvWq0+8KQo4GKAPkWu++DuZvEgtc4SXGSOv0rga9G+BrIni7c67iE+X60AfQSWSRTud5JyOajvLO2EUrMQJWGBnvTpbqVZMRw/K3UkVj69HLeXNpcJIU+zN8yD+LtQBWttDbybizuNs1tIpJVxkfSrNlBfxacLK5txrWkQtlbS5lKz2/YNbz/eQgdATjsCorUgZm2YBO/rUysYmchsdq58ThKWKjy1Ve23Rp901qn5oak47GTb/anjln0W5uNYsYcGe3kj2ajZj/AKaRD/WL/tIOewbrXL+O9SkuNCtE06ZJoryUq0iNnhSOPY+3UV217ZQzMk4EkN7Dkw3UDFJYj/ssO3qDwe4Nc34jfS77UooPFZ+x6qwDxa7Yw8OcYH2q3XhuP41/8cFcPPisD/EvVp918a9Uvi9Vr5Pcv3ZbaM8tuLgQeKYpHXFvEwhK16GNHiksri5sCkyuvKjtmreg/Cu41/Xrq31iNDYT2ck9pqtjIJbeR8qI3Rh35J2nGQDyRzXG6FqF74W8TXHh7WybW+gk8t1JykndWU9wRgj2Na4XNcLi6sqNGabST+T/AMuvYUoSirs8x8S2LWesyxSL5RLcg9qm8K6LPq2v29nGu4nLcegGSfyrvvjPpdvPa2+r27qblX8mdF+mc0vwgSKwsNT1QgNcW9q5jY9iykYr0SCz4Fto7vxJqU6DMNm5jU10uu36t4SkWQ74Hu41jHod/NZHwe06WPQp7ickG8m8xs9xWv8AEDTk0bwLpNyQf39+BtPfD0Ab/wC0XEsXwzso4hjBQsK474VRQr4Zt5Gxg9frXcfGm7guPC32e6HytGI/933rh/h7Z3Wn6KunTpuUyCSOUDgqTk/pQB1WpB007UZN2VWMsBXknxokEt3ozgYJtTn/AL6r2nWFjtNNvAwGxouK8R+MoK6rpqH7otuPzoA6P4PwH/hHZJFOGe4I/Suz0tN8Tw7cEN19a5H4QRFPD9tKckNdsAPwNdxbxsuqXK4wnBGKAFMCF9qHOw5YU02W6RnJCEnO0elaKBV6rjPU1E0QyGcncOlAGSyIZm8o4JOMHio5ERHYSffHWtWa3SZkdxjac8UTwxybiyAkDg+tAHMeTmdpcHPTHrXnHxFhVLe3ZRjD4I/OvXb9QyQpFHtfrnFea/FSEJYxNtwS4P8ASgDl/A6ebd3MYOHKAqffNezaTEt1Y/Y7shb0DcnvivKfhPYNqPiOSCLmbyWdF/vEc16ppF3byLp99cqVlLeTJ6q2eKAHsftjCOHIu4flkQ9wO9W1/eWxYBWKdVPUVPrGnstz9u0/CXS9SOjj3rPTdehpIj5Vyn+tTpmgBFWG6RlJ2GmQZS4dH5x90+tIqbJxlTg9cVoXNsPJZhlcf6t/6GgBq6K+qxEWXyXafN9RTdEuFzLC4zPAenqRW74YvTDFNIq5lACsR6Vl6vbxW3iCG5sh+6njw/8AvZoAs/ZQ9y3nnIlQ/hxXGW1r5kOoWAH71WLofWuvdpTN5RPRTz68Vi21sTqNvKflKnD47igDyzxzBvtYpgMlTtbHbHFcSK9d8Z6YsL6hYgZ3r5i/lmvIuhwetAHYfDObZrqxk8P2r2BYAJmJ/h4IrwbwrdCz1iCbOCGH86+jLKOO8tmkHBkG4GgDPlWUYuFjyvQgfzrT09ohab1cSP1VTWhHastuSAGIGCPUVhG3SPUhHETFxkH3oAt2dk6yPJd481vmA9KW383LrKOh61BBPdi6SW5BIDbV9xV0ymeS4MYG0Dr70APeA4Rw3A5NT2yeYx4yD+lUUkc2caEnPRjWzaIIbQkDqBk0AUL+Z4LuCw7XKksp7ipDbJpk0Btx+4dtpx2NS6lbx33jGy+cII4G498inS71upNPlXAfLRsaALtxYxypiTK4GQayjbSJwr8CtXSrg3EPlXA/fRfKwPf3qO/tVM+VYgEdqAPjmvY/gJBYAXlxKw+3B8Rr6jArxyvcfgJpcSaVdanKu6Z5DHF7YAzQB689yrnbgZA6+9YkSpFdStdTAljkAntW1Lbo4ypwCKx9T0e3naNpJCCOCc9aALEEhP8AqHUnGSc9BWfeak8UAa1T7Q7OVKr1GKYNF2Rsbe7dAOSoPJ9qm0uyRQ8sGY5k6q3f3oAuJcXRjVjHgkhiD2FefarJcRale6hdYluZXEVvHkfKAeTj6duM+or0J2llXzLhhEh+Zj04rzbQJh4g8b3cygtZW52pnoSOM0AereEfG/hbwhpP2YaXrFlHLIZZZpI45vMkIGWxE5x2/hHT8Tx3x3uPBXjjSotZ0fW7aHXtPGQs6PA1xCDkpiRVJYZyv4jvxzes6gdF8S3EtxF5tmQVCHkVyes2D3UkmqacfMsV5Kd0J/8Ar181DhihRxaxtKpNTvd6p37p3V9fU2dZuPK1oYHiK+uJmuFkcukoBUg5DehFen6Jon2D4J315nF1dbFjQdThq8oN1Le6jaW8w3OZB19K90+I0AtPhJZ3lk/llHRdh6dQOlfSmIvgd7ZvAtulxIILyGPyzGeCWz1qL9oO6MXhrwpaCMmGOXzGYDvxWbPYJZeBo/Es0hknSAEBT8pbPeu40eG3+JPw1s576ILIgfAx0YdCKAMv4u+VfeBY7lSD59qpz71k/C24e48D2Im+aaN2VcjkjNTyv/afw5vNMmX/AE3TQY8N1wBXNfB7VF/sV43bLwz4x6ZNAHo/i6NbvwleunyyoNv06V4b8bsLr+nxKwYJZqM17rrsEknhzVOy4JrwT40osXimCNCTttU60Ad98JFWHwhY7hzJM23jvzXZwkSXMjhTlRtzjrXPfDC1EfhDQ5JPuYMmfzrp7VCH2qQQSTn8aAGsjiHJHGaYuXADDkVfMTmMlvu5zQiDywwHJNAGdBIpm8th+FJIo2yMG+QDp6VZZTG0jun71+F47VF5Q2lSPvUAUos3ECHaBjgZ715t8XrdodJiz8x3jJ9K9PETJdKF4RRwBXFfGCEN4ekdR3DH6igDgPgveGx+ImlyAgFy0eT05Feza/ZwweKntHTZHGwkwOjHrmvn3wU+zxTp3zFcygbh296+mvFtuumNp91KPtLTAL5h7ZoAqyAxny8sYpOQ3901k3lpNFPHPGcT5wQP4q6i18ua3eJl+8OvpWbdwOYHj3fvYvuvQBX0t1l3JKm1h6ir82x9NuLN0z5ikKw/hOOtY0zXFrcwPJhywwdvfityxie8gEkHLjse9AGV4S8zTrk21ydzsCBn+LjipBHLHHOLhdzxuWXv8taOoaTM6JLGpEkXzKw9e4qK1vkuCZQAZNuyRD1U0AQo9vLskDjJHeskW039oNHEcox4I7CtR9MRogVBG9icDtRbWctlOy7i38QPp7UAYXj3TfJSC/bkgeU348V4Jr1qLTVJ41+4WJX6V9Xa7o63mjzxEF1kj3L7EDNfNfjWzERim/jHyOPegDmrR9l1E3owr6P8G3Hn6Pa7WypUD6GvmxTtYH0Ne7fCmYyaSyId0ivux6DFAHo9uz9AMnuKpanahh5uNpB/EVLbGSG7aTcfmwMVeuo/NZQ+MMfzoAyriJptO/c/6xFJ96o+D1M9rMZHzJvIZTW6YXt5Q3UsMY7Vz/hS2Y6tqsikqwkYbPxoA1ljUxFFGXVq2SuNNYMvIAP61iwOVmkUj5t2DWyZGaxaM/d6ZoAwteR9M+IWn3Lbja3ds6j2biume1/tGBYwQJVJ2Sd/pWZqCmfXYYboAvFC3l+w4q5GktrAJ0YjYcsKAKjoYrhZmUiWP5JQO/vVuUKxVozlSM9aoXZuoLyXUIx59rIhZl61Jaz2t5bxzQzGNSOVJ6GgD47r3/4Gox8JvyQrTsB9a8Ar374LakJPD8VqUCMjHB/ve9AHpTRzIDlxtFU1tZ7mQFSWOe/arNxIgYFWJB7VV3XzW9wkbCEycI3cCgDN1TXbOx1Fbewje5uujKoyAa0Yb6WaANLblT3NY2jWp0+7mgeBWu1OTMRnd+Natz9skO1CETq3FAGF8R9bI0mDTrIN9pm4bHXFQfDjThpulXFxMmHGfxNXr3TGkRtYuowGhQqq/wBas6U7DQrbA+aeU4HrzQBkX/hu4vrCZ7khpZD5gHoPSvM9chl0S4W2tJWHmH95HXv+szR6XazBm3ThcKvvivB/EV1He397ccEwRlnb0JH+NAGH4StBq3j23gQ4Bk6+mK9F+P8AqD6hfaT4a0cMyWyb50ToWIGCfpzXFfByKMeILi9uCQsERYN6t6V6LpVnFcX2p+IbniUxsFLdBgECgDrfDOj2b+BD4fvm/wBHvLfIdv8Almxrofg1YTaVEui3UQeC3L+XKPusCeK4LwVqX9qeG4RcuS4kwWU/w16V4Pvpog1rFhoQw2ueo/GgDyb9oOG78K61eXGmkxwX3LY6ZOOK5H4MQxrMVc7/ALUckD+EryK+jPjzodpqvw9vbq6jDNaxGUN34FfO/wABLRpG1S56iMxoB6Ek5oA9t1K2mXw5dofmZ88f7NfPHx0Cr44IXoLaP+VfQ9z9raK4iibny8Aeor5z+OI2/EG6TP3Yox/47QB6t4TUN4L8L20DFWkhUtj6GumtlAkkERyqDmsDwTF5Vh4XhdeUskYV00MIjfKnlmOR+NAEpLuiMV2Kw6UM4EJITaq/zq0wYkCYDj7uKgncEJlfkB5FAFOUO8SHHA5zRJbtKyYOOMn2p86OMupwmeBT1IDNuOcDj3oAq5C3KNjKjg1x/wAUbJ5fDF0wzhFJruWZVlCBMFgCaw/HsYPhu+34O6FuKAPmnw84TXLFj0Eq19eSWh1XwwICM4UMjntxXx3prbNQtie0i/zr7K8IyE6N5ocPHHFuVPXigDAhMtvcQxMMrt2k/QUsh2SM2Mx9DV/V4nuntda0yMmNWKXMHoPXFEsMV1btNZOGjY5K9xQBmw2avKXdsqRlPaizM1tJ5sRIjVvmAq5aNsYhh8g4qTyvLZ8fdbp70AaltqIeBnQBox1z61z1tpqXOq313Y/LIVLPGe9W3PkRKIuEJ+Zas6bA8N7HcRDbg4bH8QoAiBje2jlj45Ib2NRsC54HzZwKsTWjvqd0tvgWYw+P9o8mlwUvYyRlZFyG7CgDZ0f97YzQzDGwY/OvnTxxpu/WNYsXjKyIWmj46rmvobTGIa4Vzywzj6VwHxCsEuNSsNVhjALL9mk469TzQB8xEYJB6ivYvgfeqk+xiMuPLrzPxNZfYtTlUDaGYnHpzWr8P9TOn6mjhsCNw5HtQB9PpbREfKcr3qld2sy27taNumRsoPatrTlju7SGaMYMihsetV7x5Ip/Lgjw2cZoArQS+agaUfdxn61m6NA0Gq39yB8shzWzewCK8VF4RxlqtxxRLE6xryRyaAOY3f8AEylReCTkVrqpaxYvwQePzrLKMPETrgAbcg1uRDeY4SOWagCtMY5vEjCU7bpITjPpxW1EIvJdbkAB0wT+Fc/mG68V6hPIcLbp5eR6kA1qxRS3Ue2Q4RlwPpQBm+Ere6ht7iC6kEsaMQhzn5atXGk2qvxEVzzgVDBp1zoVyGhmae0kPzA8la1LiQSsrK4wVoA+Iq9s+CMaT6TM7sd8LnArxOvbfhBFd6VJfaLqNjPZ6kT5nlXCGNtvqAcEj3pOST5b6geqxkkIoUdetVLy2k+3+bNMQFHyoP51cb/REeWZgsSru/LtWNp1zJeyS3k4OxmKoh9KYGzDEskqFjuc9Wq7tBR12Zxx9aitRGEQjg9T7VNPOlvE8zNgKMgetAHO+PdSew8OyLEhLTOIgv1FWdHhEFraTzjbFZQCRgf7xWs3WZGvreO7nT5EO9YyOpHSqHiWbUdRtrHQ9NG2S7O+4cfwoOcfzoAoa9qlyugXOtyEvJcS7IRnp9PyryfWb+Cz0i5s0VheXZDyEjtnNeiePr2GPXtA0FJBHYQbS+ehbNeWa+8us+KJIYlQEyGJNoxwDQB2fw1mS20sWbQhpL05V/Q5wBXUavdS3Wj3GjWwETy/KW6dKq+FdKWG1hRuDA4ZWHbHatDV/ssl2+0lQn7wsvHI5oAxPC9nrGgqtqi7jHwymvb/AAdd2KeCrjWIpA12hxJFnlTnFeU+F9fi1rXBIxKAfKx9TWr4Ysbt9Z1ZLVmFvIwzGOh5NAHqfi2SW/8Ag9rVzLJuWSydse2K8K/Z+jDeHNecEBvPiFet/FDUG8N/A29gl+WWeL7Mg/3sCvH/ANn7zP7O1SLadk00ZB+nWgD3NoQkkbHrsC/Wvlj40kyfErVVBzhkUf8AfAr6x8oScKckHANfIvxFkF18TNTOcg3Sp+WBQB9C6HbR2Q0dHPKWSAGt1LcShZE6ZJrIhi8zXIwchYLRQF9ea2ITKntu6D0oAdIOPUngVWkwqkEZbqavIpbbxyKp6gjLIm1fqaAK8Bd2IK5Q9KcDGilgM4/nT0yB8vQGgRKMKR15NAETofK81uSTWV4uhWXR72NeW8liPy6VtOoBJByv8I96j1AwTWsqsvLRlT9TQB8fZ8q8z02SZ/I19a+HmZdC0+SzOGnjXnt0r5P1iIw6teRn+GZh+tfV/wAPopW8L6LCxBZlUk0AdDZznRw08qht2A6Doa5bW7dtI8Qi8s3KWN183lnoDXU+LxFFLHpdn817gSOD2Bqvd6a2ueH7m1nAW8tlMkTDvgUAUQiyjzEH3gDU6Wks4J3YQjBHoawvC15cXVsqSDbJCxR1PXjiuqIMas0Z5POKAMcrsvvs118rgfKT0YVtWELKCM5B6VK1nHq+iXELkLexDdFIOv0rI0fUpHtVjuVMc6cMP9qgDPv9TOkamZbkkWrny39s8CtGOWOCNbUsDk+bE3fFN8S2kF3BsdQ6SYZx6Ecis+aO3k1DT7hpCmxBCEJ/GgDp7Vf9KUgdR1qtf6Ot/YajaOuDzLCfRq0bS33wosRyynP4VaidzJKjACZOQPWgD5P+KemvDcpPjB5Vx6EcVxejvtv41J4f5DX0D8WPDouLS/dVJcgP9OOa+dAWilBHDI38qAPq74S619r0KGOc7poMp+Hauw1SN8rcKuUzzXiHwj1OSPU98ZBhnQEr7gV79bTrd2hiUfKwoAypCLtPlG5wMcUy2SRFZXGGHrU8Fi9m+6BssTyDVqeNXcMx2sBQByOpgRa3aOejnB/OtOJsajEyn5EcmqHiAgXFnKoyqyBfzNa01gJJ7cRPslc5Az14oAqNpSnXdXa3bMU5WT6ELitaykDqFI2yKgUr9KwtBvpLnVdZtG3RvbyKuT3ytdBIgnhaRfkuolGP9qgBEDF2RuPY96z76NRNiMELjpWhDdIVDyg5xn8apXt6kcoDqQSM0AfFSsVYMpIIOQR2r2z4Y+NPEfiOOTStcSy8Q2NsoeOPVFJkQ/7E4+dG/wBo7q8Sr1r9n6aNNXv0kBLNGNo/GubE4SjiklWje23dej3XyGpOOx6ZLHZSzxxxalc6XKrYGna+++3c9hHeLnHsJNzH0q3ezPpF1Cms2M2lKxAWSbDW7Z6bZlJQ57AkH2q1qn72Q+Sg+Y7XDDII78VVsILvSy8eiX7WNuQfMtXUS2jg9QYW4H/ANpPrXJ9XxeG/gT54/wAs9/lJa/8AgSl6lXi91Ysx3sfnzH70Z+6R0qGxvYNZuJYgxzbvsZCCORxn3HB5HofQ1jxXOkzNMj2l14elBObvSozc2D+7Wx+aMe0fpy1elaf4Ekl8G6YFurZdetRLJBexK3lypJK0gRwfmKEMMjqp5B9eHG8RUcByLFQlBydndbKz1TV00na9nfXboVGi5X5Wc1qkUcGnySMo+QZAqPw2yeS11MgEhTKtiq/iDUymjXkM0LQagkn2ea2c5aFsfqD1DDgggjrUupv9g0GRosAxWoY57EivoITjOKnF3TMtjxL4mGW/1T7cyGOG26OB97BrN+EejHXPFhZycQoZGPuaj8VatK3hy1tWcM0r72PfFesfAzw//ZfhV9Qni2XV8dykjkIOlUA3TTBpV7qGn3coSQncm7jIqrrkAlsJBagC6uRtjHrjrXX3vhG08RXCSysyTxPv8xTjcB2riY1dJtVugWnnsZAsEK+xwaAK/g+C30fwzqU94gS+iYjY3BzjrXsPwHhh1DwnLqkihrmWUqT9CRXjM5PiZpdp8m4uU2unTDV6b+yreyf8I1q2jXQ/eWNxu59CT/UUAYH7XushLbRNBgbLuTcOo9BwP1P6VtfCvw3/AGD4Qs4pFAu5FEj56gtzXnni+ZfGP7R/kT/Na2U6xbTyCsfP8zXvUcIW4WVuEAICjsKAHqvlBDn7vJ/Kvju9P9ofE6TjIk1Ice2//wCtX13dzKltMFbkoWU18nfDKD+0PidYlxu/fySn6gE/zoA+h4J/M8SXw2FUVAgbt1rWKkXAZ2yqjArB0sXT63qAnUeSJSVx3rooDiU7hkEdDQBMhJXP4iq9w5eUDjAHNWVbyxsPVv0qreIGRdvyyZx9aAI7eHDs0bAheSKYyMGfceX7+1S28DAP823inxIDuLnKKDz60AV4owNqlsgc/jRNGh3AjqOTSSAxuo2nDcirG4G3YEZPr70AfJXju3W28V6iifdMpb86+ivhzqySadp0cB3PDACfqK8P+MGmPYeKWlf/AJeBu/z+den/ALP8ou9Avi+C8ZCA9wMUAeleKGa41Kz1u0XNyi+XKo7qBVPW/EUXh7RYdZuQ2HkESRjq2avxAREImSXOOaxviVpS/wBnWdtKnnO8g8pOyn1oAbdMAy3kMfkG4USlenXmta2uD5IWTOSMhqqWy+Zpi216we9RAqgVLZ289rshn+eLGc+lAF9m+xvBLG/+s4Ipx09LySZ48C5DbsetTfZBPDsxypyp9KytK1eNfEbRvw8B5HrQA293Rl0uFxKOorkvF9jc3OnJc6ex861bzAB/EBXcX8iXfiC5D4BdAVX2xXI6/JcaJMJ4/ntiOR6UAdP8NfEMOs2fmxnbNGVSRD69DXVXUJk8Qp5XGY/mHvmvDYNXj07VrW/0NSttvDXCr0JJ/wD117DZamL3Ube8gkBW4QECgDM1y0Nza3COmShIbjqDXyZ480z+y/Ed1Ei4iZiy19pTAPPMVUFG4NfPfx/8Mi1uVvoxgMMgCgDh/AuqvaSWjRsQ0UoUj2Y19RaHeLbyxQzn76+YpHcGvj3wxOI78ox4ccc9D2r6V+G2p/2tooim+e6swArdyKAPRhC0lw0uSFOMVU1C8tvtAic7SeKuW8zmFSB1HSsjxHozX8Qlt2KXCDI9zQBleJvJhsoJQwKiVQfzq9c3CjyLheZI1GwD6V5n4svbu0k0+0mdgvmguD3wa9K063N3JGRxBFEJJGPYUAS2cSSXbXgCky/6zHr2rXkiEkkYALFuAorDksIrzw3qGpeHLv55lYxoTkbgMfzFZfhvxTq+naVbRS2DXOsnK9PlGB1oA6O9li025W31ILAzD5N3G6o/3Uqq0qBj0B9s8VmwQ3Piu3SfxEoW7R+FTjZWhLaLblYixbaODntQB8RV6n8BnaPVtQZUDARDc390ZryyvS/gdceXrl7CDzLCAB680Aey6lLcXGnTSQDY0Z3Z9QOtVnE2r6WqDdApUEnuatXsE0lsSsoRRyygdu9N1a8TTtIgaBd80/yIg7D1oAjtLO9WexlsZbBRBk+Rd2rzI7didsidPQ5FbWoePPGVmVUzaDJIxwFTTJufx+0VDpzbtPZpcRoq5Zz2HesiyvGv9XWSAZ06PKrIw5Zh1rz8XlWDxslPE01JruXGpKOiYeL21vXZdPvdWn0aK8hkVSbWwkR3jznYxM5BHORxkHpjJzU+Kl28Hg658o7JJERT24FWvEF7D/amnRQybpDIu/P1rhfj1q37q3skfDHlgO9dOGw1LC01Soq0V0JbcndnmPh6zOv+I9OsXY+UzhW9lzk19TPqVvYva2MMeYfL8pQo+4FGK8I+BNvCNfu76aPe8EJWEH++a9AW/udEe+1W7VWmZuIG7AntW4j0NruHR9DOohsxxvtMffH0rz2eCVPGS6loe0pcLvlQ9BkZ5rJuvE6Xlrfy3EpSeSIlLYn5R71z2geIJysjrKRxhsdcCgD07RND03VfFMrXBNrck+YgHAZ/avQ/DXgyTwjrtxqVid0V6h+0J2BA4P61T+H1tpWo6DpmryYd4yBu75969HS4W+guBCeNuB+IoA+R/h4Vu/j7rTzHOZbk5/4GBX0DzL8inAGRk+lfPXgWMWn7QOqQE8efcKf++s19BzBpmESHaBnLUAY/jq4GleEr64Q5ZYTtPvivnX4CQNN4+WXGfLgkbPuRivZ/jPM1n4A1BtxO5BGM9skV5h+zraF9U1W5zgJEqZ+uaAPZdJL/AGq4J+9uJyauZLhsn5sjFZ+lTB3nVeQHIzWkEVW3joSKAJZW34UDkDBNRuX805GQKeJFjaULyGH5Uk/7sEg5LjH0oAYFMs3yHtz70iSbFdMHrgU+NlSLjhgKeeGaQgbccUARruIJmOdvIFPkZVYgDIx+VRQtgtu5DetT5VQdoz3oA8H+P9ofOsLof7SkemcVc/ZsnzfajbF8KybsVu/GvTzf+HJJQv72Jtwx6CvP/gVfra+KGhY4LruHvjqKAPpGeKSWNDCv+rbORVTxDqcV5LYQQ4klQhpH/ugVa8W3kmiaTHJAp/0zCqfSsnR7COCMgHe7DLsTQA/RrXzLu5vSSSTtB9ga2XCl1XPzHkCk04xwxOiD5W6D3o1LT7hvDuoXVuw+2opECj1xxQAtndAzbHcIoOM5rh9UhuLD4iuCQbSePcXHbmvIJPG+v6F4kb+2FlKg/PE3H4iuo0bXZfEfipYLS8LxXqfKGPMft+lAHpHia5+za7p8qNhXVl3DvxUcMceoGeG7OYXypz2rg/iDrDf2hp9vaszG1fyn+uQK9d8O6CZtLLE7m2bmb0oA8c1OP/hD9UmgmXztPmyVBrrbbU4JNCsrnRJs3SYJhByQPpWb8RvJmmjsHiLgthJ+2e4rgLc6h4D8YQ3b/vrOUYdT0ANAH0l4U1CXUNPWSeIxMeCG9a5r40aK+peGXkjUvLBlsD0xWn4F8S22s2ZeAKwHJC9q3tRMc1vLE37yKcbT7UAfDTq1nfYHBRq9w+DWtLBrIjZsRzjBGe9eZfEvRm0XxTdQfwZyv0PNX/B1xJbSWs8RwwIwfQ0AfYFjHhflwcDIqvNdKLpFBALHFZWmasbzRbe8jfYQmJBWdD9qnuDcnO1DlB6igDD+MuiC+s7G+tV2yxyANj0z1rVu76Sw+Gs98SVJjETN69BUviOKSWzuFlf928ZYD0IFYVldt4l0FNCijJtVTErehA/+tQB0nhCyt08PW0VtJuhCcOp4Oea2oYfsCllAcKM7u/Ncf8OdVtIdFisk3RzQExtHJ1PPUZrsRKjRLdRHOxiGQ9CKAKNzayrdSX1o+PlLNH/erJvLi8u5FlhG1So49DXSRv58JZBhc/LVKeFYnwOM84FAHw/XffBm7S08WAvGXEieXnH3c964Gu8+DN4lr4xjSRFdZkKc9uRzQB9AXCxNbSKpOWGM1nW1ovkozHe0PAJ7VNqcj3NnNBa/Ln+KmaA4SzEU3JGQSe/vQAavaS6heWdnDKY7Qr+/Ufxe1bdtp9rb26QRIFijOFUVj6bczS6tOxjI8s7Y/wDarWmv4reZkU77wrnyx/DmgDhPGqW9r4qsZI28vy/mcevNeS/E/UjqOulznjoD6V6d8V4/Kh0qSU4vA2WI7jNeNeLbj7Tq7PgD5R0oA7b4cW2o2+hfbLKFjCbgNJIB0xXpXjvRjqI0+9RznaN4XvxxUnwB0q4i8CvNIFks59zMpHSux0TQZzbTo/7xGZjHn+EUAfP2vaTL/aU8j8PnamOhWpLbSBYTQADEkgzs9fWvRZ/C9zD4jmlu0Y2yAlVNZfiC0vLvXbV7SzYuBtXA4xQB6R8JreFfDt5YRsPNlcsiA/c4FetWNotnZCMfeC/MfU4rgvhT4Tk0mI39yzebKOVPY1V+PPxEPgrQYrXT8PrF+SkC9do7t+tAHhHiBZfCPx8S7useVe3AkDdgrnH6Gvoa3UmMMD97ke+a8fXwdL4i8PwDxDMzeIMefHKTyh/u16n4Mkkv9Is47g4uIiI39flOM/pQBwX7Q1wY/Ac0LLtPnoB7jIrmP2e7Jo/D9/dbf9dLgH6Cj9o7WRfJLaRPhLa68kr6kDOa6L4PxxWvw7iCkIRC8zsfUgmgDf0CEwtdl+rSGtPDxI7yfc/lWR4HvBe6NGTkuzkljW3I4fzQRlD296AEgKSQhsHP9KaWBnG8cVFBI6rgAYHH4Vb3E2+0oN56H2oAjOTMwI6j9KRGWSNgSQI/1ptuWNwyyHCgYBqw8KiMSEdOAPWgCKH/AEjaicMvOPUVOV81z5I+YDBqWOILEzrhZQMj6UsDgqqrgbRkn1NAHOeMtPFxo9zbsOTGcfWvmfww76J42tlY4Mc/lt9K+rtWJeBlZdz/ANK+Z/ivosuieJVuen2j96pHqDQB9N317HqHh+1stTA8zdujPoO1c3b3l5F4taz8opZlfvkdah+E2vWfijw2guSHu7cBXBPIrrNfEd9ZJJCoS4tmByO6jrQA+xjMzTp90JyretXrZGWBpUkLFfvDtmqeHtrcSx8wSquT6HvXUaFFbjSbp5kAUKWyfpQB5T4z8N6R42hu4NRUWd5ZJ5guQMZBBx/Kvm21i1DQtVhubXzEAf8AdTAYDDPWvY/iLrOoLqMmnouxL9wqlepUGuwsfClne6Pa6ff26iOGMKjY5z60Acr4CWy1/UY1vowLz777v4j617NPeJpPhjUiWETlGRM9+K8Zt9Mm8P8AiiUhGaKFfldR144rZbVrnxI0cd6GRInyQOAwoAlspILjwlAl9Hv8iUvvPXls1zfxA0m31GBZYpgqyDDD0rpbvY+lagkWAsYAA7VyGoWtwmlW9xkyQsv7zHagDE+FOr33hTxTLAAZbNhtcH0PevorSpYGsWw4kSb94pB6Zr5Yu7ya1uhdW7cqdpHqDXqXwi8Srca9BZXcp8llzGGPQ+lAGB+0VoflXVrqMSlklBBb3FeaeF5CbOdVb54T5gHtX098aNCGoeDr2ONPmgxKnHpzXyz4TmW11yNLkYSX922aAPcPBOrXF/p9vYxD90XBc+wNex3VlJcaU9vYqBdomUPrXz34Iu5tP1f7OCEKtznpg819B+H9QeS2Eqn94vCn1FAGLbSW+txmB1KzQ/u5h70ywtYtFS5W0jVEHJPrWy1lHZzSNEqrNMd5I7mo9Vt3utN1GNQPNe2wmOzetAGH4vgsJvDVjqVtEkWqxSKWKfxLnnNbVhEt3pzSRHAljGPr3rD+F+mC88E2lvqknmXMqSKzMc4+Y4/SofDF/caNLc6TfZaOGdhDJ/eXNAGzo0dzbW/lTNl1PSn3UsnmDK9qfdXitGkNmQZnIy57Cs7UUu45wseWG0ZOOpoA+LK6L4fz/Z/F2nMehk2ketc7VvS7trDUba7TloZA4H0NAH1pCi7QSuBjpWJ4lSSB7eHTj/pFy3Udh1qza3t3fWFpcGMRiZAxxUiTwz6osKr+8txuYnqM8cUAU5dWm0t90kJK42Iw/v8AatjQtO+zZvLkeZdT/MznsDVbWrUx6PcXLhXEbeYVPoKu2OoHUbCGSA7YjGpA9aAPO/jDcmTUorUrgqhkVvWvD79mub84HzMQo+tex/Etzq3iWBk+TyYiu315rya9tyurxxrwxk/rQB9ZfCu3XTPA1nab9uVG9frXRXXiKz0aSNZJERT0BNcXou7TdCsw7lmEYJNcBr0tzrOoyKXOASF56CgDsPiJ8VbGF3i0mFbq7IxkdBWx8GPGmma3LDYalGkeruSQpHUe1eLahokGk6ZdTrJm7X5gW54rk/CfiebTPFlhqR+Vo5ByPQ9aAP0GVQoCqAAOwr5d8c2k3ir9pGOzmBktdPjVtp5AAXd/PH5V9J6JfLqGkW15uBEqBiRXm6eHPs3xbbXUIK3ShJOOgHFAFPxxZf8ACL6JP4lvpcQqQfLHUZ6Cub8CeNYJ9YhnRGEFzE7ewIHBrd/ahi1DU/BcenaXE0iLMtxPt7qoOB+ua8t+H+vaba+FrO1mjC3UQZGY9eaAOd+LZSSxkuHbdPPqcj59V210HgNtV1Dwxa2UYaG1Cqrt0LCsr4qJaX+naZbaURJIspZ8e4xXfeF5U0+OGGUgERIAgGP4RmgDstGsorG1iht0CIqAfWpgkiSOq/dPIpV3MiGIfKF3D3pXL5/2mB49KAIUUN+8dsIvH405pGkOxD93oaRYgsKrnJY/MKcIWi24HUjmgBEjHmbZjgjk/WrNsGmg54Of0qB1Kys7DJ6VqqyBAduDjpQBXkdAmGyAOh9ahii2x7Uydx3A1ZuNskQBXBxUSMRbLEBjacg0AMnwHZ3GMqFA+leN/GbQ7nUbH7QilhaZwfavYrhv3iGYblxxj1rM1WCO5064hKhg6kcigD5n+Geu3ei+IkFq5H2j5GTsx7V7P4U8X3TazdWWoW7MXyGUD7n1rwbVba40DxLMrxtHPFJviH48V7z8MNVs9S0wXMnlNrcnM4bA3fT9KAOstvF2nXenTWAyk8T9/rXYyalBN4Ve2hkAuHGPrxXlvig2+n6deb7ZY7u5+64H3cc1gaH4wijsYFvXYTQHAOfvUAdD4r0R7nxdokhG5Ix83scV1Os3EljJbSAEqCASOgFc/a+JLeXxFbyXTL5cigL+Vd5qlrb6roV5bWxUzNCzIfQ0Acro8n9pyT3aqHhLbcGt690qzS0Tyowkr9MDrXO/DeLzNGNk7FZY5HV298mup1gNbw2lkDuuVwwf2oA43xLp5stEn+y/Mrffx1964vwlrlrIl1pdzyDnBPT6V6Vq1yllCxlUyGQYZeorxK6ENt4nMUCbY3kyD7UAVPGWizaFqS8E2sp3I3Y+tOtZo9CntbuM8TEMrD+A16brmi/234ZOnSsGuYRugk9e5FeZ2Vg2myNbauheMHgHsaAPpm3vYfEvhOEjBneEqw9eK+OvGdg2ma3dwY2vDMQPzr3z4La8kmqTadI+1o1JRSeorhvjdoYi1+e8C4W5Y/40AZsDyS2VpfqfmePY5HXPQV7Z8PtTWbTbdS+6WIBWHqK8Q8FFp/D0kbfNLA4Up6g133gW5bT7gyODuR/mU/3e1AHr2oyDyIZOrA4zUsTi31a2eX/UTIUbP0NQFTcWk6xezr+VLbuL3Tfm5ljGMUAc3p1tdaD4ae1DFp1vF8t/WMsSf51umxgkiDOoLA7yT6mqckpkgv4MbmiG9M+oFXIHafRYw3yyuozQA3wnZ2lzqFwtyQIlbJVjjmuE8Z654s0/xLfWumaeJbCOQiCTBO5OxrvL9FF7BdwjYDGVkUdGNJeBpHRi4HyjAx0FAHwzT4mCSKzLuAOSPWmUUAfQfwj1e+1Hw6z3rFxFIEi+npW9eWN3Dqbaop2qv+sUfxLXO/A/ULWXwlJaFf8ASIZsn3BJIrsdf1RrZIYzHuinfYaAJgWvLK5Vs7ZoyFz9MU/wlZNDYojkeZGxG30FLLOUs38tMCIdPXis2e8ltrGS6tsqzKCc9qAOE8fXET/ESBLUfKq7JQO5zXCapZrb+K1aUYQuSoNehaDbQ6h4olu5xudkYrn+9Wb8SdCFvLDeu2HJ6Dt70Aehw6gqeDbG6nb99C6xyJ6iufMaLcyyrwHO8H0Bq3plvbT+E9Mm1ObyhIBg54Y5qlqLsIPLgAkjU8MO4oAr+I9JN3YTjPDj5Grw7UrX7HePDnO2vb11Ce4YW9wMIp3YrznxxpHkhr1UIy2M9sUAfW/wD1L+0/htphkfe6R7Dn24rtZdMQXAlRc45xXzV+y747tNLFzoeqTiNXbdCzHjnqK+o2niFuZ96+SF37s8Y9aAOf8AE88drpF1dXcS+XFEcgjrXxrZwgf2hJP+5knkZoF6YGTX1fr/AIw8P634YvHtLyKeOMlXUHngV8oRGTXL7VLgIcq4WJF7DOKAN3wNYLdXkEEmXYNukfqBXZXbGXXbaWzjLW0OUdh0NVtHhi0nQQI1CziPLP3JqTwleF7eW2cjJfcvvQB3umX63A2KwXacFa0nj80xlD8w71zENr5d2LiMFWVf3i+tdBbTLJ86fLntQA9EYyMSMbTTxIdgB+8DxQFdG3Mc7u1DBWkLKfagBY0VpCGOQ3860AFwAxGVFUAuxh3HXNWw0SKGJy56igBs6/OMenFVowUjKE5c9atSBt2R6ZqtFl23MPxoAROblFZcgDgVUulDRyrGMZBA+tXJsvKhjO0jjNVLtSsiqQcq2cigDxf4z+Gbi7ls9UshmRV8uRR1yO9eYafJqWiXYuFeSHy2zuB6mvo/xXGs2m3COSshbOfQZryPxe1mZI4H2mJjgkcZ96AOobxI3iXRI47jlzH/AKz3Ary7WJZ7ZIogSSX5NdPaX9lZ7rW2YFdgCgeuKzrixd5YS6+YHOc+lAHRfYXGkW99Fch3CqCmeQa73wN4kurN3a6clRDtya8ou520/WYo95ERUZQnjpXV21415p5MCbFb5c0AeieCtSto98QcB3naV+fVs139z5F/M7xMMheD6V82w3Ethq4WGQ5YcsD7V6Z4c8WQhI7e4cxuq4LE9aAO4nsI5tOmdwHdAcGvD9Ss421uORh+838CvTdG8X20888MjgJnb9a4Hx1PBbeIYZrVl8pOcepoA6ixeWC4WEncyruT3HeuS+Ij28t1DIBsMgw2ezVvWSzXUtrfo+GyFK+grn/i7pGr38AitLQ+Uh3hwPvUAcNofiJNJ8caddJJtjD+XKR6E4r2L4r2UeoaG00ZDqP3sbDng18yrbPFdBJwVcNgjvmvoDQNTm1X4fzLIpYWa+Wx7kACgDkPBZNhq5DKCkyHHpkCvRnhSO/tbpsLHLGI3HYkc150gkEEckH/ACyfGR6E16baQ/b/AAksgBL27byfbpQB0WmapJDp0MTNmVuM+1aeou2lafBqcf8Ax7E/vW7CsDQgsyEbdwQjb9O9bMEh1DSdV0ac7reVNyeoJNAD45o5NREsRGyeInjvWjYDdZqAPuMR9KxFsVtdEtplcj7MhUN61saW5GnRFusnz4+tAD5YkvdOmw3KngjqDVB2LKgbBKqFz61KwfT9dRQf9FuELFT61V1O3eO6IjPyMNw/GgD4mooooA9Y+Bl0EfULZFzNIVK+w716jrtvN9gS4fGIHyc9DXifwZ1CKx8Xos5wsyFAfftXtfiMXV9cRWEeVsz8zN/SgC+7Frd584G3OPfHSqXj2C4uPASz6au2WI77kL12VO0y3mmBIFwrfKx9D0ro/B8DHTNSsZoxMskO1y3TABoA8d+HEqX8lxMgyQNw9q6XxHZrr+iTXKx5MClTx6VzXwqES3WpmzIKxyGIj616Nocq3On6jAI9nl7twx1zmgDyeyuRqvgF47uby/7KlGATgsOTioLe7v5VifSkeWErnbjPbmqHiewe0js4ZFaCO5nDE9nGcV6d4Ys1s/KNki+WI8DPOTjmgDkNOil1q3uXt5Atz90qTjaawdX0nXyslpeQtJaqpLOBx0rs7XwrcxXmpTxTCMzS7timu302zeZIolHmxhcSgjrxQB8vW+l3hEstvkNFzwcMfpXuPwl+I2o3ngbxDomrSPL5Vq32ecnlcqflJ/KneLn0DR7O7ae18m4RiImUHDGtHwV4TW48Iz6lZRgQ3A3MAO3egDwbwldXKai1rFM0YuVKMCepr1zwnov9nSSS26bmMbbmI4zivOfiH4ck8Oatb3lqrC0uQJI3HZ85K17b4GvYNQ8G204A5GHPcmgDiYryYu0Mp3Y4K+tdbp8NuJ7eO3TbIi7s1xqqF8eS2x+WFydv516TpdssQDzY3LxkUAb9tmRULYD4zj1plxBKs6mI4XOWxUcDB3GCdw+79KnyyPgsSDyaAJGmnWYd1AyT7UK0gfCpjdzUaq7HcG69qsK/mHDcP2+lAD1ZmXMzbVJxUpKbVkT5ucZqGXaUjAO4jqKIZQzGNBti96ALYkIJjXnPJNK20o2089xUQVLeVcNuzSvGUYSKeDyaAIGLGRFIwAc59aLth5THcARyc0x2Y3IE2Ah5yO1Z+p3Nlbwh55CAzgdetAGJ4nmj+xSo43Fl5A6188eI7eaS6BDHZngele0+JL37PqMk9qRIjx7dp6LxXDW0Fg9uGuG3yB8sDQB5zb+ZBMsu4lwcV2ml3UnlSwy8R43knqKl1bSrTzDcIuxQM4rnodVb7Xwu4A8r6igCTxQJZZ4rqAlh0GPaun0fWANLWKQhDEucetchrN8YZF8nAD8lD2qhdNLHtl80lJemO1AHYWN99s1JW5VATip/EGpDKlGC+X1x3rK01x/Y8k5wJEwB75rOv2QWrTSMTnt6mgDR0zXJRc7FkOD1Oa2b+X7ats0sp3hvXrXFaSI3czdNh5X1rc1F5YbWOZR8wOVHpQB6f4V1fDCG5O0KAAT+leo6peJd+Foc4EkJxu9RivBNDjluvJnOQjYMn4V7HpKre2s+mq2Uktxg+lAHhnxP0NNOv5LuLCkkMAK3/hNfySm502UgxXdvnHvV34kafK3hOB5R5jrIUL/QkCuW0AnSRZXSMUwdrGgDd0+MwvNbfxbyCPxr0zwekkWnXMEi5jKYxXAW8sNzqVzcRjnII/KvU9GKWs9quNyywgvQBX8OEW0CSkfNC+xv90n/AAq/rELabqi3kJ/0R08zj37VSt2Eet3Nnj9xcoXQ+44rb1WJrvw/FDj5lOwZ9qAINQuPO8LTlE4k+YD0rU0gCTSLZz12BR+ArJtP32hPGcbk+Q1N4cuz/Zxi2ndExGDQBpalCJ4rcvwykYPtVTUgxnXb02gVbuGYyrGw+cDOKcWRAobrigD4OooooAsafdPZX1vcx/fhcOPwNfT+h679t0OC6aHdPcoCMDgZr5Yr274La60+jTadN8xt2yGPZD0FAHf6cj6fbXHnurIcuAKNB1nU7m5a2t2W3imBWRm4O0+lV73TFihuZopHbJGATwKWTSzqc9m6zGCSFQV28b6AON06wXwb421DSbZi6TKZIye5xxXoqPPptl9ujg86GVds20cg4rj/AIhxLpviLSNZmyxiIiuMduc/yrr9E1CVTPGjCS1nUSopHY80AY/jzSLTXfBdlZpt+2ROJYyPvKOcj9a2NJ077LpdkkLb3WEKfrjmq9/pToqazaEsG/dvFngZrS8IT+ZaTPJzKCRtPbmgCLStIkhnWa9kP708A1v27Q6cztHtHHPvVaabeoa4XAhOI8dzVCXS5pS0ssrZfnFAHHfGHT4Na8OAWqgzxzeYWA5xivTPhz5OifCCS4uCBAkDHn6Y/may7zw/FLodyjAq5jPJqX4kQjSvhRp2jxNjzSinb1IB3UAfPPjHU9Q1TR1tb7CQKPOiBq38GfEXkPNpFy/7pzujyehrX+KmnW8+h6YYMpPGgjwO4xXj1hdzaZfxXEWVlibOP6UAexapYyL40TzX25+ZG9favQrCbzEQOvzMMH8K4q51nSfE/h0anp7+XqVsgLwE/MD7eorR0DUZryytpQ4+XKsPegDvrSZIkO1QSDtzVlF8wZPAPQ1lRyqloEYjfnJxU0V4AyQOwUjleetAGg0Txkn0FQ5eR1dQQF4JqdbgdZTg9veluZEA8s4UNyMd6AF8vYUKnLHlqsRwbotxGGPGapvMoeIZ/e4wPetCKYFFjHIBoAjMSQHfLJl1/hNOgiM6MrEjnNN1WKMWUzkEyr82faue1vxUg02G90+SPygwQoTg0AackZF3OskoaJFyBmuE8Y6havDDDHIonSZSUzyBVq78XWsl3cRqwDGJWVweC3pXm/iS3a+u7jVFmxLcqcoD909KALfi/VMeY1l8qqi5/wBo157daud25FIPcVuXSzSx28cjchcN+HSqj20S2k0ciKLiQ9/SgDIutcnnTYzHbj1qlFMy3KSxjBPQVBNA0M5jccirkUiJEsSrmZuPpQAusnzPKkP3iDmobQiaIWzn7zjafStHV7Ly7eMzOBLjIWsRGMbhl4ZTkUAdfbwSLaRwOCqg4Y1eufClzPol1dsD5cTfugP46m8N3Mer21zE458scY5BArr/AITXcl1q7aNeAzROMLnonvQB5bpujXUd029GjwM7SK6/QvC2peJ5Yo41ZIFPzORxXr8fgSKbVLm9vSGtwwVFHHtXc2dnYaZaRW9tEqIFxkDvQBwzeGbdNPtbK0ADIMO47mnaO4s/E0VucgqvlmuyECWrHC5DAkVzVxpiPqLOJQl1IPlagDK8YaQ1/pF1aWR3rA4kZRz3JrzhbBtQ0mdSm1YWycV6r4N1AQ3mpaTqC7blh98/xcVVsdFfTrm9heMSRSAsBigDk9NsUl0zNkR5q4z713ugxvcQ28jZACBD9a870OU2GqSxzEiKZiEUc4PpXqeiyLFpypwspbhM8j3oATVbcW1zbTnIaE7W+hNdVawi5idv+WKReb+YrL1wLLYysi7m28/XFUdG1V49Ljac+WD+7bdxnHagDjfh3r9xqd1rVjco0eJTJBuHJAzXbaU7wXoWZMJKoGfesb4h2yabd6Rr2mRBI7dxFcog6qxySa2NQkBa0uY2zbyASLj3oA2ZGMGpBZcb3Q7Se9Q3cW+QHdjjkUayDM1pdD/lngfhS38qiVCnQoDQB8JUUUUAFd78Gp7j/hMIbO2QubobSvrjmuCrpfhxrw8M+N9I1Zv9XbzjzP8AcPB/Q0AfTNxLbTQX1qrItwg+aPuOKdpSRm0tZGXMiDAx9K8/8d30OlfGOO+tJt2n3xRjj7pBABNdpFqaWGrT6bCPNR1E8Unb5j0oAh8Q2MGrXE2m3C5MyGYE+o4qn4Ynint0SBv3lqxhcdwBxUtszz+PpjcS7dsB8tfyqGxt4tM1mcou1ZXLNz1JNAHaaJGt7pt9aow8wNuC59qw9Nhl0/UbtX+420fjWj4ZItvEcSuSElbB+lWde0+eHxTcwsv+jbPNB9uTQAvnwyXaxHBKLuNX4sOC56eleeaDeyarrbXEblLWd/KU+orfbxCunS3FpqamJ4ztjbs4NAHRtOb0x2w4TdyfU15g2v6hqfjm60XVV3Q2x+Qt0Udq9C0GVcMzfdc7lPtXAfFNNnizSrSzUQveHEkw6sOKAM/XLYap4yhssjyAB5fox9K8z+K3h1tF1lZliKRTjpjoRX0zq/hS0h0TRmtT+/s7hWkl7lQOc1j/AB38LR61pptoEUXccQliOMbsDJoA+TtOvZ9PuVntnKuOD6Eehrvfhz4vis9Skh1EYinPHoDXnUiNG7I6lWU4IPY0gJByODQB9U25juFE8bZ3jbweDUT2jyzGWWQjHyqR2ryDwR49lsVhs9QO6JThXNelHVFu4VSCUNGxDjB/GgDXl1Y2d0kNwrPGgGWHartvI15qDSpOpt414UmqluEeBslZHZcsCeTWLLardosqzvazE/dHQ80Adcms2aXYiuiBgZD+ntWkdTtQrzeYqxKp+ftXjGoXbaHJMt8TNvY7R6VymseMpjAI7Vm+zSn94me9AHvd74801UNpuBdl5PrXj/iEQ6zpzx6PcMl3HJ80QPBHPNZis2s6KJ7cFZ0yM55CgVn+HNctNNthDFGZL15QGc+negBNSiudIgtobuY7yN2c81Sn8QmQCKMnGeTS+O9UXUdRUgYdFAIHQVy9AHQpq4W8iZ23AHk1S1m/N5fyTxOQCeAOMVl0o4NAEjSO7hmYlumTVrTIZJbxAASxPBqO2RZpcP8AKMcVv6fqsGj27bIlmuWXAJ/hoAxL+d7m7JckCP5STVI8McHPPWtRbSa+ZmYBHc5VR3qK4sZbCUJMuXYYwP4aAOj+HLmTX1t4xtnkQkZ6NgZrqfh/qzWnjW8uVUReVuEiHvz0FYfhu2jsLnTb1yRCjH96PU9q6XxjpMGmazpOrQtsiu5llkI6SHuKAPebGeW4sY3KFEm+bae1Tx488gnKjtTgHntLcDCq8YPH8PFZskE8MokR9wzjAoA0dTulS1DcKScD2FcxfxtG4vZSdqn91j1rpbewa7juJ7rmKFdzD04zXl9/4kkiu5WuCDaGTECf7PY0AdN4t0uW+0iPWNPG26h+Z9vUitLw5qUOqaNHeO4Vgm2TPrWr4QuIbtWjiIa2lTBX6iuQsdPjtPGGsaRcsY0CefBGOAwJoA4y+dbZNS1HaD9mlBiDd+/FXvhvd6j4n1czzO0Yxn2ArlNch1DW9fmgkb7Pp9rJmRfVR1r2Pw39ltntF0+IJZyQrtZetAHStAslpLGjHcRx7kVzPiq0j1vwbHplo/k3yz5LjjBBH+FdVE4jsXuiuApwvvXJWETy6lf3CtmOTnb/AHDmgDrNFt4tThbSr8BjLAVbI74xmuF0vUWh/tbw9dg/bNNnZI8/xRhsKR+FdPod+48QRxD/AF4jLD6Csr4sWIkutP8AEGlAK/meTdMnfHr+NAG3qN19m0m1mf8A1ZIUk+9Vb+6SOVAGyCgI5pmszGfwP9ldcuxCow9fWsm/0e4xahpTkQIDmgD5BooooAKKKKAPa/h9psHjTQrMXU3+lacdh55K5yK9O0/S4hetGMHYgUMeoxXinwIlY+Ibq2STa8kJZR64r2W51E6ZexmZT83yu3agChrkCQeINOu1JEmPLP8AtZNZeu6dq9lcSarI5ex3ZZf7grofFqCDSrPUEAkWCZTIRzhe5roovs+pWDJuWS2uIgfY5FAHK2WsR3CWV3buCQwVjXeeLtRD+E7rU4MGcRCMH26f1ryC/wBPg0uW6srVmCRN5iH+lekeG5YPEPg64sHba2zGfcUAc14Ygii0bT4YV+aMbs++TVzx9ppv9E3zkKVIxJ3HNL4TsZLWF4ZzmQHaB6VY8T+KNK0GKKHXSHTOXhHLEdjigCzoVnPp/h60ZXNwigDf3IqG68Pp4g1eK6lY/aIVJiHoQK4vwv4u1jWfFWpvpcDp4ZbcbYMv3emP616Vpl1GbsSwnLYGSD3HWgBPBGtDUPt9hd8zW8hhljPqO9dHq8Nt4iSG1STyb+2BCse4PavK/H0s2g+NNM1jSiI01EiK5TtknrXcyzfIsqkieNQxZe/FAHzJ8YPB154c8RXUs8REcrlgwHymvPK+6LoaV4r8OSf2zHFMqDEu7rivGvGfwYhuY0m8Ilfsz5bLnp7CgD58rc0PxJeaVINrmSP+6TSeIfDGqaDcSRX9q6qhxvA+U1iUAeuaP48sbi4Rpmkt5gMDJ4zWvDr0csahJI5GLZDZ6c14ZT45ZI/9W7L9DigD1LxTq9vJ5z3m0yqMIK8yvZVlnZoxhPSopJHkbMjsx9Sc0ygDUstbvLK3aG3cIrLtJ9qpQzmJW2j94TkN6VBRQA53Z2LOSWPUmm0UUAFOUbmAptFAFxHjBVScbQahimMcpcDP1pkZVWywyB2pHILEjvQBs6fqe2aN24ZTgH0zXRyaaza5BBKwle5AIPsa5PRrM3Nwu5SVPGP611+kiSG6JvSd1ouY5T6DtQB6d4c8MWMUNzpt+u+zRN5fsrEZrB8L6Bf+LfF9jZzSmTQdKcOpPRsHpXffD2/sV8H30t5+8tplYNK3rjpVT4P2U1ja3zuTC0xMkO7ulAHqM8HkWS7CNp+UD0A4qOzsnmR0gGWXksegqhFq0Ec0MeoMd7ZOB0AFNk1q71y5aw0dGtLJW2vMRguPagBdb1mOC1l0jTpALuVSXdujY7V53rGlaffaBLcx4/tO2XbLb55XHfFW/jSHdrG209Ht5LZgwnX+I+9R6Or+JpYbmGJre/t4xHdtj5ZlFAHP/CnxS1rdNpd1IVufMyue4z0r0T4i2rm5sNfswBfQAByP4k9P1rxbx3o7+Gdbh1SwLFd2VPv3r2Hw5qqeK/BQuP8Alqq4lX04oA4/xhpnkWralbvuFwAzgfrWv4H1BpNJgnX/AFKN5ar6EVH4aj/tPQLqylcM8LlQCe3NVvBdrPouoXVjqA/0S4YtCfRqAPQBeO0Bh+9FkE+1UtE06b+z7+e3JJeY/lurPv2ltPC13cQOBN5yqxPcGuy8Hana3NmbSFQY4oVkkf1Y9aAOX16+j0rx8/2TDN9jYEenSrHw+u4dSOp6ZfnfBJmUhv4WJya4/S71dS+LerLNkwtA4XPbAFavgkI+r3u1tpgkYNj+IDpQBdiku4/E0djdAHSyhaE+4NbVzeJcybkjO1P3f5GoNFtxqepz6nNxCreVFF6D1q+jJCXSRQpDHH0zQB8OUUUUAFFFFAHT/DfV10Xxlp12/wDq9+xvo3FfTbWB1K9kkulBtZFyo9DXyBE7RyI6cMpBH1FfWXg7xFb6x4fsbuA7j5SpIPRwOaAKemxTS2E9nckvbrJ5bqe61naheP4IvY4mLTaVMP3Rz9wntWtpTzPqep2+R5u/zACe2KueI9Mjv/D90k6q3lqHXJ6NQBgKV+0uNTi8tLobonb+VQ+FtS/sPxQ+lTuQs3zIf1pniLU21Hwvpsd1CVkhAkDr/Fiq+twR3llYa5aH97DgH1GPWgD1FUgh1ywmJAhkkBlHoK841fwe3if4w6lqep4/saNVWJG/j+XbgfTk12FjN/aGkxXUJ3MV3HnpUttGL35dxWcD5SPagCrpFjF4bnl0ZVVbZ0LWuO49K0vD2l/YLNlySXdmye2TmuU+N1zdXOi+HG8LrK+t2Mw84RLk4Cnr6jNdH4V1W6v9Ht21BRHdBR5i+jd/1oAp/Eawjl0L7XIC0lu+5AKj8Laqb+xRoSHwAHB6iug1SWGeGexkG1plOCw6GvLtPtdUibUIdMRoJoc59HHPIoA7Txdpc0+mvPos5hl2HzIQeHriPCvxAmvrS28O6hMdNvLKbPmHgSjdnBp+iXOszlD9p8yZPvJkfka5zxvHbS3e+4t1S5P35k42mgD2LWo9JvXTTdUMUq3i+YHPbPvXjnxE8E6BbTNPYT+SrD5QnIyKzLrxNFpcen21xdG5SPDblOSF9K1774o+HovDz2dnobXN03R5jgL70AeOXMXkzNHuDbTjIqKrlw02pXskscPzOc7UHC1HJZ3EYy8MgHrtoAr0UtJQAUUUUAFFFFABRRRQAUUoGTiporWSQkKBwM8mgDQ0HVjp9yruNyjge1en6LcaVq2kyQKu+S4HJHVDXlNtpF5cE+VESBya1/CusT+FtUF2iCQEbJI26Y9aAOjuvEdxo9vb6AWxaPMC6jsN1exeIGu7Gy0jVbeNv7OMywYQfeUjOfpXz1rhttS1Vrq3lY7jvb274r27wv8AEA/8ITZW+pRKIrUiJd3QqB1+tAHfX5tpr+NraNbiB0X94OcHHIrrNFsY5JIzGojiiXJx0riPCWmpooNm05ewuT58cjdt3JH61v3+qSQNHZ2nyWz8l/71AGDq17BrE2p2UsY3g4jcj0rI8B6oNNuLiwuIx8nDH1FWfE7x29oZIV2ODjcPfvXDWd7JaeJLZJXGJsfvc8HNAGv47NpeXRsJcJGwMkRPqO1c38OPEn/CN3l5Y3C/ubk7ce9a3xCENxcwESD7SqkAA9K4rX08qPTrmNc3ETYfA6j1oA6tp30HxlHEJGFrcHc2D0zXb+NFUaULlGAMCeahHWuPaH+17SPUIR5ssMeXHc4FP1Y30fh+1u5ZDJaXf7rYeqcZxQBP8Q9WLfB3Sru1lKvPKvmEHk4J/wAKX4ReI2Hw/wBZuc5nhbaRnkjIryzxB4jE/g+PRsnFrNnH1JP9ao+DdffTtN1GxV8Rzrkj15oA9R0q9js/GmragSDbG2diR2OBW94BxDq0shcsl9H5ifqa8W0/xMDY3FsRlpTt3HuDXrXw7mF3KlyrBX06BQF9QeKAPUfB8YGjAscncTn3zUmqwO90CF/hFJo1tPbyR3NqC1rcoXeL+771Zk1WwuW3K4yvyEehB6UAfCFFFFABRRRQAV71+z3dwXGhahp+R9pik83ae6nArwWun+HXiOTwx4ptb0MRAT5cw9UP+c0AfRmqWQiulvoJTDIp+c+q96df29xfROkE/wC5mTDn04qzqVt/aWnuqyqYp0yrqfUVR8M6gs1i1hsKz2zFJM9WXoDQBgeHHnt9ct/DeqxCT7OpeCUjh1z0rd1DSItMgupmB+wTEh0HRD6iqfj120rTLHV7ZQZ7GdQW7tH1IrSufEum6lo6LZnzbi+RR5B/hJ6n9aAOX0LxHH4Xv10u/JNlctut5uxB4r0VQI41mhxtbncPSvI/FOgXkKHQr8CUKPOsrkfwH+7muv8AhxqMlzo7WV3N5k8I2Fc8jHFAHcr9jgntrtUUO/Bkx1rNisHTUb2WNsCQhlFNtZEuLeXT5CeAdpPY1T/tS6t7mG1uIzvXI8wdCO1AHSXbWWq6ZFDcgRX6DAYd685vNcvtE1ZojbefgFQVHUH1rqrkOl5a3HWHOHI7VpWmmQpK0y7JTIc7j2oA8tgsNS0HQtW1iRHEk7GRB/dBrxXxDr1zqt3I7SOqN1UHqa+wvEdukvhy7jXaxEZGyvjHWbKSyv5kdTt3Haex5oAo10/hPwnca3KrOwitxySeprnrOGW4uY4rdC8rnCgDPNe//D/wdPpth5upH5iAwX0oAl8P+FtMstNaO2tw83QsR1NSS6YiKQ9nEiqCCSvWu1hiWL97gKQvC+tYmsKrwtHvJ8w8H0oA8c8SeGIri+MkaeQD/cHBrGHg+dRvfeVzjgda9bkgUSJAF3vnBro4NLiaNIZdodSOaAPCIvh/qdzl7dG8od2FdNo/wuJQfbS3mFS3PSvZYY/so8obSi8n3qedtw27c7hwR2oA+etf8By2/lvEcGRiiqBxxXKabpynWxYXgw27YcHoa+mprBJ4J42UeYFJiJ7NivDdC8MahdeOPLmQjZLmRj9aAOo1r4aBfDiPZxBpYsuxHVhXmd1pPlKW2Oo9fSvq427R2yw+aCQuMe1eS+L9GcLNFbR8HL9KAPH/AOzLn7K9wq7o0PJHWreiTQtmCdfmPRq67RdFmEW69zHbtkcjriuY1gpbXT+WoUbvl9hQBu+HblLGeQGQMxyAD6VPq/huTULI3Gl4kdjyo61xthesmopK/KZAb6V6Voys1vPqVjdCKO35WMnrQB5hFNNYSvFJHghsMrDmvTrq4g8W+C4NM0OArqFqPN2L1kA4IpviLQYvFOnm9sY1i1JBkgcCX1ri/Cus33hPxDDcKpiuYH+646+x9qAPorw1eTeI/hJYtbHF9YyLFMB95QrYP6Ct7VZ/NsobqE5ht0w2PWs3wfbwafq51CxOzS9chLyR9kkC8n8STWjZWyR6ZfWvWHkGgDkfE+riSF0AzbSJjd6NjivOIZpLy0msZ2Kz2/zxvnnHpW3ql2yyS2KjfFk4zXG6zfeTLFNF95PlbHegCtc6zcRa+Fu5Wb5duSevFek+FdAbWPCmpXo/eC3BKn+leG6jdfa77zR1OK+qfgxHGPhFrbQkGdvMwD64oA5P4GyNdeOJdJmH+j+Q7PnoMYqt8QNQNjNqtiTi1hnb7OB0zS/Ay+ur6+1e1W2MTu/z32Pujn5c9Kxvju8VmIra2kDneQz9yaAPI9TDpPIWJ/eHcfeqiOyNlTg9Klvbg3M288ADAFQYxg0AOjcxuCP4WBr174P3U17eaptY7PKTP/fVePk5Oa9k+CrRWngvxZfwkPeQCPMffZkc/nmgD6WsLg2NtBgAyNAVVfrXFQaDLaGbzSS8srTH23HNdDocr3tjDdy5y8WU9hVq6kVWQY3HaOaAPg6iiigAooooAKKKKAPavgx4xjlT+xdYuCpjGbd2PUf3a9H1a3le/hu9IRQyf63H8Yr5ShleCVZImKuvQivqvwBfxat4T025tZlcLGElHdXA5BoAh1WyGu2RtpZCik79n07VU+w2VvqFkbC28uaFSrMBxwK0vEh+xvFqFoN00fytGP4qsWl1HfWYuI02S9WjPUUAQ6Jcx67FdW12B56vtOeq8dq4y6jm8CeJftDKXtpWw7exrovEmlX9ts17QiReIP3sI/jXvxUV3PY+MrCG2lmEd3IMSRNwQwHagDoY5VuJDd25BimXdG471oWxjvAFbDSp1J615t4a1Cbw1eT+GNckKQ7s207dMdq9N0zTleBbiKTMijqD94UAR3UXkKUPKY5HrWZp979nd1Mx8teduelXLqdrnemdrjgiqd5YKsaNtySMFh3FACPrkF3P5ME2Y3X52z09q4L4ieENOi0R7gNmaRv3eK6qfQbNLZ2tW8syHJ56Vyt7dS3Dx6dIrSKjACU9FoA4L4XaaG8cQW5wXi+Ykjpivooo5UDd8orxP4VW6D4l6tuYP5QfBHf5gK9smkKQuAueRk0ARhWfcZOEXiud1STE/ln5TGCc1uzXJJkEhAQJwPWudkO6TY5EoZxvb09qAJdKgGRNIuXc5HH61uRRK9yxYHp+tQCFFG6Nh8oG0egq9bEuykkKT3oAfNbttWQDoMMKISyxs7JweKTzJV8xd245OKkLs1sVJ4Y4+lAFO7G2MluGXkEdwaqQWKBnniCidjvY9yBV64ZY4gMb2PGDVXfGCXJKup2ge1AFi3YsS/JDcZPaszUY4ys0mwEoCBWjbbzaSRngE5X25qC6tmzNEOYe7UAYUtgl1ZxGSMFRkhAK8/8AHfhdBbtdRxFQW6CvWRE1vEAvJAGDVDXLNrwRwtgqBuAoA+ab+xksnxkkcHFS6fqs1s7oXbyJeHUGvVvG/hRVsWuY48TBcse2K8YdSjkEEYNAHtvhG9t47GMI25sZQ9xXHfE2P7XeC72Kkq/KQB1FVfDM0ul+UZidrcgnoBUvjC+tr5xJFIMoMsfWgDvvg/4rNzpsWl375e3yYs9cV6dpU4lg1KQHjJytfMHgbUGt/EUBXh5GxmvpHw0qy6dqYzh3yoPoaAPLvE0yWlzLcqRhWIx9a83127/e5jOVk+avQdfhQf2nDeElgpKn6CvJbiYy7B2QbRQAWqlrmMAZ56V9V/BMeR8OL55vlgaZwzHoBgV8y+GYftOrwxcD5W5/Cvovwhcvc/C1fDtgCJ7q7eOaX0GM5/SgBvi7xdo/hjwfFpPheJDeXsw2mMfN15Jrw/4j3stxqkUErEtEg35P8fevc/B/w7j8IeHtW1bWwl9q8jiKzyciINxn68/pXzr4vjkh8Q3kcz75Vchz796AMapMMYunyqetR1YgYeRcKT1UEfmKAK9ek/BC7+z63fxyH/Rp4AkinofmGK82r0T4N2zT3urv5bvHDbB2Kj7vzDmgD6w01IodMtlj4jSPAqC8mVZQAnG2meH7iO88O6fPE6yq0WdynPen30IMqlWGCooA+EqKKKACiiigAooooAK6bwT4svvDF7mCVvskhHnRdiPX61zNFAH19prW2qWsWoWp8y3dQ0Z9aj1uIRLHcwARzoclR/EK8O+GHxBudBMemXLb7ORwi5/gya9uS0a5xPLN5sbYZcYxigBI9ZjuIzlhAzfKN3ANcp4i0nbqMGsacPKurQ7nROkgPeuo1nQrfWYEt5GMKqflkX1rntBWfTfE1zomoT+YVQNE5/iXrj8qANnW9LsfH2hQywDZdf8ALOQdVb0Ncr4b8WX/AIT1dvD3iLdHPCR5Zf8AiU8/yrqELaDqIngYRWd0eU7K571U+I3hpfH1/BqLyC1u7WLYCP8AloMcZoA7e+sotZ0STVtDYPOELMg7muU8PeJ0v0khuEKSwnbIh6iub+G3i2fwpra6dfsfJDbJMngj1rrvidosOm3Ft4n0CLzba5YCaOMZyD1PFAFDxgW0b+z9UEhbSZpAjKPfnNWrXS4ptDvZ4EViu1l45YHmp9UW0OmWcmsMo0mQARRt2bFZ2m38ug6u1hNGzWkoBhc9CD2/WgDyf4ZXH2H4n3UZJxL5q8/7wNe4XVyxtWCDHmdCfavELZlsPjS7bPlkuCQuP71e0LC97bgyfIFyQB9aAKcpMlowUlptuD9aq2tntiV2LBsgsp74rWwBjauCy4/GmySrwQnG0g/WgCrKJCjvCTuxwKtQXDwRQpNkh+SQOlJbMcgd+gqxMQfKXaCo4NAExnVE3Q/Nk4NSD94AAcbeTVZIFSf5WxxkCnpEzMfmOx+poAfInmSKMgLjrVO8iWa2RUID55PvVq6tztTBO5eg9azrmJ/MDlyikcAUAX1lCRqVYEjhhS3NzutxjADdRWXFCfIZHY7yeoqzHASoZm6UASg7lP8AcI/KqUis9ypR8KODmpZ90EDsT83YVCGSZDK4KkjgevvQBQ8W30S6SYHIJmO36V4j4osbW0O92AcPgKO4rv8AxrdETRQH5cfMW9q8p1qV9T1mQW+ZRu2IB3FAE8mqzX+ntarF8ykbCvXrWdqEL2vlwyMfMxuYelasOpRaLB5FtGkt1j55D0U+g+lYM0rzStJKxZ2OST3NAFzQSw1i1KcNv4r628C2O/Qxu5aQ5Y++K+WvBFuk2uRvKfkjBP444r6q8ETvZ6TZwXY8suA4Y9CKAPG/iRbNbXF2rHEmSB7ivGSMEg1798XljudbuJIPmh8vCkeuK8DlUrIynqDigC9oDMur22zqzba+l/hHbZ027k3A7LhlA9DgV8xabN9nuhMPvIpK/XFfTP7PMyJ4KuJbjMlxcXLEZ7cCgDofijq50vwNbsrEztOi5/4FXyZ4jkabXL2VyS7yFjn1NfRPx0mZb7RNM+8jt5jfUEV8569/yGr0HtM386AKFLmkooAK+gP2WxDpV7ql3qiqLO/hEC7xwcHJr5/r3fwbpl7ffDLSLizkETJcSKWzgAAdTQBp+EP7b8LfEOfwxbXDT6O5aaFmyQqZzgfnXrN0xEg3ZJxXlHhPxMupXWmrHbO17p7eTLOB/rAT616s0+cFhy3P60AfDtFFFABRRRQAUUUUAFFFFACg4OR1r6D+CviWDUNBOm3dwPt0LHaHP3lr57qeyuprK5juLaRo5UIIZTigD66neQF0i5IOcVk6zpO9F1XDNe23zHb129/0qp4V8V2Os6ZGZ2EdwIxulHTNadzrM1srQ2KrcFlPmPnI2kUAQTwWvinQWksLlXJXfGM4Kv6VQ0jxTbW8Qh1WN4Z4AY34444FYuh+EryGS7u9Iu3thO5aOEnG011FotveRS2euWSNeFdrkDrxgGgDH1HRtP1C1l1OIhy/KEdTSW3iDWvA9jbz6xbm80Zzgxnnywau+FtOWzv59OlZmEHzRKe49a6DxgYrrwrMLhVe0ix52frQBwGqa5aeMPFWmwrIyaG5DiPptPNdd42srmPwuBMoLw/PHMo6IPX8K4O202Az21zocReEgMVH8Irotd8UXtt4P1cpCbuO4CwGM9YlIIY0AeUajflvGuiau4xEzxKZMcHaRk/rX0Ayn7GXjYbBjGD1zXhnjLToD4G0c6W4mggTzZP7yM3BBrvvhvr/APbnhREMn+lWieVMD9MKaAOpQnuec9qp3N6Q+wABIyAx9aZFiJE+ctvHzH0PrWVO3liaaRi2TgLQB0ayRlVCn5jzmnSNiUFjgnpWZaSHyI7gDCKuCPWrlrMtyCQM4oAvvMGljf8AiHBp/nbMBOc9BVTI2hf4hSLMqyYU9fWgC39pZlIfqnOao3E4YKX6Z4NSb1O/HIPWqN26k4j5KKSB6GgC4ZNhDqMgdaja4EoOH2jOSBVUyGSJHc7VYYK0zT2ja4YucNsO2gC9dzp5GD87Hjiqs0xcxAjaCMUELHEJAfkOc59awNS1hdP0a6vZfvQfdB7tQB5x8SdcM941kmN6N87D07CuRtrk2MLGL/j4kGN39we3vQlylzqct3f5YMWdh6k9BVOR98jMRjcc4oAaSSSSck96SipvJYQea3Ck4HvQBpeH55LVpZVjZlJVSR25r6ms5lk8HWEt3MoWOBVQjrmvG/2dtMGseKXsri1WezKl5NwzjHSuruSB8RNWhhkY6NBIYmgzwhHfFAF74lWq2PhI6hEm5o+D75r5vlcySO56sSa+jvEl8JdC1G0uWDWzKBEe3SvnK4j8qd4+u04oAailmCjqTivqH4ehNB8MQxMNrRQiVwfevmC3bZPG5/hYH9a9913VXi8E3WqIf9bAIhj60AVvijrcep+JNGnVvlZDz+NeM+IhjW7z3kJFdhNHLqHgmx1QsTJFceST6ZNcTqhZtRm3Nk7utAFOilpKACvdfA1+8fwJvrZmMbNeMsL+xK5x+teFV9CeFNHGv/B7QtLtmCXk93IVPrgZ/pQB6R4L0Sw0/SIhbW65ChvMxy59a1bsBZACO2elYngq/nktZbOY4uNPcW8y+hxWtqF9FHPtfkgdaAPiOiiigAooooAKKKKACiiigAooooA2/DWvT6Pcbd260kIEqe3civeNCtIr7T4LjR7smzfBZiSTnuK+bK7/AOGPjWXQbj+z7r59Onbp3Vj6UAe73L7EYK4RsbVPvXO67qM8Hiuze1XfEsWJJD0Y4q68aOVubiRltzyFNWxb2l7pkkMTLtU5UjrnrQBz2t6ne2Zt9UiQJIJPLK92XrWhqmoPe+EJ9PQf8fDoXY+5zisvW0N9qGnCV9sdsQrx/wB4+tW/F0J/4R60FkTG0Mys+P4hmgDe0DSbfRbYJBz+7GQfWpBp0MgujsC+YuGXseKa1whsxN5qmMqDuz0qRLtUtmkVhLGR1XmgDxXWYZdA1O8gljZbaZTtU/dOfSuT8Ha8/h7XEuFLfZnOyZM9V/8ArV9B+PdOtr7w7bvdxK7KQysByBjpXiHxA8KPo4t9StlJ0+6+62Put6UAet3F0k0cE1uw+zugZCO4qMSqkfzqCXzwe1eb+BfEu6yGk3hJZP8Aj3fPT2rvSBcWgKv8w6mgDYtbnYIUkHyNwR2q7ZutuxjA+QNkH1rMt5beUQovHlqMn1NWbW9BVmEZOTgUAaruPO4H3vTtVe6jXzk3ttZeeO9MkmCogiYFj19qpyzlLlVkIk56+1AEl1cfvAsTYYc49apm4d5HAABHOaguHX7ZufIXPy1FfSGEsYsnewBx2oAuSs0JCSMCHGR7VHayoAZQc7TtxVSVMyqJJeSM9agSfZLISuI16j1NAG89wP7NkBGWU7h+NeQfETWZHf8As9DiMnzHHv6V6fLdm3g6feUnn0AzXg2v3X23V7qfPDOcfSgDPpQMnA60lOUkHI60AS2saySfOflHJqaVxcyxxD5Y16n0qqWCn92SMjmtLwxZNqOuWlskbStI4GxRkt7UAfRv7OtinhnQLnXbxNqzAqgPXA71xF1PKdf1vVLc5ivrxgi/3lPevRfEUo8O+CJbW5mQXLxBRED9wYry/wAJGe+nsXwWigYDbQBW+IOtrYxT6PG+75VdT3BxkivKWJYkk5J610Pj5y/iu+znIbHNc9QADqM9K9b8Q3oj+ENtCc5eUKM9xxXk0WPNTd0yM16d8QmSDwFocAwGkbeMemKAM7wxceb8Ndat2P8AqLmKRfxzXFampW5DH+NA/wCYrovCEmdC12Dkl41YD6Zrn9TOXg9RCooAp0lFFACjrXuPwC1h7zxT4Z04nbDazyt+aHFeHdq9F+FpuNOtrnW4OEs5l3n0Bx/jQB7TrlyfD/xZ8QxTKYob5orhPRh5YBP51fvIxdTedExKMMitK5ns/Et6up3caTO8BiiYD7qkcmso2tzp2LdEMijlT7UAfIlFFFABRRRQAUUUUAFFFFABRRRQAU5GKOrL1ByKbRQB9F+GNT/4THwVcvbJtu7SHY4HqB1rmPh7rMsfiF7S5kJUZBBP1rK+A3i+Hw54nay1AA6dqI8mQn+Fj0Nbvirw/D4b8cm8snL28jeYuOmGoA6fxXEm+2vLIfvA+XHbFXrBl1G2SKYZSQhQfQ1TulbV7NrRD5LynKP6VV0C8msi+nSJumtnGWx96gCtp1tKniLWNGllfyFBKgn3HSrurWc+kXFidJkaWLpKh5xS/EWY2Xirw/LYIPMu41Nyw9z0NN1u7m0+4tb0riG5+X244oA6K1lTUdNuLG7+Sc/6snpXA+PJ31ifTPCsqeVDbt87D+Ik8H9a6WDUDNdxeZjbnHuK4zxjqbL8QrGYKAVxz/eoA831/S7nwx4gkgcEGJ8xt/eXtXonhzXoruwDKMMwwV96n+MenxXemQX8bAz5yV79K8y8MagbO/RGP7uT5foaAPZtLUC2kkkPznge1W9Kdg58xhtGaxtOkdbKRycgHv3rUiZEKnJOR8woAthjIJmHG3pUBYKoZuT6+lR3UqwRusZLKecelV7i4C20YP3n4oAspK0uHmQHB4/xqG5lKL8wGW6VSjmdDIHYkKMr7VAlyxucuCxA+UHtQBoy3EL2YlKkup2j61QjDm5VrpsKwzj1p1tMMTKcHdz9DVJ5HYCRudrYH0oAsa9eg2U8qttCRlR+VeKEkkk8k816N42us6W8kPyq2E/xrzigAopQCxwBTyoQnfye1ADo4sqGc7UPevY/2btOhXWtX1+4jVrbTrcmMt/f6j8cV4y7swAJ4HQV7PHqEfg34RWlkrbb7VG+0yjvtPAH6CgDnvG+vPe37Ge4ZjJKzNk9ATwKl0PxbaaHqFpFCA0QIaQ+tec3l1JdztLMck/pUBOTzQBseL7uO/8AEV5dQkFJX3DFY9JSigCeyi865jU8LuAJ/Gu1+KV0pOk2MYIjgtlIz9Km+GOgQ3epQPqYH2RsyfXbWB8Q7/8AtDxXeuuPJjby4sdNg6UAJ4LuRDdXkbDPm27qPrisa/8A9cARyFAqTR5DHdkjqUYfpVe6YNLkHPGKAIaKKKACvUPhLZTa14X8ZaTbt++NqlxEo6sVbkfkK8vr2b9mu6g0rU9f1a7OYba2jRl9d77aAPTvgbIupeEdNmc5aJHWbPqGP9KpXGqXt1fXjLIscaTvGit12g8Vm7LzwT8YL7w7pTY0m8iN2if3Rtzx+Oa7PU9K0eedJZspK6BmA9aAPjeiiigAooooAKKKKACiiigAooooAKKKKAHIxR1ZThlOQa+i/Dl1ZeIvCumy3MiGdV2vuPORXzlXofwmVZrm5WV5MRqCqjpzQB6zdNAjkxnCx8jFZ+nXcMvmaicLJyoB/i7VWvriGys5pnV5GC7FBxjPrWPDeruhiZTs2lsD1xmgDU8VaiEk0y5k+ZQwVj6VJqhk1bT7S33fJA+8Z9M5rA1plu5dM+8IVcbkPc1b1rV0isrdrSNo33bWz3FAGxeSRxWH2eNSLmR8rJ6CuR+J9p9m1LTJ7Z921NzP71qavqEsmkxxxnaUbcW7mm6uIL6GxhmViFG4n1oA5jVtaGp+HWLkrOJCDk8AYrz4N5coZTna2Qa7n4jxwQRW62SeVE/319TiuDoA9T8O6l9tt4CT7ECuns5dqTFj8xIxXm/gG52O0ZXIzXdPIkcBfDEsQPpQBe+0KJwuzOeG+lNuWjMqZ+4nIrPWcLnqfeh7gMOQcDgUAPLl5JHHU9qq3E4jkUDjByaQXKibODkcVDcTxyLICh3AcGgCVJVUzbSfm5FSzyqpVcgHGSKy7K5KGPzBuUk03UpAGZ1z7A0AYPjK5b7HFEB8juT+VcvDA0sLFBltwGK1vFE7SG3Un5Rk/wAqp2lz9ktFZFy7NuJPoKACRobWFFRczY+bPrWcxLHJ606WRpZGdzlmOTTKANDQLB9S1e2tY13b3y3+6OT+grX+IGsHVNekWNv9Gth5MQHTAq/4SA0fwtq+ugB7rAtoP9gtkMT+FcUSWJJOSeSTQAlFFFABSjrSUUAeiaXLJeWVtBpLMR5ZEn+z61yHiKH7Pf8AlZyVUZJ7mus+Gc3kRXDrncWCn6Gub8aEN4huMDA44oAy9PYLdAnoAf5VA3LHHTNICQeKSgAopT1pKACvSPg/DLfQeJNPhJBntY3JHbZIDXm9eqfs+3yWev6xvTeH09/0INAHqPjC8tW8QaN44mkC2clm1kEP3mckgf1qea6nvtk+3apUBR7V5Z4lludZ8C+FtQkl2LDcGIQj7v3zz9eK9NW4QwW5YNny1zgUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sagittal proton density MR image of the knee shows lipomatous proliferation of the synovium in the suprapatellar space (arrows), surrounded by a small joint effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD&nbsp;and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42131=[""].join("\n");
var outline_f41_9_42131=null;
var title_f41_9_42132="Disseminated histoplasmosis - papules";
var content_f41_9_42132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated histoplasmosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous papules are present on the skin of this patient with histoplasmosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42132=[""].join("\n");
var outline_f41_9_42132=null;
var title_f41_9_42133="Pegaspargase: Drug information";
var content_f41_9_42133=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pegaspargase: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?41/34/42532?source=see_link\">",
"    see \"Pegaspargase: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/11/8374?source=see_link\">",
"    see \"Pegaspargase: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F206778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Oncaspar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F206800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent, Miscellaneous;",
"     </li>",
"     <li>",
"      Enzyme",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F206781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Details concerning dosing in combinations regimens should also be consulted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute lymphoblastic leukemia (ALL):",
"     </b>",
"     I.M., I.V.: 2500 units/m",
"     <sup>",
"      2",
"     </sup>",
"     (as part of a combination chemotherapy regimen), do not administer more frequently than every 14 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F206794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/11/8374?source=see_link\">",
"      see \"Pegaspargase: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Details concerning dosing in combinations regimens should also be consulted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute lymphoblastic leukemia:",
"     </b>",
"     I.M., I.V.: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F206782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F7697743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hemodialysis, peritoneal dialysis: Significant drug removal is unlikely based on physiochemical characteristics",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F206757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oncaspar&reg;: 750 units/mL (5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F206742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F206760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Have available appropriate agents for maintenance of an adequate airway and treatment of a hypersensitivity reaction (antihistamine, epinephrine, oxygen, I.V. corticosteroids). Be prepared to treat anaphylaxis at each administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Must only be administered as a deep intramuscular injection into a large muscle. Do not exceed 2 mL per injection site; use multiple injection sites for I.M. injection volume &gt;2 mL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Administer over 1-2 hours through a running I.V. infusion line;",
"     <b>",
"      do not administer I.V. push.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F206806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F206758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute lymphocytic leukemia (ALL); treatment of ALL with previous hypersensitivity to native L-asparaginase",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F206808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oncaspar&reg; may be confused with Elspar&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Pegaspargase may be confused with asparaginase, peginesatide",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F206798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;5%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever, malaise",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Coagulopathy (7%; grades 3/4: 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Transaminases increased (11%; grades 3/4: 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions (including bronchospasm, chills, dyspnea, edema, erythema, hypotension, rash, swelling, urticaria; no prior asparaginase hypersensitivity: 1% to 10%; grades 3/4: 2%; prior asparaginase hypersensitivity: 32%; grades 3/4: 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 5%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension, peripheral edema,  tachycardia, thrombosis (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills, CNS thrombosis (2% to 4%; grades 3/4: 3%), CNS hemorrhage (2%), headache, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Lip edema, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperglycemia (3% to 5%; grades 3/4: &le;5%), hyperuricemia, hypoglycemia,  hypoproteinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, diarrhea, pancreatitis (1% to 2%; grades 3/4: 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anticoagulant effect decreased, disseminated intravascular coagulation (DIC), fibrinogen decreased, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, thromboplastin increased, myelosuppression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Liver function tests abnormal (grades 3/4: 5%), hyperbilirubinemia (grades 3/4: 2%), jaundice",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site hypersensitivity, pain or reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, limb pain, myalgia, paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic reactions, night sweats",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abnormal renal function, alopecia, amylase increased, anemia, antithrombin III decreased, ascites, bacteremia, bone pain, bronchospasm, bruising, BUN increased, chest pain, coagulation time increased, colitis, coma, confusion, constipation, cough, creatinine increased, dizziness, DVT, emotional lability, endocarditis, epistaxis, excessive thirst, face edema, fatigue, fatty liver deposits, gastrointestinal pain, hematuria, hemorrhagic cystitis, hepatomegaly, hyperammonemia, hypertension, hypoalbuminemia, hyponatremia, lipase increased, liver failure, metabolic acidosis, mucositis, petechial rash, proteinuria, prothrombin time increased, purpura, renal failure, sagittal sinus thrombosis, sepsis, septic shock, subacute bacterial endocarditis, superficial venous thrombosis, uric acid nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F206763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     History of serious allergic reactions to pegaspargase; history of any of the following with prior L-asparaginase treatment: pancreatitis, serious hemorrhagic events, serious thrombosis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F206746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Allergic reactions: Serious allergic reactions may occur; discontinue in patients with serious allergic reaction. Observe patients for at least 1 hour after administration; immediate treatment for hypersensitivity reactions should be available during administration. Pegaspargase is indicated for use in patients who have had hypersensitivity reactions to native L-asparaginase; however, in one study, 32% of patients with a history of allergic reaction to",
"     <i>",
"      E. coli",
"     </i>",
"     asparaginase products also experienced allergic reaction to pegaspargase.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Coagulopathy: Has been reported; monitor coagulation parameters.  Severe or symptomatic coagulopathy may require treatment with fresh-frozen plasma. Use cautiously in patients with an underlying coagulopathy or previous hematologic complications from asparaginase.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glucose intolerance: May cause glucose intolerance; irreversible in some cases. Use with caution in patients with diabetes mellitus and hyperglycemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: Reversible hepatotoxicity (hyperbilirubinemia and liver enzyme elevation) may occur. Use with caution in patients with hepatic impairment or concomitant hepatotoxic medications.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pancreatitis: May occur; promptly evaluate patients with abdominal pain. Discontinue if pancreatitis occurs during treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic events: Serious thrombotic events, including sagittal sinus thrombosis may occur; discontinue with serious thrombotic event.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6222178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegloticase: May diminish the therapeutic effect of Pegaspargase.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F206753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F206766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with pegaspargase.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F206788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F2238576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse reactions in the nursing infant, breast-feeding is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Oncaspar Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 units/mL (5 mL): $6939.60",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F206755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs during administration, CBC with differential, platelets, amylase, liver enzymes, fibrinogen, PT, PTT (coagulation parameters [baseline and periodic]), renal function tests, urine glucose, blood glucose; monitor for onset of abdominal pain; observe for allergic reaction (for 1 hour after administration)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Oncaspar (DE, PL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F206745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pegaspargase is a modified version of asparaginase. Leukemic cells, especially lymphoblasts, require exogenous asparagine; normal cells can synthesize asparagine. Asparaginase contains L-asparaginase amidohydrolase type EC-2 which inhibits protein synthesis by deaminating asparagine to aspartic acid and ammonia in the plasma and extracellular fluid and therefore deprives tumor cells of the amino acid for protein synthesis. Asparaginase is cycle-specific for the G",
"     <sub>",
"      1",
"     </sub>",
"     phase of the cell cycle.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F206762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset: Asparagine depletion: I.M.: Within 4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Asparagine depletion: I.M.: ~21 days; I.V. (in asparaginase naive adults): 2-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Slow",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: I.M.: Children: 1.5 L/m",
"     <sup>",
"      2",
"     </sup>",
"     ; I.V.: Adults (asparaginase naive): 2.4 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Systemically degraded",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination:  I.M.: ~5.5-6 days; unaffected by age, renal or hepatic function; half life decreased to 1.8-3.2 days in patients with previous hypersensitivity to native L-asparaginase; I.V.: Adults (asparaginase naive): 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: I.M.: 3-4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (trace amounts)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Abshire TC, Pollock BH, Billett AL, et al, \"Weekly Polyethylene Glycol Conjugated L-Asparaginase Compared With Biweekly Dosing Produces Superior Induction Remission Rates in Childhood Relapsed Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 2000, 96(5):1709-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/10961868/pubmed\" id=\"10961868\" target=\"_blank\">",
"        10961868",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Asselin BL, Whitin JC, Cappola DJ, et al, &ldquo;Comparative Pharmacokinetic Studies of Three Asparaginase Preparations,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1993, 11(9):1780-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/8355045/pubmed\" id=\"8355045\" target=\"_blank\">",
"        8355045",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Avramis VI, Sencer S, Periclou AP, et al, &ldquo;A Randomized Comparison of Native",
"      <i>",
"       Escherichia Coli",
"      </i>",
"      Asparaginase and Polyethylene Glycol Conjugated Asparaginase for Treatment of Children With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia: A Children's Cancer Group Study,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2002, 99(6):1986-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/11877270/pubmed\" id=\"11877270\" target=\"_blank\">",
"        11877270",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Avramis VI and Spence SA, &ldquo;Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric Patients,&rdquo;",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2007, 29(4):239-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/17414566/pubmed\" id=\"17414566\" target=\"_blank\">",
"        17414566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Douer D, Yampolsky H, Cohen LJ, et al, &ldquo;Pharmacodynamics and Safety of Intravenous Pegaspargase During Remission Induction in Adults Aged 55 Years or Younger With Newly Diagnosed Acute Lymphoblastic Leukemia,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2007, 109(7):2744-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/17132721/pubmed\" id=\"17132721\" target=\"_blank\">",
"        17132721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Keating MJ, Holmes R, Lerner S, et al, &ldquo;L-Asparaginase and PEG Asparaginase - Past, Present, and Future,&rdquo;",
"      <i>",
"       Leuk Lymphoma",
"      </i>",
"      , 1993, 10(Suppl):153-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/9/42133/abstract-text/8481665/pubmed\" id=\"8481665\" target=\"_blank\">",
"        8481665",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Patel SS and Benfield P, &ldquo;Pegaspargase (Polyethylene Glycol-L-Asparaginase),&rdquo;",
"      <i>",
"       Clin Immunother",
"      </i>",
"      , 1996, 5:490-6.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9745 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C7EAEF3114-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42133=[""].join("\n");
var outline_f41_9_42133=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206778\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206800\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206781\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206794\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206782\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7697743\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206757\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206742\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206760\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206806\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206758\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206808\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206798\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206763\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206746\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299829\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6222178\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206753\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206766\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206788\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2238576\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323630\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206755\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038720\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206745\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F206762\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9745\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9745|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?41/34/42532?source=related_link\">",
"      Pegaspargase: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/11/8374?source=related_link\">",
"      Pegaspargase: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_9_42134="Dobutamine stress radionuclide myocardial perfusion imaging";
var content_f41_9_42134=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dobutamine stress radionuclide myocardial perfusion imaging",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Gary V Heller, MD, PhD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Patricia A Pellikka, MD, FACC, FAHA, FASE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42134/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/9/42134/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress radionuclide myocardial perfusion imaging (rMPI) can be used to diagnose coronary disease and to risk stratify and guide management of patients with known disease. Treadmill or bicycle exercise is the",
"    <strong>",
"     preferred",
"    </strong>",
"    form of stress for patients who can attain an adequate level of exercise (defined as at least 80 percent of the age- and sex-predicted workload in METs or &ge;85 percent of their predicted maximal heart rate) because it provides the most information concerning patient symptoms, cardiovascular function, and the hemodynamic response during usual forms of activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The inability to perform an exercise test is itself a negative prognostic factor in patients with coronary heart disease (CHD). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29129?source=see_link&amp;anchor=H10#H10\">",
"     \"Exercise ECG testing to determine prognosis of coronary heart disease\", section on 'Exercise capacity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24970?source=see_link\">",
"     \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, many patients (particularly those who are elderly) are unable to exercise to an adequate level or have contraindications to such testing. Inadequate exercise may lead to an underestimation of the presence",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severity of CHD. In addition to reducing the percentage of patients exhibiting symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electrocardiographic (ECG) changes, submaximal exercise may also reduce the diagnostic accuracy of exercise rMPI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pharmacologic stress rMPI is performed in patients who are unable to exercise. The clinical use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress rMPI for the diagnosis of CHD, for risk stratification, and for its use in specific settings will be reviewed in this topic.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography and general discussions on the use of stress testing for the diagnosis and prognosis of known or suspected CHD, including its prognostic role after an acute coronary syndrome or revascularization, and the advantages and limitations of various types of stress tests are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27466?source=see_link\">",
"     \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26521?source=see_link\">",
"     \"Stress testing for the diagnosis of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/58/2986?source=see_link\">",
"     \"Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/42/20138?source=see_link\">",
"     \"Role of stress testing after coronary revascularization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/30/44520?source=see_link\">",
"     \"Selecting the optimal cardiac stress test\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress rMPI is useful in the detection of myocardial ischemia and for risk stratification. Dobutamine stress rMPI is indicated for individuals who are unable to exercise and when vasodilator rMPI is contraindicated or likely to be nondiagnostic. Dobutamine is indicated as a stress agent for patients with contraindications to vasodilator stress including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic obstructive pulmonary disease or asthma since adenosine promotes bronchospasm. In contrast to adenosine and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"       dipyridamole",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      can be safely given to patients with reactive airways disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/4\">",
"       4",
"      </a>",
"      ], which is its primary indication for use with rMPI.",
"     </li>",
"     <li>",
"      Allergies to adenosine,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?22/38/23140?source=see_link\">",
"       regadenoson",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"       dipyridamole",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With the advent of selective A2A agonists for vasodilator rMPI, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/38/23140?source=see_link\">",
"     regadenoson",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    use with MPI may be reduced in the future. However, definitive studies remain to be performed. Dobutamine stress is also a useful alternative when vasodilator effects are likely to be attenuated due to recent (within 24 hours)",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    administration or recent significant caffeine (more than one cup of coffee) ingestion.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography is another option for patients who cannot exercise and are not candidates for vasodilator stress testing. The relative accuracy of stress echocardiography and stress rMPI may be influenced by certain patient characteristics, including body habitus. Stress echocardiography appears to be more accurate than stress rMPI in patients with left ventricular hypertrophy, while dobutamine stress rMPI may be superior in patients with high body mass index. Considerations that affect the choice between dobutamine rMPI and echocardiography include feasibility (rMPI is preferred if acoustic windows are suboptimal), cost (generally higher for rMPI), concern for radiation exposure (with rMPI), local availability and expertise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27466?source=see_link\">",
"     \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/30/44520?source=see_link\">",
"     \"Selecting the optimal cardiac stress test\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress cardiovascular magnetic resonance imaging (CMR) is another potential alternative but is not widely available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISMS AND MANIFESTATIONS OF STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    is a synthetic catecholamine that is predominantly a beta-1 agonist. It increases the force of ventricular contraction (inotropy) and the heart rate (chronotropy), thereby raising myocardial oxygen demand, similar to that seen with exercise. The onset of action is within one to two minutes of intravenous infusion, the half-life is two minutes, and the drug is metabolized via methylation and conjugation (",
"    <a class=\"graphic graphic_table graphicRef71371 \" href=\"mobipreview.htm?3/42/3757\">",
"     table 1",
"    </a>",
"    ). At a dose of 20",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min, there is a small but significant increase in systolic blood pressure (mean 12 mmHg in one report, much less than with exercise testing) and at 40",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min, the mean heart rate is 120 to",
"    <span class=\"nowrap\">",
"     125/min",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef56035 \" href=\"mobipreview.htm?7/10/7342\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    may be added to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    when target heart rate (THR) is not achieved at the peak dose of dobutamine. The combination of dobutamine and atropine produces hyperemia, with a more than fivefold increase in myocardial blood flow compared to baseline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/2\">",
"     2",
"    </a>",
"    ]. This change is comparable in magnitude to that induced by adenosine and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress rMPI has not been studied as extensively as vasodilator rMPI, data support its use for diagnosis and prognosis of CHD in selected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    rMPI, exercise rMPI, and vasodilator rMPI have comparable sensitivity and specificity for diagnosis of CHD (",
"    <a class=\"graphic graphic_table graphicRef71371 \" href=\"mobipreview.htm?3/42/3757\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The performance of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    rMPI for the diagnosis of CHD was evaluated in a review of 1014 patients from 20 studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The overall sensitivity and specificity of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress rMPI was 88 and 74 percent, respectively. When dobutamine stress rMPI was directly compared to dobutamine echocardiography, rMPI was more sensitive but less specific.",
"     </li>",
"     <li>",
"      The sensitivity for detecting the presence of CHD in patients with one, two, and three vessel disease was 84, 95, and 100 percent, respectively. In comparison, the sensitivity for predicting multivessel disease by multi-regional perfusion abnormalities varied widely, ranging from 44 to 89 percent, although specificity was excellent (89 to 94 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress rMPI is less often performed than vasodilator stress and is not recommended as a routine method of pharmacologic stress rMPI for the prognosis of CHD by the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines. Dobutamine is specifically indicated when vasodilators are contraindicated are likely to be ineffective (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Indications'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    SPECT rMPI can be a powerful predictor of cardiac events in patients with chest pain, and the number of reversible defects and the presence of defects in multiple territories can be used to identify those who require further intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Dobutamine SPECT imaging also provides important prognostic information in patients with chest pain, including those with a previous myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In one report of 392 patients with chest pain, the most important independent predictor for hard cardiac events was an abnormal image pattern; a reversible defect provided additional, independent prognostic information [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/11\">",
"     11",
"    </a>",
"    ]. The annual event rate in those without perfusion defects, with fixed defects alone, reversible defects alone, and fixed plus reversible defects was 0.8, 6.8, 8.1, and 11.6 percent, respectively; the event rate ranged from 2 to 14.6 percent for increasing reversible defect scores (",
"    <a class=\"graphic graphic_figure graphicRef81689 \" href=\"mobipreview.htm?20/12/20685\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    SPECT rMPI and dobutamine stress echocardiography appear to have equivalent predictive value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. This was best demonstrated in a study of 301 patients who were unable to exercise and who underwent both dobutamine SPECT rMPI and dobutamine echocardiography; the tests were abnormal in 66 and 60 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/14\">",
"     14",
"    </a>",
"    ]. At a mean follow-up of seven years, there were 43 cardiac deaths (14 percent) and 121 patients with cardiac events (cardiac death, myocardial infarction, or coronary revascularization; 40 percent). The predictive results for dobutamine SPECT rMPI and dobutamine echocardiography were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      With a normal test, annual cardiac death rates were 0.7 and 0.6 percent",
"     </li>",
"     <li>",
"      With an abnormal test, annual cardiac death rates were 2.6 and 2.8 percent",
"     </li>",
"     <li>",
"      With a normal test, annual cardiac event rates were 3.6 and 3.3 percent",
"     </li>",
"     <li>",
"      With an abnormal test, annual cardiac event rates were 6.5 and 6.9 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     STUDY PROTOCOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    is administered in graded doses, beginning with 5 to 10",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min, up to a maximum dose of 30 to 40",
"    <span class=\"nowrap\">",
"     &micro;g/kg;",
"    </span>",
"    three minute stages are adequate, with radionuclide injection at peak stress&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to adequately increase the heart rate, since failure to achieve 85 percent of maximum predicted heart rate during",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    rMPI impairs diagnostic accuracy and is an independent predictor of cardiac death and myocardial infarction (",
"    <a class=\"graphic graphic_figure graphicRef68283 \" href=\"mobipreview.htm?5/34/5678\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    or",
"    <span class=\"nowrap\">",
"     arm/leg",
"    </span>",
"    exercise should be added before radionuclide administration if target heart rate (generally &ge;85 percent of maximum predicted heart rate) is not achieved at the peak dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    . The combination of dobutamine and atropine produces hyperemia, with a more than five-fold increase in myocardial blood flow compared to baseline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/2\">",
"     2",
"    </a>",
"    ]. This change is comparable in magnitude to that induced by adenosine and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Arm exercise may also increase heart rate sufficiently; it could be used prior to administration of atropine. If atropine achieves required heart rate, dobutamine should be discontinued.",
"   </p>",
"   <p>",
"    The end points for the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    infusion are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Achievement of &gt;85 percent of maximum predicted heart rate",
"     </li>",
"     <li>",
"      Systolic BP &gt;230 mmHg or a diastolic BP &gt;130 mmHg",
"     </li>",
"     <li>",
"      A fall in systolic BP to &lt;80 mmHg",
"     </li>",
"     <li>",
"      Severe angina or other intolerable symptoms",
"     </li>",
"     <li>",
"      Progressive ST segment depression &gt;2 mm beyond the initial baseline ECG",
"     </li>",
"     <li>",
"      Sustained or nonsustained (&gt;5 beats) ventricular tachycardia",
"     </li>",
"     <li>",
"      Supraventricular tachycardia or atrial fibrillation",
"     </li>",
"     <li>",
"      Onset of 2:1 or complete AV block",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a review of 1118 patients who underwent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography, the main reasons for test termination were achievement of target heart rate (52 percent), administration of maximum dobutamine dose (23 percent), and development of angina (13 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ]. Only 3 percent of tests were terminated for noncardiac side effects.",
"   </p>",
"   <p>",
"    Ischemic electrocardiographic changes are more common with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    compared to vasodilator stress and carry an increased risk for future cardiac events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Contraindications to dobutamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of contraindications to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress perfusion. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ventricular arrhythmias",
"     </li>",
"     <li>",
"      Recent myocardial infarction (one to three days)",
"     </li>",
"     <li>",
"      Unstable angina",
"     </li>",
"     <li>",
"      Hemodynamically significant left ventricular outflow tract obstruction",
"     </li>",
"     <li>",
"      Aortic dissection",
"     </li>",
"     <li>",
"      Systemic hypertension",
"     </li>",
"     <li>",
"      Atrial fibrillation with uncontrolled ventricular heart rate",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    is safe and well tolerated by patients undergoing radionuclide myocardial perfusion imaging, including elderly adults and patients also receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/1,9,16-18\">",
"     1,9,16-18",
"    </a>",
"    ]. However, both cardiac and noncardiac side effects can occur.",
"   </p>",
"   <p>",
"    Cardiac side effects include arrhythmias, particularly ventricular and atrial premature beats, and occur in 8 to 19 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Sustained atrial fibrillation and ventricular tachyarrhythmias, including nonsustained ventricular tachycardia, can occur, especially in patients with poor left ventricular function or severe CHD; these arrhythmias are generally well tolerated and do not require treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Angina occurs in up to 20 percent of patients; it is more likely in those with a history of angina or a recent myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ]. However, serious complications from myocardial ischemia are rare. In a review of over 4000 patients, there was only one case of nonfatal myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/17\">",
"     17",
"    </a>",
"    ]. Symptomatic ischemia is effectively treated with test termination, sublingual",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    , or short-acting beta-blockers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a number of minor noncardiac side effects, one or more of which occur in about 26 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ]. These include nausea, anxiety, headache, tremor, and urinary hesitancy, and lead to test termination in approximately 3 percent of cases (",
"    <a class=\"graphic graphic_table graphicRef77326 \" href=\"mobipreview.htm?8/47/8957\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"     16",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    , in comparison to adenosine and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    , can be safely given to patients with reactive airways disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DRUG INTERACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;During",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress, beta blocker therapy attenuates, or in some cases eliminates, evidence of myocardial ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42134/abstract/19\">",
"     19",
"    </a>",
"    ]. Two strategies are recommended to deal with this problem.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beta blockers should be withheld for 48 hours before diagnostic assessment of patients with suspected CHD.",
"     </li>",
"     <li>",
"      In the absence of a contraindication, intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      should be administered if 85 percent of maximum predicted heart rate (target heart rate) is not achieved at the peak dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      . Atropine administration may yield target heart rates even if beta blockers have not been withheld. Arm or leg exercise is an alternative and may be attempted prior to atropine administration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The issue of medication use and stress testing is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/30/19946?source=see_link\">",
"     \"Impact of medications and methylxanthines on stress testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       Dobutamine",
"      </a>",
"      is generally considered a \"second line\" stress agent for radionuclide myocardial perfusion imaging (rMPI). However, its use in selected patients can be highly effective, providing both diagnostic and risk stratification information. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress rMPI is generally confined to patients who are unable to exercise who have contraindications to vasodilator stress. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An important aspect of the use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      is attainment of target heart rate (greater than or equal to 85 percent maximum predicted heart rate). Failure to obtain this level reduces the accuracy of diagnosis and risk stratification.",
"     </li>",
"     <li>",
"      With the advent of selective A2A agonists for vasodilator rMPI, the use of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress rMPI may be reduced in the future. This issue awaits definitive study.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/1\">",
"      Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993; 21:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/2\">",
"      Tadamura E, Iida H, Matsumoto K, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Am Coll Cardiol 2001; 37:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/3\">",
"      Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992; 20:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/4\">",
"      Pennell DJ, Underwood SR, Ell PJ. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol 1993; 71:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/5\">",
"      Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001; 142:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/6\">",
"      Taillefer R, Ahlberg AW, Masood Y, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003; 42:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/7\">",
"      Lee TH, Boucher CA. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001; 344:1840.",
"     </a>",
"    </li>",
"    <li>",
"     2009 ASNC imaging guidelines for nuclear cardiology procedures, section on \"Stress protocols and tracers\" file://www.asnc.org/imageuploads/ImagingGuidelinesStressProtocols021109.pdf (Accessed on September 27, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/9\">",
"      Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JR. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000; 36:2017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/10\">",
"      Senior R, Raval U, Lahiri A. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease. Am J Cardiol 1996; 78:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/11\">",
"      Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996; 28:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/12\">",
"      Calnon DA, McGrath PD, Doss AL, et al. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol 2001; 38:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/13\">",
"      Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/14\">",
"      Schinkel AF, Bax JJ, Elhendy A, et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 2004; 117:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/15\">",
"      Navare SM, Katten D, Johnson LL, et al. Risk stratification with electrocardiographic-gated dobutamine stress technetium-99m sestamibi single-photon emission tomographic imaging: value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol 2006; 47:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/16\">",
"      Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 1993; 88:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/17\">",
"      Mathias W Jr, Arruda A, Santos FC, et al. Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999; 12:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/18\">",
"      Elhendy A, van Domburg RT, Bax JJ, et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000; 117:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42134/abstract/19\">",
"      Shehata AR, Gillam LD, Mascitelli VA, et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997; 80:268.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5311 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-853D91569B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42134=[""].join("\n");
var outline_f41_9_42134=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISMS AND MANIFESTATIONS OF STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL USE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      STUDY PROTOCOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Contraindications to dobutamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DRUG INTERACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5311\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5311|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/10/7342\" title=\"figure 1\">",
"      Hemodynamic responses during dobutamine infusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/12/20685\" title=\"figure 2\">",
"      Dobutamine stress and outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/34/5678\" title=\"figure 3\">",
"      HR dobut rMPI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5311|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/42/3757\" title=\"table 1\">",
"      Comparison pharm stress agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/47/8957\" title=\"table 2\">",
"      Side effect pharm stress agents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29129?source=related_link\">",
"      Exercise ECG testing to determine prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24970?source=related_link\">",
"      Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/30/19946?source=related_link\">",
"      Impact of medications and methylxanthines on stress testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/42/20138?source=related_link\">",
"      Role of stress testing after coronary revascularization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/30/44520?source=related_link\">",
"      Selecting the optimal cardiac stress test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/58/2986?source=related_link\">",
"      Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_9_42135="Silent myocardial ischemia: Epidemiology and pathogenesis";
var content_f41_9_42135=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Silent myocardial ischemia: Epidemiology and pathogenesis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Prakash C Deedwania, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42135/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/9/42135/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angina pectoris has been considered the cardinal symptom of myocardial ischemia for centuries. However, studies beginning in the 1980s have clearly demonstrated that silent (asymptomatic) ischemia is the most common manifestation of coronary heart disease (CHD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1\">",
"     1",
"    </a>",
"    ]. As an example, several reports have documented that between 25 and 45 percent of patients with acute and chronic ischemic syndromes have evidence of myocardial ischemia during daily life, and most (greater than 75 percent) of these ischemic episodes are not associated with angina or anginal equivalent symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. These studies have also demonstrated that most silent ischemic episodes occur during minimal or no physical exertion&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Silent ischemia frequently occurs in patients in whom routine antianginal therapy is effective in controlling anginal symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients with diabetes, older adults, and those with prior myocardial infarction or surgical revascularization are particularly susceptible to silent ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3529?source=see_link\">",
"     \"Overview of the care of patients with stable ischemic heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The definition, epidemiology, and pathogenesis of silent ischemia will be reviewed here. Issues related to diagnosis, screening, and treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28180?source=see_link\">",
"     \"Silent myocardial ischemia: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4665?source=see_link\">",
"     \"Silent myocardial ischemia: Prognosis and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Silent ischemia is defined as the presence of objective evidence of myocardial ischemia in the absence of chest discomfort or other anginal equivalents. Objective evidence of myocardial ischemia may be obtained in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Exercise testing or ambulatory monitoring shows transient ST segment changes (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/48/11017?source=see_link&amp;anchor=H4#H4\">",
"       \"Electrocardiographic changes during exercise ECG testing\", section on 'ST segment depression'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35945?source=see_link\">",
"       \"Performance of exercise ECG testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nuclear imaging studies demonstrate myocardial perfusion defects (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24970?source=see_link\">",
"       \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43081?source=see_link\">",
"       \"Vasodilator stress radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reversible regional wall motion abnormalities are provoked during stress or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      echocardiography. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27466?source=see_link\">",
"       \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although silent ischemia was defined a number of years ago using electrocardiographic monitoring in coronary care units and exercise laboratories, it did not receive clinical attention until advances in technology permitted continuous ambulatory electrocardiographic (Holter) monitoring. This device provides an opportunity to evaluate the incidence and risk of silent ischemia during daily life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of silent ischemia may be viewed from the standpoint of two groups of patients: those who are asymptomatic (ie, patients with no history of CHD); and those who are symptomatic (ie, patients with a history of myocardial infarction or angina pectoris).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from screening studies, and studies evaluating autopsy findings in people not known to have had CHD, can be used to estimate the prevalence of asymptomatic but significant coronary disease in the general population. The following discussion relates to the epidemiology of silent ischemia. Silent myocardial infarction is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44361?source=see_link&amp;anchor=H16#H16\">",
"     \"Epidemiology of coronary heart disease\", section on 'Unrecognized MI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been estimated that between 2 and 4 percent of apparently healthy asymptomatic middle aged men have significant coronary disease. The prevalence may approach 10 percent in asymptomatic men with two or more major coronary risk factors (eg, smoking, obesity, family history of heart disease, age over 45 years, diabetes, hypertension, and hypercholesterolemia). The data in women are inconclusive because of a higher incidence of false positive electrocardiograms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41113?source=see_link\">",
"     \"Clinical features and diagnosis of coronary heart disease in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The results of several large scale screening studies of asymptomatic middle-aged men who underwent exercise testing found a positive test in 8 to 12 percent of subjects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. The men with a positive test in these studies were at increased risk for coronary mortality (adjusted risk 3.5 to 5.5) even though many of the tests were false positives when angiography was performed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/50/26409?source=see_link\">",
"       \"Screening for coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The frequency of silent ischemia was also addressed in an Italian study of 4842 asymptomatic men aged 40 to 59 who were evaluated with a three stage diagnostic procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/9\">",
"       9",
"      </a>",
"      ]. Patients advanced to subsequent stages if they were suspected of having silent ischemia or infarction in the preceding stage. The first stage included rest electrocardiogram, exercise electrocardiogram, and 24 hour Holter electrocardiogram; the second stage included echocardiogram, thallium-201 scintigraphy in conjunction with exercise testing or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"       dipyridamole",
"      </a>",
"      ; the third stage consisted of coronary angiography. The final diagnosis of silent myocardial ischemia or infarction was reached in 25 patients (adjusted prevalence 0.89 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of silent ischemia is increased substantially in patients with diabetes, particularly if they have other risk factors. The association among type 2 diabetes, silent ischemia, coronary risk factors, and angiographic coronary disease was evaluated in a study of 1900 asymptomatic patients with type 2 diabetes (age &le;60 years, mean 52 years), 60 percent of whom had &ge;2 CHD risk factors (dyslipidemia, hypertension, smoking, a positive family history of premature coronary disease, or the presence of microalbuminuria or macroalbuminuria) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/10\">",
"     10",
"    </a>",
"    ]. All patients underwent stress testing with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    myocardial contrast echocardiography, and coronary angiography was performed in those with myocardial perfusion defects. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two risk groups (&ge;2 versus 0 or 1 risk factors) had equivalent rates of an abnormal stress test (60 percent) and of significant coronary disease on angiography (65 percent).",
"     </li>",
"     <li>",
"      The patients with &ge;2 risk factors had more severe coronary disease with significantly higher rates of three-vessel disease (33 versus 8 percent), diffuse disease (55 versus 18 percent), and vessel occlusion (31 versus 4 percent); they also had a lower rate of single vessel disease (29 versus 54 percent). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/15/30970?source=see_link\">",
"       \"Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have evaluated the prevalence of silent ischemia in patients with prior MI and in those with angina pectoris [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A review of the available data suggests that between 15 and 30 percent of survivors of acute MI have silent ischemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies in patients with unstable angina have revealed that silent ischemia occurs in 30 to 40 percent despite aggressive medical treatment and that the majority of ischemic episodes are silent (",
"      <a class=\"graphic graphic_figure graphicRef54325 \" href=\"mobipreview.htm?1/16/1294\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1,2\">",
"       1,2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The largest group of patients at risk of silent ischemia is those with stable angina. Among such patients who undergo exercise testing and ambulatory monitoring, the prevalence of silent ischemia is estimated to be between 25 and 50 percent and 70 to 80 percent of ischemic episodes are silent (",
"      <a class=\"graphic graphic_figure graphicRef79580 \" href=\"mobipreview.htm?8/40/8846\">",
"       figure 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1,5,11,12\">",
"       1,5,11,12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two other observations are of interest. First, conventional or intensive antianginal drug therapy aimed at symptom control does not eliminate silent ischemic episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/5,12\">",
"     5,12",
"    </a>",
"    ]. Second, patients with silent ischemia detected during Holter monitoring have more advanced CHD with frequent evidence of multivessel disease. As an example, the Asymptomatic Cardiac Ischemia Pilot (ACIP) study evaluated 439 patients with silent ischemia who underwent coronary angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/13\">",
"     13",
"    </a>",
"    ]. Multivessel CHD was seen in 75 percent, one-half of whom had three- vessel involvement. A significant proximal stenosis (&gt;70 percent) was present in 39 percent. Plaque rupture and thrombus were infrequent, but 50 percent of patients had a \"complex plaque\" (ill-defined or irregular border and ulcer with eccentric lesion having overhanging edges).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY AND PATHOGENESIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25574124\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise reasons for the development of angina during some episodes of myocardial ischemia and the absence of symptoms during other episodes are not known. Mechanisms that have been proposed to explain the development of silent ischemia include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inability to reach pain threshold during an episode of ischemia",
"     </li>",
"     <li>",
"      Lesser severity and shorter duration of ischemic episodes",
"     </li>",
"     <li>",
"      Presence of higher threshold for pain",
"     </li>",
"     <li>",
"      Generalized defective perception of painful stimuli",
"     </li>",
"     <li>",
"      Presence of a defective anginal warning system",
"     </li>",
"     <li>",
"      Higher beta-endorphin levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Higher production of anti-inflammatory cytokines, which may block pain transmission pathways and increase the threshold for nerve activation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although there is considerable controversy regarding each of the above postulates, there is also evidence to support several of these concepts. Compatible with the first two hypotheses is the observation in one of the first studies of silent ischemia that the duration of episodes and the magnitude of ST-segment depression were less during silent compared to painful ischemic episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/17\">",
"     17",
"    </a>",
"    ]. Similar findings have been observed in another report of 300 patients with well- established ischemia and reversible defects on quantitative exercise sestamibi tomography; the ischemic burden was lower in the patients with silent ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence of generalized defective perception of painful stimuli has been provided by the demonstration of higher electrical and thermal pain thresholds in patients with silent ischemia compared to controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. In addition, autonomic neuropathy involving cardiac afferent nerves in diabetes mellitus might account for the higher incidence of silent ischemia in diabetics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exactly which mechanism(s) plays a role in a given patient with silent ischemia is dependent upon a variety of factors. These include (but are not limited to) age, ethnic background, presence or absence of diabetes or other cause of autonomic neuropathy, prior MI, prior CABG, use of certain drugs, etc.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Development of myocardial ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial ischemia occurs when there is an imbalance between myocardial oxygen supply and demand. Myocardial oxygen demand is dependent upon several factors, including heart rate, myocardial contractibility, afterload (for practical reasons systolic blood pressure is often taken as a surrogate), and ventricular wall tension (preload). However, for clinical purposes, heart rate, systolic blood pressure, and the calculated double product (HR x systolic BP) are considered the most important determinants of myocardial oxygen demand. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/50/15144?source=see_link\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Atherosclerotic CHD is the most common underlying disorder responsible for myocardial ischemia. However, changes in vasomotor tone (coronary artery vasospasm) may also play a role. The normal coronary arterial bed has sufficient reserve capacity to match the increased oxygen demand during periods of physical activity or mental stress. In contrast, the atherosclerotic arterial bed (even in early stages before the lesion becomes occlusive) is unable to maintain normal coronary reserve due to endothelial dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], as reflected in part by an inability to produce nitric oxide, the endothelial-derived relaxing factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=see_link\">",
"     \"Variant angina\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When the atherosclerotic process has advanced to produce a critical stenotic lesion (usually 50 to 70 percent luminal narrowing), there is a threshold point beyond which an increase in myocardial oxygen demand may result in myocardial ischemia (commonly referred to as the ischemic threshold). The ischemic threshold varies from patient to patient, and can even change in a given patient based upon a variety of factors, including the time of day, level of mental stress, physical activities, and neurohormonal status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Silent ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most anginal episodes appear to result from increased myocardial oxygen demand, there has been considerable debate regarding the pathophysiologic mechanisms responsible for the genesis of silent myocardial ischemia. It has been suggested that primary reduction in coronary blood flow, rather than increased oxygen demand, plays a dominant role in this setting. However, this issue remains unresolved. A predominant role for decreased coronary blood flow is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most silent ischemic episodes occur during minimal or no physical activity, suggesting that increased myocardial oxygen demand was unlikely to play a significant role [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/3-5\">",
"       3-5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ambulatory monitoring studies have shown relatively small increases in the heart rate immediately preceding silent ischemic episodes; this is in contrast to the prominent increases during exercise testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. One report, for example, used ambulatory monitoring to record episodes of transient myocardial ischemia in 30 patients with stable angina and a positive exercise test. On average, heart rate at the onset of both symptomatic and asymptomatic ST depression was significantly lower during Holter monitoring than during exercise testing (98 &plusmn; 20.5 versus 124 &plusmn; 17",
"      <span class=\"nowrap\">",
"       beats/minute)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/26\">",
"       26",
"      </a>",
"      ]. Heart rate rose by more than 10 beats in the minute preceding ST depression in only 23 percent of ambulatory episodes. However, none of these studies actually documented a reduction in coronary blood flow during the ambulatory ischemic episodes. Furthermore, other reports suggest that increased myocardial oxygen demand from any cause plays a major role in the pathogenesis of silent ischemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/28,29\">",
"       28,29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the vast majority of patients who experience silent myocardial ischemia during daily life have evidence of inducible ischemia during exercise testing that is primarily due to an increase in myocardial oxygen demand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Several factors associated with silent ischemia, such as mental stress and intrinsic physiologic changes due to the circadian rhythm, are associated with significant hemodynamic changes that raise myocardial oxygen demand [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/28\">",
"       28",
"      </a>",
"      ]. These include an increase in heart rate and blood pressure, mediated by an increase in plasma epinephrine and norepinephrine levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/30\">",
"       30",
"      </a>",
"      ]. Associated with mental-stress induced myocardial ischemia are wall motion abnormalities which can be prevented by",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/46/30440?source=see_link\">",
"       atenolol",
"      </a>",
"      therapy, a result of a lower rate-pressure product. The observation that",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/5/12377?source=see_link\">",
"       nifedipine",
"      </a>",
"      is also effective against mental-stress induced ischemia suggests that coronary vasoconstriction and a decrease in myocardial blood flow also occur.",
"     </li>",
"     <li>",
"      One study examined the changes in heart rate and blood pressure preceding and during silent ischemic episodes in 25 patients with stable angina and myocardial ischemia during exercise testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/31\">",
"       31",
"      </a>",
"      ]. Each patient underwent simultaneous ambulatory ECG and blood pressure monitoring which was preprogrammed to obtain blood pressure readings at 10-minute intervals during the periods that patients had been previously shown to have silent ischemia. Most silent ischemic episodes were preceded by significant increases in heart rate and systolic blood pressure (61 percent of silent events were preceded by an increase in heart rate of 5",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      or more, 73 percent showed an average increase of 10 mmHg in systolic blood pressure within six minutes preceding ST depression). Similar observations have been made in other reports which demonstrated that more than two-thirds of ambulatory ischemic episodes are preceded by increases in heart rate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/32-35\">",
"       32-35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, similar to the pathophysiologic processes involved in the genesis of angina pectoris, most episodes of silent ischemia are preceded by an increase in oxygen demand; only 20 to 30 percent are due to reduced coronary flow secondary to vasospasm or other factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/31\">",
"     31",
"    </a>",
"    ]. The importance of increased myocardial oxygen demand has obvious therapeutic implications. Although a number of antiischemic drugs have been evaluated for the treatment of silent ischemia, drugs that reduce heart rate (eg, beta blockers) are most effective. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4665?source=see_link\">",
"     \"Silent myocardial ischemia: Prognosis and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Circadian pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to the circadian pattern of myocardial infarction and sudden cardiac death, silent myocardial ischemia has a bimodal distribution, with a peak between 6 AM and noon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. The predominance of silent ischemia in the morning hours may be related to one or more of the physiologic changes observed during this period, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1,27,36\">",
"     1,27,36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased heart rate and blood pressure",
"     </li>",
"     <li>",
"      Elevated catecholamine levels",
"     </li>",
"     <li>",
"      Heightened coronary vasomotor tone",
"     </li>",
"     <li>",
"      Enhanced platelet aggregation",
"     </li>",
"     <li>",
"      Decreased intrinsic fibrinolytic activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The increase in ischemic episodes during the morning hours closely parallels the increase in heart rate and systolic blood pressure and the calculated double product, suggesting a major role for enhanced oxygen demand (",
"    <a class=\"graphic graphic_figure graphicRef66796 \" href=\"mobipreview.htm?42/2/43054\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/32\">",
"     32",
"    </a>",
"    ]. The simultaneous increase in ischemic events, heart rate, and blood pressure during the morning hours suggests that enhanced sympathetic activity may contribute to the morning surge of silent ischemia. It is also conceivable that a combination of factors, including increased vasomotor tone and heightened sympathetic activity, could act in concert and trigger the episodes of silent ischemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Role of mental stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mental stress can precipitate myocardial ischemia in some patients with CHD and has been implicated as a trigger for myocardial infarction and sudden cardiac death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16250?source=see_link\">",
"     \"Psychosocial and other social factors in acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/15/23800?source=see_link\">",
"     \"Psychosocial factors in sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of mental stress in patients with ischemia during daily life activities and exercise was evaluated in the Psychologic Investigations of Myocardial Ischemia (PIMI) study, which enrolled 196 patients with CHD and a positive exercise test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/37\">",
"     37",
"    </a>",
"    ]. Ischemia during mental stress, documented by &ge;1 mm ST segment depression on ECG or reversible left ventricular dysfunction on radionuclide ventriculography, developed in 58 percent of patients.",
"   </p>",
"   <p>",
"    Those with ischemia during mental stress were more likely to have daily life ischemia. There were no differences in clinical or exercise test parameters or in blood pressure or catecholamine levels at rest or with exercise or mental stress in patients with or without mental stress-induced ischemia.",
"   </p>",
"   <p>",
"    The induction of ischemia with mental stress is not limited to patients with CHD in whom ischemia is induced during stress testing. This was illustrated in a report of 21 patients (mean age 67) with a documented history of CHD who had a recent negative exercise or pharmacologic stress test with radionuclide myocardial perfusion imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/38\">",
"     38",
"    </a>",
"    ]. Six of the patients had reversible ischemia with mental stress. At peak stress, there were increases in systolic and diastolic pressures and heart rate, but no patient had chest pain or ECG changes.",
"   </p>",
"   <p>",
"    How mental stress predisposes to ischemia is not well understood. In a study evaluating heart rate variability in patients with ambulatory ischemic events, changes consistent with withdrawal of vagal tone were noted before the onset of ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42135/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H462116234\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although angina pectoris is considered the cardinal symptom of myocardial ischemia and coronary heart disease (CHD), studies have established that silent myocardial ischemia (defined as objective evidence of ischemia without associated chest pain) is the most common manifestation in patients with CHD. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Silent ischemia can be detected during stress testing in asymptomatic patients as well as in patients with a previously established history of CHD. Studies have also demonstrated that silent ischemia can be detected by ambulatory ECG monitoring in patients with an established diagnosis of CHD and angina, even when they are symptom-free and treated with multiple anti-anginal drugs. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Silent ischemia is seen in both asymptomatic and symptomatic patients with CHD and appears to represent the majority of episodes of ischemia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the precise mechanism responsible for silent ischemia has not been established, a number of possible reasons for a lack of anginal symptoms during some episodes of ischemia have been proposed and include: lesser severity and shorter duration of episodes, higher threshold for pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      inability to reach pain threshold, impaired perception of painful stimuli, defective anginal warning system, and higher beta-endorphin levels. (See",
"      <a class=\"local\" href=\"#H25574124\">",
"       'Mechanisms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathophysiologic mechanism responsible for myocardial ischemia, whether it is silent or symptomatic, seems to be identical and primarily relates to an imbalance between myocardial oxygen supply and demand. Most episodes of ischemia occur due to an increase in myocardial oxygen demand in the presence of significant CAD with limited flow reserve. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Development of myocardial ischemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/1\">",
"      Deedwania PC, Carbajal EV. Silent myocardial ischemia. A clinical perspective. Arch Intern Med 1991; 151:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/2\">",
"      Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986; 314:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/3\">",
"      Gottlieb SO, Gottlieb SH, Achuff SC, et al. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 1988; 259:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/4\">",
"      Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988; 62:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/5\">",
"      Deedwania PC, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol 1990; 65:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/6\">",
"      Ekelund LG, Suchindran CM, McMahon RP, et al. Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention Trial. J Am Coll Cardiol 1989; 14:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/7\">",
"      Rautaharju PM, Prineas RJ, Eifler WJ, et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol 1986; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/8\">",
"      Erikssen J, Enge I, Forfang K, Storstein O. False positive diagnostic tests and coronary angiographic findings in 105 presumably healthy males. Circulation 1976; 54:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/9\">",
"      Fazzini PF, Prati PL, Rovelli F, et al. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol 1993; 72:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/10\">",
"      Scognamiglio R, Negut C, Ramondo A, et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006; 47:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/11\">",
"      Langou RA, Huang EK, Kelley MJ, Cohen LS. Predictive accuracy of coronary artery calcification and abnormal exercise test for coronary artery disease in asymptomatic men. Circulation 1980; 62:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/12\">",
"      Yeung AC, Barry J, Orav J, et al. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease. Circulation 1991; 83:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/13\">",
"      Sharaf BL, Williams DO, Miele NJ, et al. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory. J Am Coll Cardiol 1997; 29:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/14\">",
"      Falcone C, Guasti L, Ochan M, et al. Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia. J Am Coll Cardiol 1993; 22:1614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/15\">",
"      Hikita H, Etsuda H, Takase B, et al. Extent of ischemic stimulus and plasma beta-endorphin levels in silent myocardial ischemia. Am Heart J 1998; 135:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/16\">",
"      Mazzone A, Cusa C, Mazzucchelli I, et al. Increased production of inflammatory cytokines in patients with silent myocardial ischemia. J Am Coll Cardiol 2001; 38:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/17\">",
"      Deanfield JE, Shea M, Ribiero P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984; 54:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/18\">",
"      Marcassa C, Galli M, Baroffio C, et al. Ischemic burden in silent and painful myocardial ischemia: a quantitative exercise sestamibi tomographic study. J Am Coll Cardiol 1997; 29:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/19\">",
"      Cohn PF. Silent myocardial ischemia in patients with a defective anginal warning system. Am J Cardiol 1980; 45:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/20\">",
"      Maseri A, Crea F, Kaski JC, Davies G. Mechanisms and significance of cardiac ischemic pain. Prog Cardiovasc Dis 1992; 35:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/21\">",
"      Glazier JJ, Chierchia S, Brown MJ, Maseri A. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol 1986; 58:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/22\">",
"      Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983; 1:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/23\">",
"      Gordon JB, Ganz P, Nabel EG, et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 1989; 83:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/24\">",
"      Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991; 325:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/25\">",
"      Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/26\">",
"      Deanfield JE, Maseri A, Selwyn AP, et al. Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 1983; 2:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/27\">",
"      Deedwania PC, Carbajal EV. Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life. Am J Cardiol 1992; 70:19F.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/28\">",
"      Deedwania PC. Increased myocardial oxygen demand and ischemia during daily life: resurrection of an age-old concept. J Am Coll Cardiol 1992; 20:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/29\">",
"      Gullette EC, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997; 277:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/30\">",
"      Andrews TC, Parker JD, Jacobs S, et al. Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. J Am Coll Cardiol 1998; 32:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/31\">",
"      Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990; 82:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/32\">",
"      Hinderliter A, Miller P, Bragdon E, et al. Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand. J Am Coll Cardiol 1991; 18:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/33\">",
"      McLenachan JM, Weidinger FF, Barry J, et al. Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease. Circulation 1991; 83:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/34\">",
"      Andrews TC, Fenton T, Toyosaki N, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation 1993; 88:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/35\">",
"      Benhorin J, Banai S, Moriel M, et al. Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes. Circulation 1993; 87:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/36\">",
"      Deedwania PC. Increased demand versus reduced supply and the circadian variations in ambulatory myocardial ischemia. Therapeutic implications. Circulation 1993; 88:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/37\">",
"      Stone PH, Krantz DS, McMahon RP, et al. Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: the Psychophysiologic Investigations of Myocardial Ischemia (PIMI) study. J Am Coll Cardiol 1999; 33:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/38\">",
"      Ramachandruni S, Fillingim RB, McGorray SP, et al. Mental stress provokes ischemia in coronary artery disease subjects without exercise- or adenosine-induced ischemia. J Am Coll Cardiol 2006; 47:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42135/abstract/39\">",
"      Kop WJ, Verdino RJ, Gottdiener JS, et al. Changes in heart rate and heart rate variability before ambulatory ischemic events(1). J Am Coll Cardiol 2001; 38:742.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1488 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42135=[""].join("\n");
var outline_f41_9_42135=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H462116234\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOPHYSIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25574124\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Development of myocardial ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Silent ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Circadian pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Role of mental stress",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462116234\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1488\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1488|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/16/1294\" title=\"figure 1\">",
"      Silent ischemia unstable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/40/8846\" title=\"figure 2\">",
"      Silent ischemia stable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/2/43054\" title=\"figure 3\">",
"      Circadian silent ischemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41113?source=related_link\">",
"      Clinical features and diagnosis of coronary heart disease in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/15/30970?source=related_link\">",
"      Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/48/11017?source=related_link\">",
"      Electrocardiographic changes during exercise ECG testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44361?source=related_link\">",
"      Epidemiology of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/24/24970?source=related_link\">",
"      Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/28/3529?source=related_link\">",
"      Overview of the care of patients with stable ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35945?source=related_link\">",
"      Performance of exercise ECG testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16250?source=related_link\">",
"      Psychosocial and other social factors in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/15/23800?source=related_link\">",
"      Psychosocial factors in sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/50/26409?source=related_link\">",
"      Screening for coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28180?source=related_link\">",
"      Silent myocardial ischemia: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/35/4665?source=related_link\">",
"      Silent myocardial ischemia: Prognosis and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3706?source=related_link\">",
"      Variant angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43081?source=related_link\">",
"      Vasodilator stress radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_9_42136="Intraductal carcinoma of the prostate";
var content_f41_9_42136=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F62418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F62418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intraductal carcinoma of the prostate",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42136=[""].join("\n");
var outline_f41_9_42136=null;
var title_f41_9_42137="Alopecia areata 2";
var content_f41_9_42137=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71583%7EDERM%2F58252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71583%7EDERM%2F58252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alopecia areata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The hair loss is a round patch. Note the absence of scales or inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alopecia areata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patchy hair loss is seen in this patient with alopecia areata.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman, W, Jaeger, E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, Second Edition, Lippincott Williams &amp; Wilkins 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42137=[""].join("\n");
var outline_f41_9_42137=null;
var title_f41_9_42138="Medical care of the nursing home patient in the United States";
var content_f41_9_42138=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medical care of the nursing home patient in the United States",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Muriel R Gillick, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Mark Yurkofsky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/9/42138/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/9/42138/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6972745\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nursing home care in the United States includes both long-term residential care and short-term postacute or rehabilitative care. While the number of Americans living in nursing homes for extended periods has fallen steadily over the past decade as an increasing proportion of older individuals remain in their homes or in assisted living facilities, the number receiving short term nursing home care has risen dramatically. In 2008, approximately 1.4 million people lived in a nursing home at any given time. However, over the course of the year, over 3.25 million people spent time in a skilled nursing facility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nursing home residents, whether short- or long-stay, tend to be old, female, and have multiple impairments in their activities of daily living (ADLs). Of those in nursing homes in 2008, 16.2 percent were between the ages of 65 and 74, 33.0 percent were between 75 and 84, 32.0 percent were between 85 and 94, and 5.2 percent were 95 years of age or older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/1\">",
"     1",
"    </a>",
"    ]. In the same population, 8.5 percent had impairments in 3 ADLs, 30.8 percent had impairments in 4 ADLs, and 18.4 percent had impairments in 5 ADLs. Cognitive impairment is also widespread in this population, with 10.4 percent exhibiting severe or very severe impairment, 30.7 percent having moderate or moderately severe impairment, and only 32.0 percent showing no impairment.",
"   </p>",
"   <p>",
"    Nursing home care represents a substantial segment of health care costs for older individuals: in the US in 2006, $124.9 billion was spent on nursing home care, of which 17 percent was paid by Medicare, 43 percent by Medicaid, 7 percent by private insurance, and 26 percent out of pocket [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/2\">",
"     2",
"    </a>",
"    ]. Long-term patients live at the facility and are often described as receiving custodial care. Room and board costs for this group are generally paid for by Medicaid, long term care insurance, or out-of-pocket by patients or their families. For most short-stay nursing home patients discharged from a hospital setting, the goal is to return to the community. A subset of these patients may be at the nursing home for short-term end of life care and some will require long-term nursing home care. Room and board costs for this group are generally paid by their skilled nursing facility (SNF) benefit, which, in the case of Medicare, covers up to 100 days per benefit period if care needs meet specific clinical criteria.",
"   </p>",
"   <p>",
"    Physicians providing medical care in the nursing home must be knowledgeable about regulatory, ethical, and epidemiological as well as geriatric issues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/3\">",
"     3",
"    </a>",
"    ]. For certain conditions, such as heart failure, diabetes mellitus, and chronic obstructive pulmonary disease, medical management is similar to outpatient management. This topic will focus on those conditions in nursing home patients that warrant a particular approach or heightened awareness. Many are geriatric syndromes that comprise constellations of symptoms that may have any of several etiologies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPREHENSIVE GERIATRIC ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comprehensive geriatric assessment includes an evaluation of the patient's functional, physical, cognitive, emotional, and psychosocial status. It is a cost-effective intervention that improves quality of life in a variety of settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/4\">",
"     4",
"    </a>",
"    ] and is recommended for use in frail elders by the American Geriatrics Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/5\">",
"     5",
"    </a>",
"    ]. The nursing home is an ideal environment in which to carry out comprehensive geriatric assessment since its population is at high risk and its residential character facilitates implementation of recommendations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=see_link\">",
"     \"Comprehensive geriatric assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26429831\">",
"    <span class=\"h2\">",
"     The Minimum Data Set",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the Omnibus Reconciliation Act of 1987 (OBRA) mandates that nursing homes complete a comprehensive evaluation of residents at the time of admission, an assessment that is intended to serve as the basis for the plan of care. A pivotal part of the assessment is the Minimum Data Set (MDS), a standardized instrument mandated by the Centers for Medicare and Medicaid Services (CMS). Completion of the MDS 3.0 serves as the basis for the creation of an individualized treatment plan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/6\">",
"     6",
"    </a>",
"    ]. Data from the MDS are also used to determine levels of nursing home reimbursement and to measure quality of care in nursing homes. Prevalence of falls, depression, incontinence and pressure ulcers are examples of quality indicators. A subset of these measures is posted on the CMS website, Nursing Home Compare, to help patients and families select a nursing home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A key component of the MDS is measurement of the nursing home resident&rsquo;s ability to perform activities of daily living including transferring, ambulating, hygiene, toileting, communicating and eating. For most short-stay patients the focus is on achieving independence with these activities. The emphasis for long-term care patients is on preventing functional decline.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26429838\">",
"    <span class=\"h2\">",
"     Goals for postacute care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postacute patients are typically expected to make gains in function and therefore usually receive some combination of physical therapy, occupational therapy, or speech therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical therapists focus on mobility including ambulation with and without assistive devices, as well as wheelchair mobility. Stair training is provided when appropriate.",
"     </li>",
"     <li>",
"      Occupational therapists address hygiene, self-feeding, and dressing. Often they work together with physical therapists to address transfers to and from bed, chair, and toilet.",
"     </li>",
"     <li>",
"      Speech therapists address safety in eating and swallowing by advising on food and beverage consistency as well as chewing and swallowing techniques. They also assist patients who suffer from communication problems such as dysarthria, aphasia, or hearing impairment. They may train facility staff, family, and home caregivers in techniques to optimize communication.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To achieve home discharge, nursing facilities provide interdisciplinary care that incorporates physicians, advance practice clinicians, facility nurses, case managers, and social workers. Mental health clinicians and dieticians are often active members of the team as well. In addition to providing ongoing medical care for problems diagnosed in the acute care hospital and to facilitating rehabilitation, nursing facilities must be alert for the occurrence of new problems. Nurses, recreation therapists, and certified nursing assistants (CNAs) will typically be the first facility staff members to recognize that a new medical problem is developing. Close communication with the attending physician is important to assure that new acute medical conditions, drug side effects, or psychiatric issues such as depression are addressed rapidly and effectively.",
"   </p>",
"   <p>",
"    <br/>",
"    In addition to optimizing function and medical care, the interdisciplinary team must identify what home supports the patient will need. These supports may be provided by the family and may also involve agencies such as a local visiting nurse association (VNA). Caregiver education is a crucial aspect of preparation for discharge to a home setting, with an emphasis on how to monitor and manage the patient&rsquo;s medical conditions and how to administer medications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26429845\">",
"    <span class=\"h2\">",
"     Family meetings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Family meetings are an important component of care in nursing facilities. Such meetings serve as a means of learning and sharing information and can facilitate medical decision making and advance care planning. Whenever possible, the patient and surrogate decision makers should attend the meeting along with key staff from the nursing home, including representatives of the rehabilitation team, nursing, and social service along with the attending physician or advance practice clinician. A useful format for family meetings includes the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Review of the current medical situation to be sure that clinicians, patient, and family have the same understanding.",
"     </li>",
"     <li>",
"      Review of advance directives currently in place, including the name of the surrogate decision maker and any agreed-upon limitations of care.",
"     </li>",
"     <li>",
"      Review of treatment options, including an explanation of what can be done at home, in the nursing facility and at the hospital.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972760\">",
"    <span class=\"h1\">",
"     CLINICAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The issues addressed here are those identified by the MDS as especially important in the nursing home patient population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972768\">",
"    <span class=\"h2\">",
"     Vision and hearing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual impairment is a reversible cause of impaired quality of life in long term nursing home residents. Testing for refractive errors and supplying glasses to correct vision improved measures of quality of life and symptoms of depression at two months in a randomized study of nursing home residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/18/38186?source=see_link&amp;anchor=H25#H25\">",
"     \"Geriatric health maintenance\", section on 'Vision screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, cataract surgery in nursing home residents led to significant improvement in vision, psychological distress, and social interaction when compared to matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/9\">",
"     9",
"    </a>",
"    ]. A comprehensive vision restoration-rehabilitation program introduced in a random sample of nursing homes led to a higher rate of cataract surgery in eligible residents, compared to usual care facilities (31 versus 2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hearing impairment is found in 70 to 90 percent of older nursing homes residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/11\">",
"     11",
"    </a>",
"    ]. Uncorrected hearing impairment adversely affects quality of life by leading to depression, cognitive impairment, and social isolation. However, in the long term care setting, many individuals who have hearing aids are unable to use them independently and rely on assistance from certified nursing assistants. Many residents with hearing impairment have not been evaluated for a hearing aid. In part, this reflects inadequate insurance coverage. Medicare pays for 80 percent of the cost of a hearing evaluation but does not cover hearing aids; Medicaid pays some or all of the cost of a hearing aid in 30 states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41896?source=see_link\">",
"     \"Presbycusis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39300?source=see_link\">",
"     \"Hearing amplification in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Long-term stay residents should have an examination for impacted cerumen. When feasible, residents should undergo a screening hearing test using the whisper test, and audiologic evaluation for a hearing aid if the screening test is positive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/32/39429?source=see_link\">",
"     \"Evaluation of hearing loss in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972777\">",
"    <span class=\"h2\">",
"     Dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia is widespread in the nursing home, with 30.7 percent of residents diagnosed with moderate to moderately severe dementia and 10.4 percent with severe or very severe dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/1\">",
"     1",
"    </a>",
"    ]. Prevalence in the long stay population is even higher, as the behavioral and cognitive problems associated with dementia are a frequent reason for admission to the nursing facility.",
"   </p>",
"   <p>",
"    Although the rate of dementia is high among patients in nursing homes, some patients remain undiagnosed. Routine screening of new admissions is recommended, using either the Mini-Mental State Exam (MMSE), the Mini-Cog [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/13\">",
"     13",
"    </a>",
"    ], or the Brief Instrument of Mental Status (BIMS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of cognitive impairment and dementia\", section on 'Mini-Mental State Examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation of cognitive impairment and dementia\", section on 'Other brief cognitive assessments'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6976115\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment for cognitive symptoms due to Alzheimer&rsquo;s disease and other dementias is controversial. A review of high quality studies that evaluated the impact of cholinesterase inhibitors and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    on cognition, behavior, and quality of life concluded that the average change attributed to these drugs, although statistically significant, was not clinically significant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/15\">",
"     15",
"    </a>",
"    ]. Practice guidelines from the American College of Physicians and the American Academy of Family Physicians advise that the decision to initiate a trial of therapy with either a cholinesterase inhibitor or memantine be based upon individualized assessment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/16\">",
"     16",
"    </a>",
"    ]. One rationale for a trial of therapy, to maximize the potential that a patient continues to be able to live in the community setting, becomes moot once patients are admitted for long-term nursing home care.",
"   </p>",
"   <p>",
"    A discussion of pharmacologic options for dementia treatment is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=see_link\">",
"     \"Treatment of dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of dementia-related behavioral symptoms (agitation, wandering, aggression, and other symptoms) is often difficult in the nursing home environment and is discussed separately. (See",
"    <a class=\"local\" href=\"#H6972802\">",
"     'Behavioral issues'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6976148\">",
"    <span class=\"h3\">",
"     Advanced dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Very advanced dementia (Cognitive Performance Scale 5 to 6 on the MDS or MMSE score less than 10) engenders special challenges. A prospective study of 323 residents with advanced dementia followed for 18 months found a mortality rate of 54.8 percent, with 41.1 percent developing pneumonia and 85.8 percent developing problems with eating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/17\">",
"     17",
"    </a>",
"    ]. In the same population, during the last three months of life, 40.7 percent of residents were hospitalized, had an emergency room visit, were treated with intravenous medications, or underwent tube feeding.",
"   </p>",
"   <p>",
"    Enrollment of patients with advanced dementia in hospice is sometimes problematic, given the difficulty of predicting six-month mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/18\">",
"     18",
"    </a>",
"    ]. However, adoption of a palliative approach to care is both feasible and advisable even when patients are not referred for hospice care. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Palliative care'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20855?source=see_link\">",
"     \"Palliative care: Issues specific to geriatric patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972786\">",
"    <span class=\"h2\">",
"     Delirium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delirium is a geriatric syndrome present in over one-third of hospitalized elderly patients, many of whom continue to have delirium on hospital discharge. In one study of 4744 admissions to eight postacute facilities, one in seven patients was found to have delirium on admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/19\">",
"     19",
"    </a>",
"    ]. Shortened hospital stays and the increasing age of the population are likely to increase these numbers. Delirium has been identified in 16 percent of all patients admitted to nursing facilities, affecting both long-term and postacute residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delirium is often unrecognized, both in the hospital and nursing home setting, and is associated with poor outcomes. Patients with delirium who are admitted to postacute nursing facilities are more likely to experience complications or require rehospitalization than patients without delirium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/21\">",
"     21",
"    </a>",
"    ]. Delirium is also a risk factor for increased mortality, whether in the acute or long-term care setting.",
"   </p>",
"   <p>",
"    The signs and symptoms of delirium can be subtle and transient, making detection difficult. This can be especially problematic for new admissions to nursing facilities when staff may be unaware of the baseline status of patients and thus not realize that cognitive, behavioral or functional changes are new. Patients with delirium can be incorrectly thought to have dementia, depression, psychosis or even &ldquo;normal&rdquo; aging. Attending physicians in nursing facilities should incorporate observations of facility staff as well as the family members of patients in order to identify and monitor delirium. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link&amp;anchor=H17#H17\">",
"     \"Diagnosis of delirium and confusional states\", section on 'Recognizing the disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    New admissions to skilled nursing facilities are screened for delirium utilizing the Confusion Assessment Method (CAM) (",
"    <a class=\"graphic graphic_table graphicRef69489 \" href=\"mobipreview.htm?1/48/1804\">",
"     table 1",
"    </a>",
"    ). The diagnosis of delirium requires that a patient satisfy both of the first two items, plus at least one of the third and fourth items. This tool has a sensitivity of 94 to 100 percent and specificity of 90 to 95 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/22\">",
"     22",
"    </a>",
"    ]. While other instruments are available for screening, a review of 11 bedside instruments used to identify the presence of delirium in adults concluded that the best evidence supported the use of the CAM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients are often transferred to emergency departments for evaluation of symptoms related to delirium. While transfer can provide rapid medical assessment, it is a source of disruption and stress to patients, especially those with dementia. Additionally, it can be difficult for clinicians not familiar with the patient to assess for significant changes in cognition. While delirium is often described as a medical emergency and prompt evaluation is needed, consideration should be given as to whether a delirium evaluation can be performed within the nursing facility using laboratory and x-ray services.",
"   </p>",
"   <p>",
"    Once delirium is diagnosed, management includes treatment of concurrent medical conditions including electrolyte imbalance, dehydration, pain and infection and minimizing medications that increase delirium risk, especially those with anticholinergic properties [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/24\">",
"     24",
"    </a>",
"    ]. Although the evidence base supporting nonpharmacological supportive measures to treat delirium is weak, nursing facility care for delirious patients should include relieving symptoms and keeping patients safe.",
"   </p>",
"   <p>",
"    Pharmacological management of delirium needs to be tailored to the symptoms. More severe symptoms may require the use of antipsychotic medications. Whether atypical antipsychotics are more effective than typical antipsychotics in delirium management remains uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/24\">",
"     24",
"    </a>",
"    ]. Antipsychotic agents are considered chemical restraints and their use is carefully scrutinized in the nursing home setting. Supportive documentation for their appropriate use must be provided in the medical record. Benzodiazepines should generally be avoided unless the delirium is specifically caused by alcohol or benzodiazepine withdrawal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link&amp;anchor=H13#H13\">",
"     \"Prevention and treatment of delirium and confusional states\", section on 'Medications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primary prevention of delirium is probably the most effective treatment strategy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/25\">",
"     25",
"    </a>",
"    ]. An observational prospective study of delirious hospitalized patients showed that factors related to worsening delirium severity include: the number of room changes, the absence of a clock or watch, the absence of reading glasses and restraint use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=see_link&amp;anchor=H9#H9\">",
"     \"Prevention and treatment of delirium and confusional states\", section on 'Prevention strategies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delirium can persist for months in some patients and become more of a chronic rather than an acute condition. In one study of 551 patients admitted to 55 rehabilitation hospitals and 30 skilled nursing facilities in 29 states, 23 percent of patients had delirium on admission and, at one week, only 14 percent of the cases of delirium had resolved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/27\">",
"     27",
"    </a>",
"    ]. The percentage of short-stay nursing home residents with delirium two&nbsp;weeks after admission is one of five quality measures publicly reported by CMS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis of delirium and confusional states\", section on 'Temporal course'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972793\">",
"    <span class=\"h2\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression is widespread and undertreated in nursing homes. One study of 634,060 long-term residents in 4216 US nursing homes in 2005 found that 55 percent had depression during their first year. Depression was present at the time of admission for 33 percent and another 22 percent developed depression during the year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/28\">",
"     28",
"    </a>",
"    ]. Analysis of nursing home residents in Ohio found a similar prevalence rate of depression, but noted that 23 percent of those diagnosed with depression were untreated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Untreated depression in the post-acute setting can decrease motivation, resulting in lack of participation in the rehabilitation program. In the residential setting, depression impairs quality of life by causing social isolation, loss of interest in usual activities, and problems with eating and sleeping.",
"   </p>",
"   <p>",
"    Screening should be carried out on all nursing home residents using validated measures. The short version of the Geriatric Depression Scale, which takes five to ten minutes to administer, is appropriate for those with no more than minimal cognitive impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/30\">",
"     30",
"    </a>",
"    ]. The Cornell Scale for Depression in Dementia is appropriate for those with cognitive impairment (",
"    <a class=\"graphic graphic_table graphicRef59906 \" href=\"mobipreview.htm?41/16/42251\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39514?source=see_link&amp;anchor=H22#H22\">",
"     \"Diagnosis and management of late-life depression\", section on 'Screening instruments'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A prior history of depression should be ascertained as patients with a history of depression are at risk of recurrence and should be considered for long-term maintenance therapy. One randomized trial of antidepressant treatment, psychotherapy, or placebo in 210 older individuals with major depression found a two-year recurrence rate of 37 percent in those maintained on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    versus 68 percent in those on placebo and psychotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medical treatment of depression is generally guided by the side effect profile of pharmacologic agents. Tricyclic antidepressants, although highly effective, are generally to be avoided due to the high risk of anticholinergic effects, orthostatic hypotension, and sedation. SSRIs are the drug of choice, with agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    serving as second line alternatives. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39514?source=see_link&amp;anchor=H23#H23\">",
"     \"Diagnosis and management of late-life depression\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972802\">",
"    <span class=\"h2\">",
"     Behavioral issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of behavioral disorders in the nursing home is difficult, whether behavior issues arise from long-standing mental illness or from dementia. Misuse of psychotropics in older adults to address these issues leads to frequent adverse effects and deteriorating medical and cognitive status. To combat this problem in the United States, nursing home reform legislation, the Omnibus Budget Reconciliation Act of 1987 (OBRA&ndash;87), mandated freedom for every resident from medically unnecessary \"physical or chemical restraints imposed for purposes of discipline or convenience.\" Nonetheless, a study of 16,586 newly admitted residents to nursing homes across the United States found that 28 percent received at least one antipsychotic medication in the year following admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972811\">",
"    <span class=\"h3\">",
"     Agitation and psychotic symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 80 percent of patients with dementia develop neuropsychiatric symptoms at some point during the course of their disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Managing dementia-related agitation and psychotic symptoms in the nursing home patient is challenging. Agitation may be due to the dementing process or to a reversible medical condition such as urinary retention or infection. Once acute medical problems have been excluded, clinicians should consider empirical treatment of pain. One cluster randomized trial of nursing home patients with dementia found that a systematic approach to the management of pain, compared to usual care, decreased agitation and did not worsen activities of daily living or cognition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/35\">",
"     35",
"    </a>",
"    ]. Studies indicate an increased mortality associated with use of either conventional or atypical antipsychotic medications for dementia-related psychosis, and the FDA in June 2008 has issued a black box warning that \"antipsychotics are not indicated for the treatment of dementia-related psychosis\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27402?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Antipsychotic drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While treatment options other than antipsychotic medications are available for behavioral problems (eg, mood stabilizers or benzodiazepines), there are no other medication options for delusions or hallucinations. The only recourse for clinicians is to inform the patient, family, and caregivers of the mortality risk associated with antipsychotic medications in older adults, and to decide with them whether to proceed with treatment.",
"   </p>",
"   <p>",
"    If neuroleptics are used, sedating, highly anticholinergic medications such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    should be avoided, as should conventional neuroleptics such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    , which may cause parkinsonism. One population-based cohort study in nursing home patients found that the hazard ratio of death within 180 days of initiating treatment with an antipsychotic medication was twice as high for haloperidol as for atypical antipsychotics, even after adjusting for predefined potential confounding factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/37\">",
"     37",
"    </a>",
"    ]. The atypical antipsychotics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ) may be effective for agitation and psychotic symptoms in demented patients in nursing homes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/38\">",
"     38",
"    </a>",
"    ], although this is not confirmed in all studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/39\">",
"     39",
"    </a>",
"    ]. When possible, these drugs should be prescribed for short-term use with regular reassessment of risks and benefits. The use of these medications is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27402?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Antipsychotic drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972818\">",
"    <span class=\"h3\">",
"     Aggressive behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aggressive behavior develops in 20 to 57 percent of individuals with dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/40\">",
"     40",
"    </a>",
"    ]. Such behavior is particularly troubling in the nursing home where roommates are impacted and caregivers are compromised by violent outbursts. A useful framework for clinicians to use in responding to demented patients exhibiting aggressive behavior is as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assess the danger of the situation to the patient and others.",
"     </li>",
"     <li>",
"      Establish an etiology of the symptoms.",
"     </li>",
"     <li>",
"      Determine how severe and frequent the symptoms are.",
"     </li>",
"     <li>",
"      Explore past treatments and caregiver strategies for similar problems that have been effective.",
"     </li>",
"     <li>",
"      Institute non-pharmacological strategies for behavior management if no underlying medical cause discovered.",
"     </li>",
"     <li>",
"      Discuss with the patient&rsquo;s surrogate the risks and benefits of pharmacologic treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While the documented benefit of non-neuroleptic medication in this setting is limited, several nonpharmacologic strategies have been effective, including music therapy, cognitive stimulation therapy, and behavioral management therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/41\">",
"     41",
"    </a>",
"    ]. Caregiver education to help the staff manage difficult situations is paramount.",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27402?source=see_link\">",
"     \"Treatment of behavioral symptoms related to dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972825\">",
"    <span class=\"h3\">",
"     Wandering",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wandering or aimless walking around are difficult issues for nursing homes because of liability concerns as well as a cultural emphasis on patient safety. Nursing home administrators often fear that a demented resident will leave the facility and get hurt.",
"   </p>",
"   <p>",
"    Residents who simply enjoy walking in the facility and do not intend to leave the premises are frequently labeled wanderers. Creative approaches to allowing the residents freedom of movement without endangering their security include the use of door alarms, magnetized identification bracelets, enclosed patios, and circular corridors that promote contained walking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972832\">",
"    <span class=\"h2\">",
"     Falls",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls are a common problem in the nursing home, with the mean incidence of falls reported to be 1.5 falls per bed per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/42\">",
"     42",
"    </a>",
"    ]. The cause is often multifactorial, with intrinsic factors such as gait disorders, visual impairment, and dementia as well as extrinsic factors such as environmental hazards and medications contributing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22602?source=see_link\">",
"     \"Falls in older persons: Risk factors and patient evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/59/31673?source=see_link\">",
"     \"Prevention of falls in nursing care facilities and the hospital setting\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of interventions may reduce the risk of falls in the nursing home:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial found that a nursing home-based falls consultation service resulted in a 19 percent decrease in the proportion of recurrent fallers in facilities using the service compared with controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Medications should be carefully scrutinized in nursing home residents with recurrent falls: tricyclic antidepressants and selective serotonin-reuptake inhibitors (SSRIs) have been associated with a doubled risk of falls in users compared with nonusers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/44\">",
"       44",
"      </a>",
"      ], and benzodiazepines have been associated with a 44 percent increased risk of falls in nursing home residents after adjusting for comorbidities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hip protectors, which had been thought to be a valuable preventive measure, have not been found to be effective for injury protection in the nursing home. In a large randomized trial in 37 nursing homes, there was no difference in hip fracture rates between protected and unprotected hips [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/59/31673?source=see_link&amp;anchor=H971307#H971307\">",
"       \"Prevention of falls in nursing care facilities and the hospital setting\", section on 'Hip protectors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972841\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection is one of the leading causes of morbidity and mortality in the nursing home. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/34/26152?source=see_link\">",
"     \"Important sites and pathogens causing infections in long-term care facilities\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Frail elders are at high risk of contracting a variety of infections because of impaired immune defenses, multiple comorbidities, nutritional deficiencies, and exposures within the nursing home environment. In addition, patients with advanced dementia or multiple strokes often have impaired swallowing, which puts them at high risk of aspirating and developing pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/54/32618?source=see_link&amp;anchor=H1498008#H1498008\">",
"     \"Evaluation of infection in the older adult\", section on 'Factors contributing to increased risk for infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Age-appropriate immunizations (for influenza, pneumococcus, herpes zoster, as well as diphtheria-tetanus boosters) should be administered to patients in long-term care. Despite diminished vaccine efficacy in the nursing home population, vaccination will help to both prevent infection in the immunized patient and prevent spread of infection within the institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/44/41670?source=see_link\">",
"     \"Approach to immunizations in healthy adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/489?source=see_link&amp;anchor=H23#H23\">",
"     \"Principles of infection control in long-term care facilities\", section on 'Immunizations for residents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initiating antibiotic treatment in patients with advanced dementia may not achieve either the goal of life-prolongation or amelioration of symptoms. A study of fever episodes in 104 nursing home residents with Alzheimer disease found no difference in survival among those with advanced dementia treated with antibiotics and those treated with intensive comfort measures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/48\">",
"     48",
"    </a>",
"    ]. Studies have also found that antibiotic treatment was not more effective than oxygen and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    in alleviating suffering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the ethical issues posed by antimicrobial therapy, physicians must also be aware of the epidemiologic challenges posed by nursing homes. While the benefits of antibiotic treatment to the patient are small, the public health risk of fostering antibiotic resistance with treatment may be considerable. Inappropriate antibiotic use in long-term care facilities contributes to higher rates of antibiotic-resistant pathogens (eg, methicillin-resistant Staphylococcus. aureus and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -resistant Enterococcus) and to antibiotic-induced Clostridium difficile colitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/50\">",
"     50",
"    </a>",
"    ]. A study of 214 nursing home residents with advanced dementia found that over approximately one year, two-thirds received at least one course of antimicrobial therapy, with quinolones and third-generation cephalosporins most commonly prescribed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/51\">",
"     51",
"    </a>",
"    ]. Antimicrobial use increased significantly in the two weeks prior to death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Evaluation for infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors may compromise the recognition of infection in patients who are nursing home residents, including communication difficulties, medical comorbidities, and atypical presentations. Fever, as typically defined (temperature &gt;100.4F or 38C), is absent in more than 50 percent of nursing home patients with serious infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/54/32618?source=see_link&amp;anchor=H1498015#H1498015\">",
"     \"Evaluation of infection in the older adult\", section on 'General issues in diagnosis and management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infection should be suspected in nursing home residents who exhibit the following signs and symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      New or increasing confusion, incontinence, deteriorating mobility",
"     </li>",
"     <li>",
"      Decreased food intake",
"     </li>",
"     <li>",
"      Change in behavior (eg, agitation, aggressiveness)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    2008 updated guidelines from the Infectious Diseases Society of America suggest the following parameters for defining a fever in patients in long-term care facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A single oral temperature &gt;100&deg;F (37.8&deg;C), or",
"     </li>",
"     <li>",
"      Repeated oral temperatures &gt;99&deg;F (37.2&deg;C) or rectal temperatures &gt;99.5&deg;F (&gt;37.5&deg;C), or",
"     </li>",
"     <li>",
"      An increase in temperature of &gt;2&deg;F (or &gt;1.1&deg;C) over baseline",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Initial evaluation, often by nursing staff, should include assessment of respiratory rate, hydration, mental status, skin inspection, and evaluation of oropharynx, chest, heart, abdomen, and catheters if present.",
"   </p>",
"   <p>",
"    Advance directives should be reviewed prior to further assessment. A complete blood count, with differential cell counts, is reasonable as an initial test if work-up is consistent with the advance care plan. Blood cultures generally have a low yield and should be performed only when bacteremia is highly suspected. Pulse oximetry should be done for patients with tachypnea (respiratory rate &gt;25 breaths per minute). Chest radiography should be ordered when hypoxemia is present (oxygen saturation &lt;90 percent) or suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Influenza virus is typically brought into the nursing home by staff or visitors and spreads rapidly among the residents who share rooms and eat in a communal dining room. Hospitalization rates soar during epidemics as frail elderly patients develop cardiac complications, principally myocardial infarction and congestive heart failure, and pulmonary complications, particularly bronchospasm and pneumonia. In addition, many nursing home residents affected with influenza infection experience a subsequent decline in functional status, including a decrease in independence in bathing, dressing, and mobility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Every effort should be made to vaccinate residents against influenza in the early fall. Vaccination of nursing home staff has been particularly effective in preventing resident morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/489?source=see_link\">",
"     \"Principles of infection control in long-term care facilities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/489?source=see_link&amp;anchor=H24#H24\">",
"     \"Principles of infection control in long-term care facilities\", section on 'Employee health policies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If an outbreak of respiratory illness characterized by fever, nonproductive cough, and myalgias occurs, influenza should be suspected. The diagnosis of influenza is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/1/18456?source=see_link\">",
"     \"Clinical manifestations of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5528?source=see_link\">",
"     \"Diagnosis of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Emergence in the US of influenza strains resistant to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/46/13031?source=see_link\">",
"     amantadine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/10/30885?source=see_link\">",
"     rimantadine",
"    </a>",
"    has led to CDC recommendations for use of neuraminidase inhibitors",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/27/26038?source=see_link\">",
"     zanamivir",
"    </a>",
"    (inhaled) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/20/40263?source=see_link\">",
"     oseltamivir",
"    </a>",
"    (oral) for the treatment and prevention of both influenza A and B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. One study conducted in 548 frail older nursing homes residents, many of whom were vaccinated for influenza, found that prophylaxis with oseltamivir (75 mg daily) for six weeks, beginning when influenza was detected locally, reduced the incidence of laboratory confirmed influenza compared with placebo (4.4 versus 0.4 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/58\">",
"     58",
"    </a>",
"    ]. Treatment doses and prophylactic use of neuraminidase inhibitors are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22250?source=see_link\">",
"     \"Treatment of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=see_link\">",
"     \"Prevention of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional infection control measures should be instituted in the event of an influenza outbreak, including closing the affected units to new admissions and limiting the movement of both residents and staff from affected to unaffected parts of the nursing home. A coordinated approach to respiratory infection can decrease the number of cases, hospitalizations, and deaths at a relatively modest cost [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2599?source=see_link\">",
"     \"Infection control measures to prevent seasonal influenza in healthcare settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clostridium difficile",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridium difficile, another organism to which nursing home residents are particularly prone, presents an infection control challenge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/60\">",
"     60",
"    </a>",
"    ]. Debilitated patients who are treated with broad spectrum antibiotics are highly susceptible to developing C. difficile diarrhea. The organism forms spores that can survive for considerable periods on fomites, thereby leading to high transmission rates. Fecal incontinence and poor personal hygiene, both widespread problems in the nursing home, compound the risk of spread. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/18/36137?source=see_link\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnostic testing for C. difficile by culture or its toxins should be performed on diarrheal (unformed) stool (unless ileus due to C. difficile is suspected). The optimal strategy to provide timely and accurate diagnostic results is controversial. Anaerobic stool culture is the most sensitive test but has a slow turnaround time; toxin assays are less sensitive than stool culture but have fast turnaround time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link&amp;anchor=H15443551#H15443551\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\", section on 'Laboratory diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to containing C. difficile infection in the nursing home depends upon the use of precautions and minimizing the use of antibiotics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All personnel in nursing homes should be instructed in the use of universal precautions.",
"     </li>",
"     <li>",
"      When C. difficile has been diagnosed in a patient with diarrhea, universal precautions should be supplemented with enteric precautions: gloves should be used when handling body substances and all contaminated materials should be treated as infectious waste.",
"     </li>",
"     <li>",
"      Decreasing antibiotic use is important. An estimated 50 to 70 percent of nursing home residents are treated with antibiotics at least once each year; the antibiotics are unjustified in approximately 25 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/62\">",
"       62",
"      </a>",
"      ]. The staff should be educated about the high prevalence of asymptomatic bacteriuria in the nursing home and of viral upper respiratory infections, neither of which warrants the use of antibiotics. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/19/42295?source=see_link\">",
"       \"Approach to the adult with asymptomatic bacteriuria\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who develop diarrhea and are found to have C. difficile infection should be treated. When possible, the inciting antibiotic should be discontinued. Specific treatment for C. difficile colitis depends upon the severity of illness. Oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    is used as initial therapy for milder cases and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    for more severe cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/29/20954?source=see_link\">",
"     \"Clostridium difficile in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no need to retest the stool for toxin if the diarrhea resolves; the practice of requiring multiple negative stool samples, common in some nursing homes, is not supported by data. Asymptomatic patients often continue to excrete toxin for some time and do not benefit from retreatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/29/20954?source=see_link\">",
"     \"Clostridium difficile in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of asymptomatic carriers of C. difficile also is not warranted. Although the organism can be eliminated by oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    is ineffective), most carriers become culture-positive again within three weeks after therapy is discontinued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12184?source=see_link&amp;anchor=H16#H16\">",
"     \"Prevention and control of Clostridium difficile in hospital and institutional settings\", section on 'Treatment of asymptomatic carriers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Asymptomatic bacteriuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic bacteriuria can be found in approximately 50 percent of nursing home residents, both men and women. A variety of factors predispose elderly patients to develop urinary tract colonization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/65\">",
"     65",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dementia",
"     </li>",
"     <li>",
"      Physical inability to get to the toilet",
"     </li>",
"     <li>",
"      Neurologic processes affecting the bladder",
"     </li>",
"     <li>",
"      A general rise in the incidence of urinary tract infection (UTI) with age that starts in childhood and continues throughout life",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diagnostic criteria for bacteriuria in older adults are the same as those for younger subjects. However, the presence of pyuria is not specific for UTI in older nursing home subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24214?source=see_link\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of asymptomatic bacteriuria in older adults does not prevent symptomatic infection, improve urinary function, or enhance survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/19/42295?source=see_link\">",
"     \"Approach to the adult with asymptomatic bacteriuria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening for asymptomatic bacteriuria in institutionalized (or community-dwelling) older adults is not recommended by the United States Preventive Services Task Force (USPSTF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/67\">",
"     67",
"    </a>",
"    ] or the Infectious Diseases Society for America (ISDA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/68\">",
"     68",
"    </a>",
"    ]. Antimicrobial therapy is indicated, however, in patients with bacteriuria who are symptomatic (eg, who are febrile, have frequency, urgency, dysuria, lower abdominal pain, new onset incontinence, or flank pain).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia occurring in patients in the long term care setting is referred to as \"nursing home associated pneumonia\" (NHAP) and is a leading cause of death in the nursing home. Patients with advanced dementia, severe Parkinson disease, or other neurologic conditions, are at high risk for aspiration pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=see_link\">",
"     \"Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunization with pneumococcal vaccine is recommended for all residents who do not have evidence of adequate vaccination, unless the goal of care is exclusively to maintain comfort. A single dose of vaccine is recommended; a second dose is indicated if a person was under age 65 years at the time of their initial vaccination, and it has been &gt;5 years since the initial vaccination. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies have identified the importance of oral hygiene for the prevention of pneumonia in older adults (&gt;65 years of age) nursing home residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/69-72\">",
"     69-72",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 613 nursing home residents followed for one year, 112 (18 percent) developed radiographically documented pneumonia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/69\">",
"       69",
"      </a>",
"      ]. Inadequate oral care (hazard ratio 1.55) and swallowing difficulty (hazard ratio 1.61) were independently associated with pneumonia.",
"     </li>",
"     <li>",
"      The importance of oral care in preventing pneumonia and pneumonia death was illustrated in a trial of 417 patients (average age 82 years) who were in a nursing home and at baseline had poor oral health [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/70\">",
"       70",
"      </a>",
"      ]. Patients were randomly assigned to an oral care group (including nurses or caregivers brushing the teeth after every meal and hygienists providing professional care once per week) or no oral care. During two years of follow-up, patients in the non-oral care group had a significantly higher incidence of pneumonia (19 versus 11 percent in those receiving oral care, relative risk [RR] 1.67, 95% CI 1.01-2.75) and, among those who developed pneumonia, a higher incidence of death due to pneumonia (16 versus 7 percent, RR 2.40, 95% CI 1.54-3.74). The benefits of oral care were evident whether the patient had teeth or was edentulous.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pneumonia can often be successfully treated in the nursing home, with two studies showing comparable outcomes to patients treated in the hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. One of these studies showed that implementation of a clinical care pathway decreased hospitalizations by a mean of 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/74\">",
"     74",
"    </a>",
"    ]. Details of this pathway are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/36/38473?source=see_link&amp;anchor=H16#H16\">",
"     \"Community-acquired pneumonia in adults: Risk stratification and the decision to admit\", section on 'Nursing home residents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An evidence-based review recommended hospitalization for patients with two or more of the following symptoms if consistent with the patient&rsquo;s preferences or advance directives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/75\">",
"     75",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Oxygen saturation &lt;90 percent on room air",
"     </li>",
"     <li>",
"      Systolic blood pressure &lt;90 mmHg or 20 mmHg less than baseline",
"     </li>",
"     <li>",
"      Respiratory rate &gt;30 breaths per minute or 10 breaths per minute more than baseline",
"     </li>",
"     <li>",
"      Requirement for 3 liters oxygen per minute more than baseline",
"     </li>",
"     <li>",
"      Uncontrolled chronic obstructive pulmonary disease, congestive heart failure, or diabetes mellitus",
"     </li>",
"     <li>",
"      Unarousable if previously conscious",
"     </li>",
"     <li>",
"      New or increased agitation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obtaining a bacteriologic diagnosis of pneumonia is impossible in most nursing home residents; thus, initial treatment is usually empiric. The most common bacterial pathogen causing nursing home-acquired pneumonia is S pneumoniae, with S. aureus and enteric gram negative organisms commonly found in the sickest patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36858?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2098763\">",
"    <span class=\"h4\">",
"     Pneumonia in patients with advanced dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regardless of the site of treatment, the long-term prognosis for residents with advanced dementia who develop pneumonia is poor: one study found a 53 percent six-month mortality in such patients, compared with 13 percent in cognitively intact elders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/77\">",
"     77",
"    </a>",
"    ]. One prospective observational study found that nursing home patients with advanced dementia who received antibiotic treatment for pneumonia had longer survival but lower scores on measures of comfort than those who were not treated for pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/78\">",
"     78",
"    </a>",
"    ]. This suggests that, among those patients with advanced dementia for whom comfort is the overriding goal of care, it is appropriate to withhold antibiotics and focus on palliative care. When antibiotics are elected, oral administration and treatment in the nursing home may be more consistent with the goals of care than intravenous antibiotics or hospital care.",
"   </p>",
"   <p>",
"    Tube-feeding, which is sometimes recommended for nursing home residents with recurrent aspiration pneumonia, has not been shown to prevent aspiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/63/20473?source=see_link\">",
"     \"Percutaneous endoscopic gastrostomy (PEG) tubes: Uses and efficacy\"",
"    </a>",
"    .) Instead, the physician should recommend palliative care in the nursing home setting. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Palliative care'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6976451\">",
"    <span class=\"h3\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of tuberculosis in US nursing home residents was",
"    <span class=\"nowrap\">",
"     39.2/1000",
"    </span>",
"    in 2001, four times the rate of the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/80\">",
"     80",
"    </a>",
"    ]. The Centers for Disease Control recommends that patients who are admitted to long-term care facilities be screened for symptoms of tuberculosis and &ldquo;possibly a test for M. tuberculosis infection&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/81\">",
"     81",
"    </a>",
"    ], while the American Geriatrics Society has recommended a more active approach with two-step skin testing on admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/82\">",
"     82",
"    </a>",
"    ]. Two-step skin testing, with a booster test administered one week after the initial skin test, is recommended because skin test reactivity may wane in older individuals with a remote history of infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\", section on 'Repeat and serial testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Geriatrics Society has also recommended that the frequency of follow-up of PPD testing in nursing home residents who had a negative two-step test on admission should be determined by the nursing home, based on its prevalence of tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972850\">",
"    <span class=\"h2\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain is common in the nursing home setting and is often undertreated. One cross-sectional study of 49,971 patients found daily pain in 26 percent of nursing home patients of whom almost one quarter received no treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/83\">",
"     83",
"    </a>",
"    ]. Under-treated pain places patients at risk for a myriad of complications including depression, weight loss, delirium, functional decline and skin breakdown.",
"   </p>",
"   <p>",
"    The Center for Medicare and Medicaid Services (CMS) uses the prevalence of pain as a quality indicator for both short- and long-term nursing home patients. Even patients with moderately severe cognitive impairment are able to identify if they have experienced pain in the preceding five days. Accordingly, MDS 3.0 incorporates resident interviews in the assessment of pain and measures the impact of pain on quality of life by asking whether pain has impaired sleeping or day-to-day activities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients in skilled nursing facilities may experience pain that is persistent, acute, or related to end-of-life.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent pain, often caused by arthritis, is present in up to 80 percent of nursing home patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acute pain related to a new medical or surgical condition is especially prevalent in short-term patients recently discharged from the hospital. Patients with postoperative pain represent a significant subset of this population.",
"     </li>",
"     <li>",
"      Pain at the end of life is common in the skilled nursing facility, which is the site of death of 25 to 30 percent of all deaths. Malignancy is a common cause for pain at the end-of-life but other conditions such as advanced dementia have been shown to cause similar distress [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All three types of pain should be treated using the World Health Organization (WHO) pain ladder, a three-step approach that uses non-opioids, weak opioids and strong opioids coupled with adjuvant medications where appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/86\">",
"     86",
"    </a>",
"    ]. Patients with pain should be assessed as to whether pain medications should be given &ldquo;on demand&rdquo; (prn) or on a scheduled basis, and whether long",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    short acting preparations should be used. Anticipating the loss of bowel motility caused by opioids is essential. Bowel medication programs may need to be adjusted with escalations or reductions in opioid doses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9290?source=see_link&amp;anchor=H2#H2\">",
"     \"Cancer pain management with opioids: Prevention and management of side effects\", section on 'Bowel issues'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with persistent pain are often frail and elderly. They frequently have cognitive deficits and impaired communication that make obtaining an adequate history challenging. For these same reasons it can also be difficult monitoring the response to pain medications. An algorithm may be helpful in assessing pain in patients with severe cognitive impairment (",
"    <a class=\"graphic graphic_algorithm graphicRef66129 \" href=\"mobipreview.htm?36/54/37728\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Persistent pain should be managed by following the WHO pain ladder, often using scheduled rather than prn medications and using nonpharmacologic modalities including heat, cold, and range of motion exercises. Prolonged use of non-steroidal anti-inflammatory agents in this population carries risk; hence,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    and weak opioid analgesics may be preferred over non-steroidal anti-inflammatory agents for some patients.",
"   </p>",
"   <p>",
"    Factors that contribute to patients experiencing uncontrolled pain in nursing facilities include using medications with insufficient potency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inadequate frequency of administration, particularly for patients recently transitioned from parenteral to oral medications. Postacute nursing home patients typically require physical and occupational therapy, which can result in increased pain as activity increases.",
"   </p>",
"   <p>",
"    Postacute patients typically have conditions that are expected to improve. Ongoing assessment needs to be made regarding optimal timing for gradual dose reduction of pain medications. Planning how opioids will be administered and tapered after discharge is essential and must be coordinated with the clinicians who will assume care post discharge.",
"   </p>",
"   <p>",
"    Pain at the end of life poses unique challenges. Often patients are unable to take oral medications necessitating that pain medications be administered via alternate routes. Transdermal and sublingual preparations of opioids can be particularly useful in the nursing home setting. While subcutaneous injections can often be used in nursing facilities, the duration of pain relief tends to be shorter than with oral or transdermal preparations with an increased likelihood of suboptimal pain control. While some facilities are able to give pain medications via subcutaneous infusion pumps, most do not.",
"   </p>",
"   <p>",
"    Staff resistance to opioid administration at the end of life can occur and is often related to fears of causing harm to the patient. Strong physician and facility leadership coupled with educational programs for staff are essential to provide effective pain management to this population. In addition, hospice involvement can provide additional support and expertise in managing pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972857\">",
"    <span class=\"h2\">",
"     Nutrition and hydration",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6976530\">",
"    <span class=\"h3\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both short- and long-term nursing home patients are particularly vulnerable to difficulties maintaining adequate nutrition and hydration. Patients admitted from the acute care hospital setting are at risk for weight loss because they may have been NPO or on a restricted diet in the hospital for significant periods of time perioperatively or in order to obtain imaging studies. In addition, delirium, pain and gastrointestinal disorders can impact nutritional status even after such conditions resolve or improve. Institutional settings may not provide food choice offerings that match patient preferences. Chronic illness, depression and medication side effects can further cause or contribute to anorexia and weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/87\">",
"     87",
"    </a>",
"    ]. Long stay nursing home patients often have chronic, progressive illnesses that impact appetite, chewing, swallowing and digesting of food, and some weight loss is unavoidable.",
"   </p>",
"   <p>",
"    The Centers for Medicare and Medicaid Services (CMS) standards dictate that every nursing home resident should be provided with sufficient food and fluids to maintain proper nutrition and hydration. Nursing facilities assess patients for weight loss as part of the MDS assessment process. Unintentional weight changes of 5 percent in 30 days and 10 percent in 180 days require care plan review. Studies indicate that unintentional weight loss of 5 percent is a marker for a 5 to 10-fold increased risk of death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/88\">",
"     88",
"    </a>",
"    ]. Information regarding prior weights is often lacking on new nursing home admissions and may not be identified by routine screening procedures. Laboratory markers of malnutrition are non-specific and can be influenced by renal and hepatic disease as well as medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/87\">",
"     87",
"    </a>",
"    ]. Hence, weight loss is often identified or suspected based on history, physical exam findings and monitoring of intake.",
"   </p>",
"   <p>",
"    Nursing facilities should document whether weight loss is expected or is unintentional. In residents who are terminally ill, weight loss may be unavoidable and palliative treatment plans should be in place indicating that low oral intake and weight loss is expected. If unintended weight loss is present, the resident should be assessed for remediable causes.",
"   </p>",
"   <p>",
"    The interdisciplinary team is important in the prevention and management of weight loss. Facilities have registered dieticians who perform nutritional assessments and can make recommendations regarding diet and the use of nutritional supplements. The Mini-Nutritional Assessment (MNA) can identify patients with, or at risk for, malnutrition with 96 percent sensitivity and 98 percent specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interventions related to weight loss and optimizing nutrition need to be integrated with the patients&rsquo; overall goals and a well documented plan of care. Interventions by speech therapists, occupational therapists, or behavioral health clinicians may be indicated, depending on the etiology of the weight loss. Dysphagia, for example, is commonly associated with neurologic problems such as Parkinson disease, Alzheimer disease, or stroke. Postacute patients may have oral infections such as thrush, inflammation related to radiation therapy or dentures that are misplaced or ill-fitting. Speech therapists can identify the most appropriate food consistency and can work with patients to optimize chewing and swallowing techniques. Impaired dexterity, whether due to arthritis, stroke, or a recent fracture, can make it difficult for patients to use utensils. Occupational therapists can teach patients to use assistive devices such as utensils with thickened handles that are easy to grasp. Nursing assistants provide supervision, encouragement and assistance with feeding. Nursing home staff members also teach family members and other caregivers how to manage these nutrition-related issues prior to discharge to home for short stay patients.",
"   </p>",
"   <p>",
"    Patients with advanced dementia often have difficulty chewing and swallowing. There is no evidence that percutaneous endoscopic gastrostomy tubes improve nutritional status or prolong life in the nursing home resident with advanced dementia, the most common situation in which dysphagia occurs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/90\">",
"     90",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/63/20473?source=see_link&amp;anchor=H7#H7\">",
"     \"Percutaneous endoscopic gastrostomy (PEG) tubes: Uses and efficacy\", section on 'Long-term care facilities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depression is a major factor associated with malnutrition, and weight loss in older persons is a condition for which antidepressant medication is often indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/91\">",
"     91",
"    </a>",
"    ]. However, antidepressants can also cause anorexia (selective serotonin uptake inhibitors (SSRI's)) or anticholinergic symptoms such as dry mouth and constipation (tricyclic antidepressants). Evidence suggests that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    may be more effective than SSRI&rsquo;s in promoting weight gain, most likely because its mechanism of action is both serotonergic and noradrenergic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oral supplements are often used in the management of weight loss. A meta-analysis of 15 studies in malnourished geriatric patients (including some patients in hospital, as well as nursing home, settings) found a small survival advantage for patients provided with liquid diet supplements compared to no specific nutrition treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/93\">",
"     93",
"    </a>",
"    ]. Factors that may interfere with the success of oral supplements in the nursing home include inadequate nursing staff time to deliver and assist with the between-meal supplements, interference with calorie consumption at meals, and unrealistic dosing schedules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/94\">",
"     94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/12/31946?source=see_link&amp;anchor=H19#H19\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\", section on 'Nutritional supplements'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When no reversible etiology of weight loss is identified,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/55/33653?source=see_link\">",
"     megestrol acetate",
"    </a>",
"    is often tried. Evidence of benefit is weak, since studies in the nursing home population are small and inconclusive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/95\">",
"     95",
"    </a>",
"    ]. Based on limited data, it is unlikely that benefits from megestrol use outweigh potential adverse effects. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/12/31946?source=see_link&amp;anchor=H20#H20\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\", section on 'Appetite stimulants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/40/42628?source=see_link\">",
"     Total parenteral nutrition",
"    </a>",
"    (TPN) is sometimes advocated in the setting of weight loss. However, few nursing facilities have the clinical resources and expertise to manage TPN. This modality of nutrition should be limited to short-term use for a reversible condition and feeding via the gastrointestinal route should be restarted as soon as possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6976657\">",
"    <span class=\"h3\">",
"     Hydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older individuals are at increased risk of dehydration due to an impaired thirst mechanism and age-related reduction in renin and aldosterone production that results in increased renal excretion of salt and water. This risk is magnified in the cognitively impaired nursing home resident who may be unable to articulate the experience of thirst and in the physically impaired resident who may have difficulty procuring fluids. Medications such as diuretics further increase the risk of dehydration. Simple interventions such as regularly offering fluids to residents have been shown to significantly decrease the frequency with which dehydration develops [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The symptoms of dehydration in frail elders are often nonspecific, such as a change in mental status or falls. Only with more profound degrees of volume depletion, typically associated with marked hypernatremia and uremia, will orthostatic hypotension and dry mucous membranes be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For residents in whom a decision is made to provide artificial hydration, subcutaneous fluid infusion (hypodermoclysis) is an underused option for treatment of mild to moderate dehydration. Clysis is especially useful in patients with poor veins or those who repeatedly remove intravenous lines secondary to agitation; it is also useful in facilities without continuous availability of nurses or physicians to insert an intravenous catheter. Clysis has been associated with clinical improvement in 57 percent of cases, compared with 81 percent of cases in which intravenous hydration was utilized [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972866\">",
"    <span class=\"h2\">",
"     Pressure ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of pressure ulcers is an important quality indicator in nursing facilities. Pressure ulcers are often painful and increase the risk for reduced mobility, infection, and death in nursing facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/99\">",
"     99",
"    </a>",
"    ]. Whether the pressure ulcers are an independent risk factor for mortality, or are a marker for underlying comorbidities, is unclear.",
"   </p>",
"   <p>",
"    MDS 3.0 requires assessment by nursing facility staff of patients for pressure ulcers based on the Pressure Ulcer Scale for Healing tool (PUSH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/100\">",
"     100",
"    </a>",
"    ]. This tool standardizes documentation of pressure ulcers based on location and size. In addition, pressure ulcers are staged by a I-IV grading system based on the degree of penetration into underlying structures. When the wound bed cannot be adequately visualized because of slough, wounds are &ldquo;unstageable.&rdquo; (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/20/34120?source=see_link\">",
"     \"Pressure ulcers: Epidemiology, pathogenesis, clinical manifestations, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nursing home patients are at risk for pressure ulcers for a variety of reasons including immobility after surgical procedures, impaired nutritional intake, sensory and cognitive impairment, and incontinence. Hip fractures and strokes can lead to pressure ulcers of the heel, coccyx and sacrum because of pain and reduced mobility. Patients with terminal conditions may choose to forgo interventions that could reduce the risk of pressure ulcer development or promote pressure ulcer healing. Examples include requests to minimize repositioning or decisions to decline surgical debridement or wound grafts.",
"   </p>",
"   <p>",
"    The extent to which pressure ulcers are preventable is controversial. In surveys of prevention practices among hospitalized Medicare beneficiaries, there was no link between documentation of a quality indicator such as being on a turning schedule every two hours or using a pressure&ndash;reducing device and the incidence of pressure ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/99\">",
"     99",
"    </a>",
"    ]. Nonetheless, these modalities are an integral part of pressure ulcer care. A cost-effectiveness analysis based upon a Markov model compared four potential strategies to prevent pressure ulcers in the nursing home setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/101\">",
"     101",
"    </a>",
"    ]. Assuming a cost-effective threshold of $50,000 for one quality-adjusted life year (QALY), using a foam-cleanser for patients needing incontinence care and using pressure redistribution mattresses for all residents were likely to be cost-effective; skin-emollients for dry skin and oral nutritional supplements for residents with recent weight loss were likely not cost-effective.",
"   </p>",
"   <p>",
"    MDS 3.0 requires documentation of interventions put in place to manage pressure ulcers including pressure relieving devices, positioning and turning protocols and specific wound treatments. Pressure ulcer management requires an interdisciplinary approach for which the nursing home environment can be well-suited. Nurses, dieticians, nursing aids, physical, occupation and speech therapists and wound care consultants all have roles to play in pressure ulcer management. Their services and interventions must be coordinated in order to develop, implement and monitor a plan of care to meet the needs of a patient at risk for developing or with a pressure ulcer. The attending physician must oversee this effort and enlist additional consultation when appropriate.",
"   </p>",
"   <p>",
"    Patients with pressure ulcers often are nutritionally compromised based on assessments such as prealbumin and albumin levels, calorie counts and weight loss. These patients usually have coexisting medical issues that affect appetite and nutrient absorption. Healing of wounds is thought to require higher protein intake over baseline. Small studies have found oral nutritional supplementation helpful in the healing of pressure ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/102\">",
"     102",
"    </a>",
"    ]. Zinc and vitamin C have been found in small randomized trials to promote wound healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of products may be used in the care of pressure ulcers. Product choice is based on the specific characteristics of the wound: the presence of slough, the amount of exudate, and the size and depth of the wound. The general categories of wound care products available for pressure ulcers are hydrogels, hydrocolloid dressings and alginates. Hydrogels are used in shallow wounds to keep the wound bed moist and often need to be changed one or more times per day. Hydrocolloid dressings are used for larger wounds and can absorb small amounts of exudate. They often do not require daily changes. For wounds with high volumes of exudate, alginates are used. In addition, some wounds with excess slough may benefit from topical debriding agents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=see_link\">",
"     \"Treatment of pressure ulcers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vacuum-assisted closure devices are commonly used to assist with wound healing for both acute and chronic wounds. They decrease the need for frequent dressing changes but are very costly. Little data indicate they are superior to other commonly used modalities for the treatment of pressure ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972875\">",
"    <span class=\"h2\">",
"     Prevention of adverse drug events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polypharmacy, traditionally defined as taking five or more medications, puts patients at increased risk of adverse drug reactions and, especially in frail older individuals, is associated with risks of falling, delirium, and other geriatric syndromes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/104\">",
"     104",
"    </a>",
"    ]. While MDS 2.0 used nine medications as the threshold for worrisome polypharmacy, MDS 3.0 has eliminated the simple numerical approach. The focus is now exclusively on medications with a high risk of side effects, principally antipsychotics, anxiolytics, anticoagulants, and hypnotics. This change acknowledges that multiple medications are often used synergistically for many common conditions. However, the risk of medication-related problems is proportional to the number of medications taken. Nationally, 68.8 percent of residents in nursing homes in the United States take nine or more medications and nearly 20 percent take antipsychotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/105\">",
"     105",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=see_link&amp;anchor=H18186995#H18186995\">",
"     \"Drug prescribing for older adults\", section on 'Polypharmacy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Age-related pharmacodynamic and pharmacokinetic changes increase the vulnerability of older nursing facility patients to adverse reactions from medications. Drug accumulation is related to changes in the distribution and concentration of drugs due to increase in body fat, and decreased hepatic and renal clearance. Enhanced central nervous system sensitivity to anticholinergic agents predisposes older patients to problems such as delirium, constipation, urinary retention and gait instability.",
"   </p>",
"   <p>",
"    Medication toxicity is a major cause of hospitalization in older patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/106\">",
"     106",
"    </a>",
"    ]. In a study of risk factors for adverse drug events among nursing home residents, independent risk factors included taking opioid medications, antipsychotics, antidepressants, taking more than nine medications, and multiple comorbidities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/107\">",
"     107",
"    </a>",
"    ]. All nursing facility staff need to be alert to common medication related side effects such as altered mental status, falls, constipation, and functional decline. It is also important for facilities to have a culture that encourages the reporting of adverse drug events or medication errors so that systems can be improved.",
"   </p>",
"   <p>",
"    Care transitions accentuate the risks from polypharmacy. Patients often go from hospital to nursing facility with no explanation as to why certain medications are being given, why doses may have been changed, and what medications may have been purposely omitted. Nursing staff need to be encouraged to question orders if the indication for medications they are administering is unclear. Proton pump inhibitors (PPIs) are one class of medication, frequently prescribed during hospitalization, that often may be safely discontinued in patients without known gastric acid disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/108\">",
"     108",
"    </a>",
"    ]. PPIs have been associated with increased risk for pneumonia, C difficile infection, and osteoporotic fracture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25034?source=see_link&amp;anchor=H59974871#H59974871\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\", section on 'Safety'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An accurate medication list that reflects prehospitalization medications and changes made during the hospital stay is often not available when patients arrive at nursing facilities. Effective medication reconciliation is the gold standard for all nursing home admissions. When medication dosing or indications are unclear, family members, prior physicians and pharmacies must be contacted for clarification. When available, electronic medical records should be reviewed.",
"   </p>",
"   <p>",
"    The nursing home can reduce unnecessary medication use through pharmacy consultants who review medication regimens and make recommendations to eliminate medications, modify dosages or to monitor parameters with clinical or laboratory tests. Compared to usual care, involvement of a pharmacist to review medications on transfer from the hospital to the acute care facility and to communicate recommended changes to the attending clinician decreased the risk of a discrepancy-related adverse drug event (OR 0.11, 95% CI 0.1-1.0) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/109\">",
"     109",
"    </a>",
"    ]. A cluster randomized trial of a pharmacist-led medication review in 25 facilities likewise was found to decrease the rate of delirium in nursing home residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The issuance of monthly medication sheets serves as an opportunity for reviewing medication regimens on longer stay patients. As the nursing home patient's status changes, medications that were once appropriate may no longer be necessary. A study in 22 nursing homes in the Boston area found that 37.5 percent of patients with advanced dementia received at least one medication that was not appropriate in late dementia (most commonly acetylcholinesterase inhibitors and lipid lowering agents) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several factors may contribute to polypharmacy in older adults. Frail patients often have multiple chronic diseases, each of which typically triggers a clinical algorithm designed to define optimal care. However, what is optimal for a patient with one disease is not necessarily optimal for someone with multiple conditions; moreover, patients whose life expectancy is limited and whose goal of care is comfort may not be appropriate candidates for algorithms designed to prolong life. Risk-benefit analysis is needed in considering indications for treatment for all conditions, and particularly for diabetes, osteoporosis, hypertension, and hyperlipidemia in the nursing home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/112\">",
"     112",
"    </a>",
"    ]. Polypharmacy also results when the side effects of medication are interpreted as a new condition which is then treated with an additional medication rather than by stopping or adjusting the dose of the offending medication. As an example, laxatives may cause diarrhea, leading to the prescription of anti-diarrheal agents instead of discontinuing the laxative.",
"   </p>",
"   <p>",
"    Discharges from the nursing facility to home provide an opportunity to review and optimize the medication regimen. Schedules should be practical and patients or caregivers need to understand the indication and potential side effects of all medications. It is also important to be sure that patients can afford to buy their medications. Finally, the physician(s) assuming care for the patient must receive an accurate medication list.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972884\">",
"    <span class=\"h2\">",
"     Urinary and bowel issues",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49568988\">",
"    <span class=\"h3\">",
"     Incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary incontinence, affecting at least 57 percent of nursing home residents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/113\">",
"     113",
"    </a>",
"    ], is associated with increased risk of hospitalization, urinary tract infection, and pressure ulcers, and significantly impairs quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Practice guidelines outlining an accepted approach to the diagnosis and management of incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/115\">",
"     115",
"    </a>",
"    ] have been adapted for use in the nursing home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. The diagnosis and treatment of urinary incontinence is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link\">",
"     \"Treatment of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnosis and management of urinary incontinence in the nursing home setting includes the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Establish a diagnosis of the type of incontinence (stress, urge, overflow, mixed, or functional) with a targeted history and physical examination.",
"     </li>",
"     <li>",
"      Evaluate for potentially reversible conditions such as delirium, urinary retention, bladder infection, diabetes, or medications (eg, anticholinergics and diuretics).",
"     </li>",
"     <li>",
"      Institute prompted voiding, which was found to be somewhat effective at short-term follow-up in reducing daytime incontinence in two systematic reviews of randomized trials involving nursing home patients with cognitive impairment and urinary incontinence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/118,119\">",
"       118,119",
"      </a>",
"      ]. One study suggested a persistent benefit four months after the intervention period [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/120\">",
"       120",
"      </a>",
"      ]. Most trials used research staff to provide the prompting intervention, and it is uncertain whether implementation with usual nursing staff would be similarly effective, given constraints of added cost and nursing time.",
"     </li>",
"     <li>",
"      Consider an exercise program (graded strength and endurance training) as an adjunct to prompted voiding, although its effectiveness is uncertain, with benefit found in two trials and no benefit in one [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/119\">",
"       119",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Consider pharmacologic therapy with antimuscarinic agents, which have been shown to be effective in older adults in the community, although the applicability of findings to the nursing home population is uncertain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/119\">",
"       119",
"      </a>",
"      ]. Studies of these drugs in the nursing home are generally of poor quality, and these patients may be particularly vulnerable to adverse effects (dry mouth, constipation, confusion). The extended release forms of antimuscarinic medications appear to produce fewer adverse drug reactions and a lower incidence of dry mouth [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/117\">",
"       117",
"      </a>",
"      ]. Antimuscarinic agents may be tried for selected patients with urge incontinence (detrusor hyperactivity) who attempt to toilet, with close monitoring for adverse effects.",
"     </li>",
"     <li>",
"      Evaluate further with urodynamic studies or a gyneco-urologic assessment if incontinence persists. CMS uses the prevalence of urinary incontinence as a quality indicator.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49569008\">",
"    <span class=\"h3\">",
"     Constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintaining continence and avoiding constipation are the two major goals of bowel management in nursing facilities. Constipation is common in nursing home patients, with nearly 50 percent of nursing home patients using laxatives regularly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/121\">",
"     121",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35048?source=see_link\">",
"     \"Constipation in the older adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Constipation can lead to anorexia, urinary retention, incontinence, social isolation, rectal prolapse and fecal impaction which in turn increase the risk of hospitalization. Rarely, severe constipation results in intestinal perforation.",
"   </p>",
"   <p>",
"    Many medications cause constipation including anticholinergics, opioids, iron, calcium and non-steroidal anti-inflammatory agents. Recognition of constipation is impeded in patients with cognitive deficits and impaired communication abilities. Constipation may also be missed because of suboptimal communication amongst nursing staff. Constipation can lead to polypharmacy if it is managed with laxatives rather than by eliminating or modifying the inciting medication(s).",
"   </p>",
"   <p>",
"    Privacy, responsiveness and flexibility around the timing of toileting are important factors in helping avoid constipation and incontinence. There is variation in nursing facilities both in types of medications used to manage constipation and the amount of staff time required to deliver constipation related care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nursing home patients recently discharged from an acute care hospital often have constipation related to inactivity, impaired oral intake, medications such as opioids, and hospital-related environmental factors. These factors often resolve as functional status, diet and the overall medical condition improves. Accordingly, bowel medications may need to be initiated on admission but reduced or eliminated later in the course of the nursing home stay.",
"   </p>",
"   <p>",
"    If constipation does not respond to treatment, the patient should be assessed for fecal impaction. Sometimes liquid stool is passed around a fecal impaction delaying the diagnosis of constipation. Urinary retention may also be a symptom of fecal impaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6972893\">",
"    <span class=\"h1\">",
"     ADVANCE CARE PLANNING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in the nursing home setting often are elderly, frail, and have life-limiting conditions. They are at high risk for morbidity and mortality. Cognitive impairment from reversible or permanent causes is frequent. Identification of surrogate decision makers and establishing the goals of care are essential in this population.",
"   </p>",
"   <p>",
"    Nursing homes in the United States, like other health care institutions receiving federal funding, are required by the Patient Self-Determination Act (PSDA) of 1990 to ask residents if they have an advance directive and, if they do not, whether they would be interested in information about advance care planning. Since implementation of the PSDA, the rate of completion of advance directives among nursing home residents has risen from 5 to 35 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/123\">",
"     123",
"    </a>",
"    ]. Identifying a surrogate to serve as health care proxy in the event that important medical decisions must be made is imperative since the majority of long-term nursing home residents have some degree of dementia, and even cognitively intact older individuals are at risk of delirium should they become acutely ill.",
"   </p>",
"   <p>",
"    Conversations between the nursing home resident and the health care proxy can help prioritize among the patient's goals of care (eg, life-prolongation, maintenance of function, maximization of comfort) and allow the proxy, working with the physician, to infer what kind of approach to treatment would be most appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/124\">",
"     124",
"    </a>",
"    ]. Living wills and instructional directives may also be of use. A systematic program to increase the use of advance directives in nursing homes can reduce utilization of health care services (and therefore reduce costs) , without adversely affecting patient or family satisfaction or mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/125\">",
"     125",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=see_link\">",
"     \"Ethical issues near the end of life\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assessment of decision-making capacity of a patient is needed in order to determine if a health care proxy needs to be activated. This assessment is often performed with the input from the nursing home care team including physician, therapists, nurses, and social worker. Mental health clinicians may be asked to participate as well. This includes the ability of the patient to understand current medical issues and the ramifications of choosing or not choosing specific treatments. Facilities may require that the physician meet specific documentation requirements in order to activate a health care proxy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14473?source=see_link&amp;anchor=H6#H6\">",
"     \"Legal aspects of end of life care\", section on 'Assessing decision-making capacity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Cardiopulmonary resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specifying the desired response to a possible cardiopulmonary arrest is critically important in the nursing home setting. Nursing homes differ in their policies toward resuscitation (CPR): some facilities provide on-site CPR; others contact emergency medical technicians with advanced life support training in the event of an arrest; a few homes specifically state that they do not offer CPR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/126\">",
"     126",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=see_link\">",
"     \"Ethical issues near the end of life\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unfortunately, there are no large-scale studies of the outcome of CPR in the skilled nursing facility. In two small studies in geriatric care facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/127,128\">",
"     127,128",
"    </a>",
"    ] and one study that reviewed survival in patients over age 70 from a combination of acute care, chronic care and long-term care facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/129\">",
"     129",
"    </a>",
"    ], survival rates following out-of-hospital CPR were low. As an example, in a retrospective review of patients in a multilevel facility that offered a 24-hour a day on-site code team, 41 patients underwent CPR during the course of the study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/127\">",
"     127",
"    </a>",
"    ]. There were only four survivors of 60 days or more; three were short-term patients who had previously been ambulatory and virtually independent in their activities of daily living. One fully dependent bed-ridden patient returned to that level of care for a survival period of 100 days. Of the four long-term survivors, three of the arrests were witnessed, and one was indeterminate. No unwitnessed arrests resulted in long-term survival. Other studies have reported that only 1 percent of individuals who arrested in a nursing home survived to be discharged from the acute hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The data on functional status of those who do survive is scarce. A study of in-hospital cardiac arrests among sick, older individuals found that 44 percent experienced a decline in function at two months following the event, with an average decline of 3.9 activities of daily living [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advance directives should be portable; discussions about the goals of treatment or limitations of treatment should travel with a nursing home resident who is subsequently hospitalized. In practice, however, they do not regularly survive the move from one setting to another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/131\">",
"     131",
"    </a>",
"    ]. Documentation of advance care planning should accompany residents who are hospitalized, and a formal mechanism should be put in place to promote communication between the nursing home and the acute care hospital. A uniform system of documentation, such as the Physician Order Form for Life-Sustaining Treatment (POLST), introduced in Oregon and subsequently available in several states, can vastly improve communication between the nursing home and the acute care hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/132\">",
"     132",
"    </a>",
"    ]. In addition, using the POLST as part of the advance care planning process has been shown in a retrospective cohort study to result in 98 percent of residents having orders about life-sustaining treatment beyond cardiopulmonary resuscitation, compared to 16 percent in residents with no POLST usage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to specifying whether particular interventions such as CPR or intubation are desired, nursing home residents may request that they not be hospitalized at all. The option of a \"do not hospitalize\" order should be available since around-the-clock nursing care is already provided at the nursing home, laboratory tests can often be obtained, medications can be administered (and in some facilities, intravenous therapy), and a physician is on-call.",
"   </p>",
"   <p>",
"    One form of advance care planning that has been used successfully in a number of institutions is a system of defining levels of care. A sample schema designates the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Level I &mdash; All forms of medical care, including attempted CPR and intensive care",
"     </li>",
"     <li>",
"      Level II &mdash; Hospital level care exclusive of CPR and intensive care",
"     </li>",
"     <li>",
"      Level III &mdash; Medical treatment available at the nursing home",
"     </li>",
"     <li>",
"      Level IV &mdash; Palliative care only",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Implementation of such a system requires extensive education of staff, residents, families, and physicians but has the virtue of clarifying in advance the approach to be taken in the event of acute illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/134,135\">",
"     134,135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The likelihood of hospitalization is significantly increased in patients with dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/136\">",
"     136",
"    </a>",
"    ]. Restricting treatment to the nursing home may be particularly reasonable in the case of severely demented individuals for whom transfer to another location can be traumatic and who will have difficulty undergoing the procedures available in the acute hospital. Discussion with patients and their families about the goals of care may lead to a \"do not hospitalize\" order or to enrollment in hospice. Orders to forgo hospitalization for patients with advanced dementia are written for only a minority of such patients, with rates varying between states from 0.7 to 25.9 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/137\">",
"     137",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Palliative care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even though the majority of residents of long-stay nursing homes die in the facility and about one-quarter of all deaths in the US take place in the nursing home, access to palliative care services has been limited. Most nursing homes do not have palliative care consultation available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/138\">",
"     138",
"    </a>",
"    ]. Moreover, in a large national study, only 41.6 percent of bereaved family members whose loved one died in a nursing home reported the quality of care as excellent compared to 70.7 percent of family members whose loved one was home with hospice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/139\">",
"     139",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study found that the quality of care of dying nursing home patients improved with the addition of hospice, with the percent of families rating physical symptom control as good or excellent rising from 64 to 93 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/140\">",
"     140",
"    </a>",
"    ]. Hospice use in the nursing home has been rising, going from 14 percent in 1999 to 33 percent in 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/141\">",
"     141",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32008?source=see_link\">",
"     \"Hospice: Philosophy of care and appropriate utilization in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11661985\">",
"    <span class=\"h1\">",
"     PREVENTING UNNECESSARY HOSPITALIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute hospitalization exposes patients to the risk of hospital-associated delirium, iatrogenic infections, falls, and increases medical care costs. Hospitalizations may be unnecessary or avoidable for nursing home patients for one of several reasons, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient&rsquo;s goals of care are not consistent with acute hospitalization",
"     </li>",
"     <li>",
"      The condition can be appropriately treated in the nursing home setting",
"     </li>",
"     <li>",
"      Appropriate preventive measures might have avoided the acute condition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With these factors in mind, several strategies have been proposed to avoid inappropriate hospitalization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preventive interventions can decrease the risk of many &ldquo;ambulatory-care sensitive conditions&rdquo; that account for hospitalizations in older adults. These conditions include bacterial pneumonia, heart failure, dehydration, duodenal ulcer, and urinary tract infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/136\">",
"       136",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Early recognition of medical problems with proactive treatment may avoid later need for hospitalization. A study of 25 nursing homes using such an approach found a 17 percent decrease in hospitalization rate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/142\">",
"       142",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alternatives to surgical procedures for nursing home patients (eg, medical treatment for appendicitis) could avoid the increased operative mortality and perioperative morbidity experienced by nursing home patients after major surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/143\">",
"       143",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Medication reconciliation can ensure that no clinically important medications have been omitted when patients are transferred between settings. (See",
"      <a class=\"local\" href=\"#H6972875\">",
"       'Prevention of adverse drug events'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      An alert to clinicians identifying hospice-eligible nursing home patients led to an increase in patients enrolled in hospice and to a 40 percent decrease in subsequent acute care admissions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/144\">",
"       144",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11662087\">",
"    <span class=\"h2\">",
"     Rehospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Readmission to the hospital of older individuals has increasingly been identified as a major problem. Among Medicare beneficiaries who were discharged from an acute care hospital in 2003 to 2004, 19.6 percent were rehospitalized within 20 days and 24.0 percent within 90 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/145\">",
"     145",
"    </a>",
"    ]. Rates of rehospitalization are higher for patients discharged to skilled nursing facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/146\">",
"     146",
"    </a>",
"    ], and it has been estimated that as many as 40 percent of the readmissions from such facilities may be avoidable with high-quality skilled care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/147\">",
"     147",
"    </a>",
"    ]. Care transitions are particularly burdensome for residents with advanced dementia. One study of care transitions prior to death in 475,000 nursing home residents with advanced dementia found burdensome transitions (transfers in the last three days of life, lack of continuity in nursing homes in the last 90 days of life, or multiple hospitalizations in the last 90 days of life) occurred in 20 percent of those studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/9/42138/abstract/148\">",
"     148",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients entering long-term nursing home care should undergo comprehensive geriatric assessment. In long-term care facilities in the United States, the Minimum Data Set is a tool for the comprehensive evaluation of residents at the time of admission and serves as a basis for development of individual treatment plans. At the time of admission, residents of long-term care facilities should undergo evaluation for vision and hearing impairments, dementia, delirium, depression, fall risk, active infection, immunization status, pain, weight loss, pressure ulcers, continence, and use of inappropriate medications. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Comprehensive geriatric assessment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26429831\">",
"       'The Minimum Data Set'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Behavioral issues can be difficult challenges in the nursing home setting. Delirium is often unrecognized and should be considered as a potential cause of disruptive behavior. Delirium requires assessing for and managing underlying medical conditions, including electrolyte imbalance, dehydration, pain, and infection. Although antipsychotic agents are considered chemical restraints and their use is carefully scrutinized in the nursing home setting, psychotic symptoms and aggressive behaviors may need to be managed with psychotropic medications, typically atypical antipsychotics. (See",
"      <a class=\"local\" href=\"#H6972786\">",
"       'Delirium'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6972802\">",
"       'Behavioral issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Depression is widespread and undertreated in nursing homes. SSRIs are the drug of choice, and tricyclic antidepressants should be avoided due to the high risk of anticholinergic effects. (See",
"      <a class=\"local\" href=\"#H6972793\">",
"       'Depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      This risk of falls may be reduced by multidisciplinary interventions and by limiting medications that are associated with falls. (See",
"      <a class=\"local\" href=\"#H6972832\">",
"       'Falls'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nursing home staff and residents should be vaccinated for influenza in the early fall. In the event of an influenza outbreak, exposed residents should receive antiviral prophylaxis. Additional infection control measures should be instituted such as limiting movement between affected and unaffected units of the nursing home and closing affected units to new admissions. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Influenza'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Debilitated patients who are treated with broad spectrum antibiotics are highly susceptible to developing C. difficile diarrhea. When C. difficile has been diagnosed in a patient with diarrhea, universal precautions should be supplemented with enteric precautions. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clostridium difficile'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pain is common and often undertreated in the nursing home setting. Pain at the end of life poses unique challenges; transdermal and sublingual preparations of opioids can be particularly useful. (See",
"      <a class=\"local\" href=\"#H6972850\">",
"       'Pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unintentional weight loss is correlated with increased mortality and requires evaluation for reversible causes, such as depression, oral or neurologic issues, or medication side effects. There is no evidence that percutaneous endoscopic gastrostomy tubes improve nutritional status or prolong life in the nursing home resident with advanced dementia. Oral nutritional supplements may be modestly helpful. (See",
"      <a class=\"local\" href=\"#H6976530\">",
"       'Nutrition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Policies to regularly offer fluids may prevent dehydration. When artificial hydration is indicated, subcutaneous fluid infusion may be an alternative to intravenous fluids. (See",
"      <a class=\"local\" href=\"#H6976657\">",
"       'Hydration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pressure ulcer management requires an interdisciplinary approach. Patients with pressure ulcers often are nutritionally compromised and may require increased protein intake for wound healing. (See",
"      <a class=\"local\" href=\"#H6972866\">",
"       'Pressure ulcers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Care transitions accentuate the risks from polypharmacy. Pharmacists and physicians should regularly review medication lists, with recognition that indications for treatment change as patient status changes. (See",
"      <a class=\"local\" href=\"#H6972875\">",
"       'Prevention of adverse drug events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Advance care planning is an important part of nursing home care. In addition to addressing issues around resuscitation, residents should be given the option of choosing not to be hospitalized in the event of illness. (See",
"      <a class=\"local\" href=\"#H6972893\">",
"       'Advance care planning'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Medicare and Medicaid Services. Nursing Home Data Compendium 2009 Edition. Available at: https://www.cms.gov/CertificationandComplianc/Downloads/nursinghomedatacompendium_508.pdf (Accessed on October 18, 2011).",
"    </li>",
"    <li>",
"     Henry J Kaiser Family Foundation. Medicaid and long-term care services and supplies, October 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/3\">",
"      Zweig SC, Popejoy LL, Parker-Oliver D, Meadows SE. The physician's role in patients' nursing home care: \"She's a very courageous and lovely woman. I enjoy caring for her\". JAMA 2011; 306:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/4\">",
"      Keeler EB, Robalino DA, Frank JC, et al. Cost-effectiveness of outpatient geriatric assessment with an intervention to increase adherence. Med Care 1999; 37:1199.",
"     </a>",
"    </li>",
"    <li>",
"     American Geriatrics Society. Comprehensive geriatric assessment position statement 2005. Available at: www.americangeriatrics.org/products/positionpapers/cga.shtml (Accessed on April 30, 2007).",
"    </li>",
"    <li>",
"     https://www.cms.gov/NursingHomeQualityInits/25_NHQIMDS30.asp.",
"    </li>",
"    <li>",
"     file://www.medicare.gov/NHCompare (Accessed on January 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/8\">",
"      Owsley C, McGwin G Jr, Scilley K, et al. Effect of refractive error correction on health-related quality of life and depression in older nursing home residents. Arch Ophthalmol 2007; 125:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/9\">",
"      Owsley C, McGwin G Jr, Scilley K, et al. Impact of cataract surgery on health-related quality of life in nursing home residents. Br J Ophthalmol 2007; 91:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/10\">",
"      Friedman DS, Mu&ntilde;oz B, Roche KB, et al. Poor uptake of cataract surgery in nursing home residents: the Salisbury Eye Evaluation in Nursing Home Groups study. Arch Ophthalmol 2005; 123:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/11\">",
"      Cohen-Mansfield J, Taylor JW. Hearing aid use in nursing homes. Part 1: Prevalence rates of hearing impairment and hearing aid use. J Am Med Dir Assoc 2004; 5:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/12\">",
"      Cohen-Mansfield J, Infeld DL. Hearing aids for nursing home residents: current policy and future needs. Health Policy 2006; 79:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/13\">",
"      Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc 2003; 51:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/14\">",
"      Chodosh J, Edelen MO, Buchanan JL, et al. Nursing home assessment of cognitive impairment: development and testing of a brief instrument of mental status. J Am Geriatr Soc 2008; 56:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/15\">",
"      Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008; 148:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/16\">",
"      Qaseem A, Snow V, Cross JT Jr, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008; 148:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/17\">",
"      Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med 2009; 361:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/18\">",
"      Mitchell SL, Miller SC, Teno JM, et al. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA 2010; 304:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/19\">",
"      Jones RN, Kiely DK, Marcantonio ER. Prevalence of delirium on admission to postacute care is associated with a higher number of nursing home deficiencies. J Am Med Dir Assoc 2010; 11:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/20\">",
"      Kiely DK, Bergmann MA, Murphy KM, et al. Delirium among newly admitted postacute facility patients: prevalence, symptoms, and severity. J Gerontol A Biol Sci Med Sci 2003; 58:M441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/21\">",
"      Marcantonio ER, Kiely DK, Simon SE, et al. Outcomes of older people admitted to postacute facilities with delirium. J Am Geriatr Soc 2005; 53:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/22\">",
"      Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; 113:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/23\">",
"      Wong CL, Holroyd-Leduc J, Simel DL, Straus SE. Does this patient have delirium?: value of bedside instruments. JAMA 2010; 304:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/24\">",
"      Lyons WL. Delirium in postacute and long-term care. J Am Med Dir Assoc 2006; 7:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/25\">",
"      Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/26\">",
"      McCusker J, Cole M, Abrahamowicz M, et al. Environmental risk factors for delirium in hospitalized older people. J Am Geriatr Soc 2001; 49:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/27\">",
"      Marcantonio ER, Simon SE, Bergmann MA, et al. Delirium symptoms in post-acute care: prevalent, persistent, and associated with poor functional recovery. J Am Geriatr Soc 2003; 51:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/28\">",
"      Hoover DR, Siegel M, Lucas J, et al. Depression in the first year of stay for elderly long-term nursing home residents in the USA. Int Psychogeriatr 2010; 22:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/29\">",
"      Levin CA, Wei W, Akincigil A, et al. Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio. J Am Med Dir Assoc 2007; 8:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/30\">",
"      McGivney SA, Mulvihill M, Taylor B. Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 1994; 42:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/31\">",
"      Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/32\">",
"      Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/33\">",
"      Chen Y, Briesacher BA, Field TS, et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010; 170:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/34\">",
"      Cummings JL. Alzheimer's disease. N Engl J Med 2004; 351:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/35\">",
"      Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ 2011; 343:d4065.",
"     </a>",
"    </li>",
"    <li>",
"     www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics (Accessed on September 15, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/37\">",
"      Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ 2012; 344:e977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/38\">",
"      Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000; 57:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/39\">",
"      Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006; 355:1525.",
"     </a>",
"    </li>",
"    <li>",
"     Folstein M, Bylsma F. Noncognitive symptoms of Alzheimer disease. In: Alzheimer Disease, Terry R, Katzman R, Bick K.  (Eds), Raven Press, New York 1994. p.27.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/41\">",
"      Meeks TW, Jeste DV. Beyond the Black Box: What is The Role for Antipsychotics in Dementia? Curr Psychiatr 2008; 7:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/42\">",
"      Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med 1994; 121:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/43\">",
"      Ray WA, Taylor JA, Meador KG, et al. A randomized trial of a consultation service to reduce falls in nursing homes. JAMA 1997; 278:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/44\">",
"      Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/45\">",
"      Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000; 48:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/46\">",
"      Kiel DP, Magaziner J, Zimmerman S, et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA 2007; 298:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/47\">",
"      Fulop T, Pawelec G, Castle S, Loeb M. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis 2009; 48:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/48\">",
"      Fabiszewski KJ, Volicer B, Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA 1990; 263:3168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/49\">",
"      van der Steen JT, Ooms ME, van der Wal G, Ribbe MW. Pneumonia: the demented patient's best friend? Discomfort after starting or withholding antibiotic treatment. J Am Geriatr Soc 2002; 50:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/50\">",
"      High KP, Bradley SF, Gravenstein S, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/51\">",
"      D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008; 168:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/52\">",
"      Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998; 158:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/53\">",
"      Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006; 333:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/54\">",
"      Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/55\">",
"      Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/56\">",
"      Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999; 282:1240.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/flu/han011406.htm (Accessed on September 15, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/58\">",
"      Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/59\">",
"      Patriarca PA, Arden NH, Koplan JP, Goodman RA. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 1987; 107:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/60\">",
"      Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010; 58:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/61\">",
"      Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/62\">",
"      Nicolle LE, Bentley D, Garibaldi R, et al. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996; 17:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/63\">",
"      Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/64\">",
"      Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992; 117:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/65\">",
"      Nicolle LE, Henderson E, Bjornson J, et al. The association of bacteriuria with resident characteristics and survival in elderly institutionalized men. Ann Intern Med 1987; 106:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/66\">",
"      Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician 2006; 74:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/67\">",
"      U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008; 149:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/68\">",
"      Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/69\">",
"      Quagliarello V, Ginter S, Han L, et al. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005; 40:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/70\">",
"      Yoneyama T, Yoshida M, Ohrui T, et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc 2002; 50:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/71\">",
"      Terpenning MS, Taylor GW, Lopatin DE, et al. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc 2001; 49:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/72\">",
"      Terpenning M. Geriatric oral health and pneumonia risk. Clin Infect Dis 2005; 40:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/73\">",
"      Naughton BJ, Mylotte JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc 2000; 48:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/74\">",
"      Loeb M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006; 295:2503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/75\">",
"      Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002; 51:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/76\">",
"      Mills K, Graham AC, Winslow BT, Springer KL. Treatment of nursing home-acquired pneumonia. Am Fam Physician 2009; 79:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/77\">",
"      Morrison RS, Siu AL. Survival in end-stage dementia following acute illness. JAMA 2000; 284:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/78\">",
"      Givens JL, Jones RN, Shaffer ML, et al. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010; 170:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/79\">",
"      Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999; 282:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/80\">",
"      Schultz M, Hern&aacute;ndez JM, Hern&aacute;ndez NE, Sanchez RO. Onset of tuberculosis disease: new converters in long-term care settings. Am J Alzheimers Dis Other Demen 2001; 16:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/81\">",
"      Jensen PA, Lambert LA, Iademarco MF, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/82\">",
"      Finucane TE. The American Geriatrics Society statement on two-step PPD testing for nursing home patients on admission. J Am Geriatr Soc 1988; 36:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/83\">",
"      Won A, Lapane K, Gambassi G, et al. Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. J Am Geriatr Soc 1999; 47:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/84\">",
"      Jensen PA, Lambert LA, Iademarco MF, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/85\">",
"      Hollenack KA, Cranmer KW, Zarowitz BJ, O'Shea T. The application of evidence-based principles of care in older persons (issue 4): pain management. J Am Med Dir Assoc 2007; 8:e77.",
"     </a>",
"    </li>",
"    <li>",
"     www.chcr.brown.edu/commstate/PDF/FASTFACTS3.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/87\">",
"      Sloane PD, Ivey J, Helton M, et al. Nutritional issues in long-term care. J Am Med Dir Assoc 2008; 9:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/88\">",
"      Sullivan DH, Johnson LE, Bopp MM, Roberson PK. Prognostic significance of monthly weight fluctuations among older nursing home residents. J Gerontol A Biol Sci Med Sci 2004; 59:M633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/89\">",
"      Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999; 15:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/90\">",
"      Sampson EL, Candy B, Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2009; :CD007209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/91\">",
"      Robertson RG, Montagnini M. Geriatric failure to thrive. Am Fam Physician 2004; 70:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/92\">",
"      Rigler SK, Webb MJ, Redford L, et al. Weight outcomes among antidepressant users in nursing facilities. J Am Geriatr Soc 2001; 49:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/93\">",
"      Koretz RL, Avenell A, Lipman TO, et al. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 2007; 102:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/94\">",
"      Simmons SF, Keeler E, Zhuo X, et al. Prevention of unintentional weight loss in nursing home residents: a controlled trial of feeding assistance. J Am Geriatr Soc 2008; 56:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/95\">",
"      Yeh S, Wu SY, Levine DM, et al. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 2000; 4:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/96\">",
"      Simmons SF, Alessi C, Schnelle JF. An intervention to increase fluid intake in nursing home residents: prompting and preference compliance. J Am Geriatr Soc 2001; 49:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/97\">",
"      Feinsod FM, Levenson SA, Rapp K, et al. Dehydration in frail, older residents in long-term care facilities. J Am Med Dir Assoc 2004; 5:S35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/98\">",
"      Dasgupta M, Binns MA, Rochon PA. Subcutaneous fluid infusion in a long-term care setting. J Am Geriatr Soc 2000; 48:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/99\">",
"      Thomas DR. Prevention and treatment of pressure ulcers. J Am Med Dir Assoc 2006; 7:46.",
"     </a>",
"    </li>",
"    <li>",
"     www.npuap.org/PDF/push3.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/101\">",
"      Pham B, Stern A, Chen W, et al. Preventing pressure ulcers in long-term care: a cost-effectiveness analysis. Arch Intern Med 2011; 171:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/102\">",
"      Fr&iacute;as Soriano L, Lage V&aacute;zquez MA, Maristany CP, et al. The effectiveness of oral nutritional supplementation in the healing of pressure ulcers. J Wound Care 2004; 13:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/103\">",
"      Desneves KJ, Todorovic BE, Cassar A, Crowe TC. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clin Nutr 2005; 24:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/104\">",
"      Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/105\">",
"      Messinger-Rapport BJ, Thomas DR, Gammack JK, Morley JE. Clinical update on nursing home medicine: 2009. J Am Med Dir Assoc 2009; 10:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/106\">",
"      Witherington EM, Pirzada OM, Avery AJ. Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Qual Saf Health Care 2008; 17:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/107\">",
"      Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/108\">",
"      Linsky A, Hermos JA, Lawler EV, Rudolph JL. Proton pump inhibitor discontinuation in long-term care. J Am Geriatr Soc 2011; 59:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/109\">",
"      Boockvar KS, Carlson LaCorte H, Giambanco V, et al. Medication reconciliation for reducing drug-discrepancy adverse events. Am J Geriatr Pharmacother 2006; 4:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/110\">",
"      Lapane KL, Hughes CM, Daiello LA, et al. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc 2011; 59:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/111\">",
"      Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 2010; 58:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/112\">",
"      Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351:2870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/113\">",
"      Gabrel CS. Characteristics of elderly nursing home current residents and discharges: data from the 1997 National Nursing Home Survey. Adv Data 2000; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/114\">",
"      Dubeau CE, Simon SE, Morris JN. The effect of urinary incontinence on quality of life in older nursing home residents. J Am Geriatr Soc 2006; 54:1325.",
"     </a>",
"    </li>",
"    <li>",
"     Fantl, JA, Newman, DK, Colling, J et al. Urinary incontinence in adults: acute and chronic management. Clinical Practice Guideline No. 2. 1996 Update. Rockville, MD: Agency for Health Care Policy and Research.",
"    </li>",
"    <li>",
"     www.amda.com/tools/cpg/incontinence.cfm (Accessed on April 30, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/117\">",
"      Zarowitz BJ, Ouslander JG. The application of evidence-based principles of care in older persons (issue 6): urinary incontinence. J Am Med Dir Assoc 2007; 8:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/118\">",
"      Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev 2000; :CD002113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/119\">",
"      Fink HA, Taylor BC, Tacklind JW, et al. Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials. Mayo Clin Proc 2008; 83:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/120\">",
"      Hu TW, Igou JF, Kaltreider DL, et al. A clinical trial of a behavioral therapy to reduce urinary incontinence in nursing homes. Outcome and implications. JAMA 1989; 261:2656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/121\">",
"      Phillips C, Polakoff D, Maue SK, Mauch R. Assessment of constipation management in long-term care patients. J Am Med Dir Assoc 2001; 2:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/122\">",
"      Volicer L, Lane P, Panke J, Lyman P. Management of constipation in residents with dementia: sorbitol effectiveness and cost. J Am Med Dir Assoc 2004; 5:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/123\">",
"      Bradley EH, Wetle T, Horwitz SM. The patient self-determination act and advance directive completion in nursing homes. Arch Fam Med 1998; 7:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/124\">",
"      Gillick MR. Adapting advance medical planning for the nursing home. J Palliat Med 2004; 7:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/125\">",
"      Molloy DW, Guyatt GH, Russo R, et al. Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA 2000; 283:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/126\">",
"      Kane RS, Burns EA. Cardiopulmonary resuscitation policies in long-term care facilities. J Am Geriatr Soc 1997; 45:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/127\">",
"      Gordon M, Cheung M. Poor outcome of on-site CPR in a multi-level geriatric facility: three and a half years experience at the Baycrest Centre for Geriatric Care. J Am Geriatr Soc 1993; 41:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/128\">",
"      Shah MN, Fairbanks RJ, Lerner EB. Cardiac arrests in skilled nursing facilities: continuing room for improvement? J Am Med Dir Assoc 2006; 7:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/129\">",
"      Murphy DJ, Murray AM, Robinson BE, Campion EW. Outcomes of cardiopulmonary resuscitation in the elderly. Ann Intern Med 1989; 111:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/130\">",
"      FitzGerald JD, Wenger NS, Califf RM, et al. Functional status among survivors of in-hospital cardiopulmonary resuscitation. SUPPORT Investigators Study to Understand Progress and Preferences for Outcomes and Risks of Treatment. Arch Intern Med 1997; 157:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/131\">",
"      Lahn M, Friedman B, Bijur P, et al. Advance directives in skilled nursing facility residents transferred to emergency departments. Acad Emerg Med 2001; 8:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/132\">",
"      Tolle SW, Tilden VP, Nelson CA, Dunn PM. A prospective study of the efficacy of the physician order form for life-sustaining treatment. J Am Geriatr Soc 1998; 46:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/133\">",
"      Hickman SE, Nelson CA, Perrin NA, et al. A comparison of methods to communicate treatment preferences in nursing facilities: traditional practices versus the physician orders for life-sustaining treatment program. J Am Geriatr Soc 2010; 58:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/134\">",
"      Volicer L, Rheaume Y, Brown J, et al. Hospice approach to the treatment of patients with advanced dementia of the Alzheimer type. JAMA 1986; 256:2210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/135\">",
"      Molloy DW, Guyatt GH. A comprehensive health care directive in a home for the aged. CMAJ 1991; 145:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/136\">",
"      Phelan EA, Borson S, Grothaus L, et al. Association of incident dementia with hospitalizations. JAMA 2012; 307:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/137\">",
"      Mitchell SL, Teno JM, Intrator O, et al. Decisions to forgo hospitalization in advanced dementia: a nationwide study. J Am Geriatr Soc 2007; 55:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/138\">",
"      Hanson LC, Ersek M. Meeting palliative care needs in post-acute care settings: \"to help them live until they die\". JAMA 2006; 295:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/139\">",
"      Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004; 291:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/140\">",
"      Baer WM, Hanson LC. Families' perception of the added value of hospice in the nursing home. J Am Geriatr Soc 2000; 48:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/141\">",
"      Miller SC, Lima J, Gozalo PL, Mor V. The growth of hospice care in U.S. nursing homes. J Am Geriatr Soc 2010; 58:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/142\">",
"      Ouslander JG, Lamb G, Tappen R, et al. Interventions to reduce hospitalizations from nursing homes: evaluation of the INTERACT II collaborative quality improvement project. J Am Geriatr Soc 2011; 59:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/143\">",
"      Finlayson E, Wang L, Landefeld CS, Dudley RA. Major abdominal surgery in nursing home residents: a national study. Ann Surg 2011; 254:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/144\">",
"      Casarett D, Karlawish J, Morales K, et al. Improving the use of hospice services in nursing homes: a randomized controlled trial. JAMA 2005; 294:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/145\">",
"      Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360:1418.",
"     </a>",
"    </li>",
"    <li>",
"     Medicare Payment Advisory Commission. Report to the Congress: Promoting greater efficiency in Medicare. June 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/147\">",
"      Saliba D, Kington R, Buchanan J, et al. Appropriateness of the decision to transfer nursing facility residents to the hospital. J Am Geriatr Soc 2000; 48:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/9/42138/abstract/148\">",
"      Gozalo P, Teno JM, Mitchell SL, et al. End-of-life transitions among nursing home residents with cognitive issues. N Engl J Med 2011; 365:1212.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3011 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-652B83C886-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42138=[""].join("\n");
var outline_f41_9_42138=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6972745\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPREHENSIVE GERIATRIC ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26429831\">",
"      The Minimum Data Set",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26429838\">",
"      Goals for postacute care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26429845\">",
"      Family meetings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6972760\">",
"      CLINICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972768\">",
"      Vision and hearing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972777\">",
"      Dementia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6976115\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6976148\">",
"      - Advanced dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972786\">",
"      Delirium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972793\">",
"      Depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972802\">",
"      Behavioral issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6972811\">",
"      - Agitation and psychotic symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6972818\">",
"      - Aggressive behavior",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6972825\">",
"      - Wandering",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972832\">",
"      Falls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972841\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Evaluation for infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Influenza",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clostridium difficile",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Asymptomatic bacteriuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2098763\">",
"      Pneumonia in patients with advanced dementia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6976451\">",
"      - Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972850\">",
"      Pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972857\">",
"      Nutrition and hydration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6976530\">",
"      - Nutrition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6976657\">",
"      - Hydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972866\">",
"      Pressure ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972875\">",
"      Prevention of adverse drug events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6972884\">",
"      Urinary and bowel issues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H49568988\">",
"      - Incontinence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H49569008\">",
"      - Constipation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6972893\">",
"      ADVANCE CARE PLANNING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Cardiopulmonary resuscitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hospitalization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Palliative care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11661985\">",
"      PREVENTING UNNECESSARY HOSPITALIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11662087\">",
"      Rehospitalization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/3011\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/3011|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?36/54/37728\" title=\"algorithm 1\">",
"      Assess pain cogn impaired",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/3011|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/48/1804\" title=\"table 1\">",
"      Confusion assessment method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/16/42251\" title=\"table 2\">",
"      Screening tests",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/44/41670?source=related_link\">",
"      Approach to immunizations in healthy adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/19/42295?source=related_link\">",
"      Approach to the adult with asymptomatic bacteriuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9290?source=related_link\">",
"      Cancer pain management with opioids: Prevention and management of side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=related_link\">",
"      Clostridium difficile in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/18/36137?source=related_link\">",
"      Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/29/20954?source=related_link\">",
"      Clostridium difficile in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/36/38473?source=related_link\">",
"      Community-acquired pneumonia in adults: Risk stratification and the decision to admit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=related_link\">",
"      Comprehensive geriatric assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35048?source=related_link\">",
"      Constipation in the older adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/37/39514?source=related_link\">",
"      Diagnosis and management of late-life depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5528?source=related_link\">",
"      Diagnosis of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=related_link\">",
"      Drug prescribing for older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12183?source=related_link\">",
"      Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=related_link\">",
"      Ethical issues near the end of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/32/39429?source=related_link\">",
"      Evaluation of hearing loss in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/54/32618?source=related_link\">",
"      Evaluation of infection in the older adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22602?source=related_link\">",
"      Falls in older persons: Risk factors and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/18/38186?source=related_link\">",
"      Geriatric health maintenance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/12/31946?source=related_link\">",
"      Geriatric nutrition: Nutritional issues in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/24/39300?source=related_link\">",
"      Hearing amplification in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32008?source=related_link\">",
"      Hospice: Philosophy of care and appropriate utilization in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/34/26152?source=related_link\">",
"      Important sites and pathogens causing infections in long-term care facilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2599?source=related_link\">",
"      Infection control measures to prevent seasonal influenza in healthcare settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/8/14473?source=related_link\">",
"      Legal aspects of end of life care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/28/25034?source=related_link\">",
"      Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20855?source=related_link\">",
"      Palliative care: Issues specific to geriatric patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/63/20473?source=related_link\">",
"      Percutaneous endoscopic gastrostomy (PEG) tubes: Uses and efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41896?source=related_link\">",
"      Presbycusis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/20/34120?source=related_link\">",
"      Pressure ulcers: Epidemiology, pathogenesis, clinical manifestations, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/57/12184?source=related_link\">",
"      Prevention and control of Clostridium difficile in hospital and institutional settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/33/28185?source=related_link\">",
"      Prevention and treatment of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/59/31673?source=related_link\">",
"      Prevention of falls in nursing care facilities and the hospital setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/489?source=related_link\">",
"      Principles of infection control in long-term care facilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33865?source=related_link\">",
"      Treatment of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36858?source=related_link\">",
"      Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=related_link\">",
"      Treatment of pressure ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22250?source=related_link\">",
"      Treatment of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=related_link\">",
"      Treatment of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24214?source=related_link\">",
"      Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_9_42139="CNS causes of autonomic dysfunction";
var content_f41_9_42139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F77788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F77788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Autonomic dysfunction with central nervous system manifestations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Multiple system atrophy (Shy-Drager syndrome)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       With cerebellar features (MSA-C, olivopontocerebellar atrophy)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       With extrapyramidal features (MSA-P, striatonigral degeneration)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dementia with Lewy bodies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parkinson disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Brain tumors (brainstem, cerebellum, diencephalon)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Wernicke's disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Multiple cerebral infarcts",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Syringomyelia and syringobulbia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hydrocephalus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Multiple sclerosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Myelopathies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Traumatic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Inflammatory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Pernicious anemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       System degenerative",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Tabes dorsalis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Progressive supranuclear palsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Huntington's disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Amyotrophic lateral sclerosis",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Freeman, R. Autonomic dysfunction. In: The Office Practice of Neurology, 2nd ed, Samuels, M, Feske, S (Eds), Churchill-Livingstone, Philadelphia 2003; 14:145. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42139=[""].join("\n");
var outline_f41_9_42139=null;
var title_f41_9_42140="Strep bovis susceptibilities I";
var content_f41_9_42140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Representative susceptibilities of Streptococcus bovis to antibiotics*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antimicrobial",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC range, &micro;g/mL",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC50 range, &micro;g/mL&Delta;",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC90 range, &micro;g/mL&Delta;",
"       </td>",
"       <td class=\"subtitle1\">",
"        References",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin",
"       </td>",
"       <td>",
"        &le;0.008-2",
"       </td>",
"       <td>",
"        0.03-0.09",
"       </td>",
"       <td>",
"        0.06-1",
"       </td>",
"       <td>",
"        Pfaller, 1997; Eggers, 1992; Thornsberry, 1974; Mouton, 1997; Kerawala, 2000; Hoogkamp-Korstanje, 2000; Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ampicillin",
"       </td>",
"       <td>",
"        &le;0.015-0.25",
"       </td>",
"       <td>",
"        0.03-0.25",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Eggers, 1992; Fass, 1991",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amoxicillin",
"       </td>",
"       <td>",
"        0.06-8",
"       </td>",
"       <td>",
"        0.06",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Mouton, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Piperacillin",
"       </td>",
"       <td>",
"        0.125-0.5",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Etienne, 1988",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cefuroxime",
"       </td>",
"       <td>",
"        &le;0.01-2",
"       </td>",
"       <td>",
"        0.125",
"       </td>",
"       <td>",
"        0.12-0.25",
"       </td>",
"       <td>",
"        Mouton, 1997; Fass, 1990; Fass, 1993",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cefotaxime",
"       </td>",
"       <td>",
"        0.016-0.25",
"       </td>",
"       <td>",
"        0.063-0.125",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Eggers, 1992; Mouton, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ceftriaxone",
"       </td>",
"       <td>",
"        0.03-0.38",
"       </td>",
"       <td>",
"        0.125",
"       </td>",
"       <td>",
"        0.125",
"       </td>",
"       <td>",
"        Pfaller, 1997; Etienne, 1988",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ceftazidime",
"       </td>",
"       <td>",
"        0.25-1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        Etienne, 1988",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxacillin",
"       </td>",
"       <td>",
"        &le;0.015-0.5",
"       </td>",
"       <td>",
"        0.13",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Fass, 1991",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Imipenem",
"       </td>",
"       <td>",
"        0.007-0.25",
"       </td>",
"       <td>",
"        &le;0.008-0.12",
"       </td>",
"       <td>",
"        &le;0.008-0.25",
"       </td>",
"       <td>",
"        Eggers, 1992; Etienne, 1988; Schouten, 1997; Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Compilations of susceptibility data for S. bovis need to be viewed with caution because they were generated by different methods from various geographically disparate collections over a number of years. Inaccuracies in speciation were also possible in these studies. Thus, direct comparisons of antimicrobial potencies should not be made.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Minimum and maximum values of Minimal inhibitory concentration (MIC) ranges given.",
"      <br>",
"       &Delta; Range of concentrations inhibiting 50 percent (MIC50) and 90 percent (MIC90) of isolates.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42140=[""].join("\n");
var outline_f41_9_42140=null;
var title_f41_9_42141="Melanoma 1 PI";
var content_f41_9_42141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F66667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F66667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acral lentiginous melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 193px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photo shows how melanoma has irregular edges and color.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James C Shaw, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42141=[""].join("\n");
var outline_f41_9_42141=null;
var title_f41_9_42142="Hill Sachs lesion AP radiograph";
var content_f41_9_42142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hill Sachs lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 343px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFXAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5bnmk8+T94/3j/EfWmedL/wA9H/76NWJ4D50mR/Ef51EYDQAzzpf+ej/99Gjzpf8Ano//AH0acIGo8hqAG+dL/wA9H/76NHnS/wDPR/8Avo04wMKDA1ADfOl/56P/AN9Gjzpf+ej/APfRpTC1J5TUAHnS/wDPR/8Avo0edL/z0f8A76NIY2Hak2N6UAO86X/no/8A30aPOl/56P8A99Gm7SOxpKAH+dL/AM9H/wC+jR50v/PR/wDvo1HSqCxwASfagB/nS/8APR/++jR50v8Az0f/AL6NOMDquX+UVGVI7cUAO86X/no//fRo86X/AJ6P/wB9GmbTjOOKKAH+dL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UASedL/z0f8A76NHnS/89H/76NR0UATwTSefH+8f7w/iPrRTIP8AXx/7w/nRQBvTW376Tj+I0z7N2rcmg/fPxj5j/OmC29aAMb7P7cUv2b0Wtv7NntmlFt2oAwhbE9uaQ2p64Nb32X2FL9m9elAHPm27YpDbewrf+yjGcU0WuThVJPoBQBgG1AHNIbYd66mHRbmbBCbF96vweGlzmXLH06UAcGbYk4VST7VPHo9xMR+72j1NeiJpNtbLyqqfpUcnloD5YFAHGR+Ho4l3XBJPpTmtIYxhFAFdDJFvJODntk1F9kkx9zmgDmntN5+Vc+5qI2A6GMhj6iupNiCoyME9cU17JFySTjoCaAOTNl8wAAAPtQtgfnPB445rpnt0j5IBGMcDFV3hUKcgBumDxgUAc01phclevSomtGU8jrXRPBgAoFDH7oPPFMMBIwMcdRmgDnJICvY1GEJPeukltAy8YHfHrUAsDvGASfegDCmjMcm0+gNR1o6nCWviq9hj8qlttKd/vD86AMmiuhfSLdf9YxX0202PSrU/elYc9DQBgUV0baVYK21pWHuDTW0GKQZgugvoH5/lQBz1FbbeHpuPLnifP1qldaXd2xPmREj1XkUAUaKcyshwwIPvTaACiiigAooooAKKKKACiiigAooooAKKKKAJIP8AXx/7w/nRRB/r4/8AeH86KAPSpYwZW/3jQIlxV6SL96w9zUiQAjOKAKAhX/GnCFa0BbjNSx2pZgsaFmPQCgDMECjmnw2j3DbYYy3v2rsNM8LmXEl3wP7g/rW/HYW9rFhEAC8cCgDh7Tw0W+afJ/2RWtBpEFuuAqoK3ZCSD5YG32qtJbu65KmgDKlWKLhE3GqkzucgcfpW6LB3GD36U1tHdxx+RFAHMSQljksTmo/swJ+7kehrqToz+hJpDo0pxldooA5Q24AO0DFNa3J5PUc4rrP7DkHUD8TTX0hgSTtH40Aci9q2OTz1qNrYkgkD3FdQ2m46nNV5dOkfB7fWgDmGthnjB+gqFrVTksDtHUetdLJpj9NvX3FVptPkBChM8cnrQBzEkIJLFQB0XHaoXjVfUZ5+tdBNYt0wefWqr2RwQcUAZAVWOCMt2YelSR2+MnjAGatyWqoRlwO+M1Wu2PlGFOjH5moAz7SyFxcNMVBBPGa247A7DleB61b8N2QmnJX7qjPtmulWz+XIUYJ64oA4a506Sc/KMEjGQKrnRZlGdpJrvGtXBz09OMfhUMkQ3EHHqOKAPP5NOm8whIWYn2pDptzv/wBUy+ldtMijp37CqUiKhyThfUnOKAOdgsrhHyVJx3q0yuEYODk9Cehq5JwSAx/CoSzbjx8vagDnNXs1kjkKjDIMisEQZHFd3qEKG3lZcb8HC1yaxnjigDNaFhTCjDqK2DDnqKie3z2oAyyMUlXZLf8AOoHhK0AQ0UpBHWkoAKKKKACiiigAooooAkg/18f+8P50UQf6+P8A3h/OigD2p7ciZsjjcf51KsACdK1pbcLIx9zWppGgyXhDygrCeQO7UAYWmaVPfTBYV4/iYjgV2+laDBZKCcFz95j1rYtLKK0hARAijjApWyzEjp2oAp3EeeFOF7Y71Ua1L9Ome9a6W7MMnk5q2LZAgLKOPagDDh04tnI49h0q4lggUBlBx61eYdk6CmsD9RQBWa2hjHQVC6xAfd4pL27hgUl2GfaudvtXmkJWAbV9TQBsTSxRZJKr9azLjV7dDhWDGsKYSTHMrs1ReQOlAGpLqav0cCqct2nXcST71B9nyemaY0IHvQAsl6oztUmqsl1IeFXBqVoxngZpjQ98UAU5Z5zxuxmq7NOT/rGH0rRMHUU3yeaAMtvOI/1rk/WoHhds5ZjWwYPamPD3xigDCe2PUjNNt9OkvJhHEp9z6V0Frp8l3LsjHHc9hXS2WlpaxhYkzx8zGgDDg02OytEjhGM9T3JqYearHZuP16AVryxKZM4ZlH5CoHi6bF2k9KAKMm84VyW44xVCWM5Y8Yx161qTiRnbgYHfuarPGcEHqRQBlyICgI5HqPWqjx/IcjI5zWs0JXK4yKhaEbOnB7YoAxWtwQT0JqKSE4AX8K2ZI8E9Ae1Q3MICjPOKAOeuUYDHUjjisWW3yzYGBnjFdPcxEDJFUDBx0oAxFiIPIpTACBitSS2BzUJhK8igDKkg56VXeDrkdK3GiB7c1XkgyOlAHPTwegqo8ZWuikg9RVGaD2oAyKKsTwlear0AFFFFABRRRQBJB/r4/wDeH86KIP8AXx/7w/nRQB9daf4eJl826GeeE7D610McKwrgDgelacqBNwGNxqq8LMeORQBQkUucdqkit/QZ46+tXobbDc4zUr7IVznmgCqUEK5PXHFV5XY8nj29KdNMD945qlPKCDk8UAPedVHHPqRWPqepkfJGefQdqZfXmTsi/MVnlMnJyT60AVJd8rkyEmomhzjoKv7OnrQI/XpQBRWE+nNKYsA1r29i8uD0U+3Jq2NNjHLAmgDmWQkcVF5JJ6V0zabEc/LjPcVRudPkh+YLlD0IoAxjDxTfJx61peVnHH4Uhh9aAM4w5JzUZhznjFahjHYfWlS1eVtsaEk+1AGO0QGeKtWWkyXRDONsf6mujstEUEST8sO3YVrLbxxrwOlAGPbWMdvGAqhVHenSoNhJJIHQCtOULtyVB9KrOGYklQFFAGU0YIyw471TljSSXdtIGMAmtSaIED5iBnGD3qsYd8mxQeO46UAZz267VYDnkk4qGO0LHEakn1rfi0xmIMnCA8DvV5YESNQiBVHYdSaAOW/sqVjkgLnnJPeom0XozS4GcnArqnTrnqOoFV5PmY4Bz6GgDmZtJiZtwd8jtiqU2j5O1ZevUMK6qSLk5/HFUrhNuflGTx+FAHFXunzGQkAMo4AFZz27KcMCD7iu5eAbfujbVd7JJ1KsgbPf0oA4l4cHpmoHgroLqy8piAp4OKqNB3xQBiPDjORULw56VtSQdeKrPDg9KAMSWHk5FVJYMg8c1vyQZHTmqksOOcUAc5PBx0rMuICCSK6ieDOTWbcW/BGOaAOfoqzcQlWPFVqACiiigCSD/Xx/7w/nRRB/r4/94fzooA++GiyzAUgj9qvvGATg1WlyAcEZoAqzvtUBR83qKzJlJYliSavy9/51QupQmQOWoApXLqiksaxbmZpWKgYSr9whkbdJg1Ue2PVc0AURHnOKfs9qmaNgMEH603GcdqAIvL5qzaWwkkAx8tIENa2kW5ZS2OvagByxBeg+WlEeRyKuGEk4P4+1OFueCaAKYgyeQKmWBdu1hn1q0sI471YSIDAwDQBkzaTbzDhdpPcVn3HhydTmFgw9O9dUIwenAp6AjG38qAOKi0kqR5iNn3FacFosI+VRmupZAwzge4qtJaof4QB7UAYjRjqeaYwOCFwa1Dp+TlM+2agexkVcFMkdxQBktGxdmIIPtUJQAH5efetoWcx6AgUpsHb76j8aAOeWFmbKqSferUFkIsHA3Hv6VsrYrEuWIz/KmSKucA8D0oAzvLA4POajaLjpirrgZ7VE4GMZoAoSxjPzVC8W1QRx61ekOO5qpJubGenpQBRnAHA5x6dKqtblm5BP9av3lrNNbvHbzGCU4xJsDY59D7VnHStW/wCg13xk2if40ABtx39MYNNitlDjHBNZniDSNWudF1C3i1TzpJYJI1j+zom8lSAM54z61yfhTwd4vsShm8QfY4lIPlAm4/Da3yj8KAOy1SyKz7tvyt+VYl1p5I3RjB9K7drZhZIlzJ5zqPmkKhdx+grOktgeR+HFAHDvD1BHNQSQe1dbeWCSgnG1x/F/jWLcWrRHbIOv60AYUkOM1Vlh9RW3JDnPGRVWSHqAM0AYM0PHAxVC4g5PFdDND14qhPD1oA5a8tx1xWNPEUY+ldfcwcHisW8tu2KAMSinyIUYg0ygCSD/AF8f+8P50UQf6+P/AHh/OigD9CJvlY49apSdDmrsxG4881n3HzDCnrQBQup9uQKzZDzljkmtGW1c8jk9KqyWkwP+rOKAKjAdQKjK8EVdFq/cY+tKLcA0AUPJDdqUWIb7wrRWMAZNPVfSgDOFinp09a09Mj2xlTgEGnbOMmrdnENrZ46YoAjZQWJGaZgg4J4rSa2JUbec1E1o+MnA+tAFULxyBj0qVF5461OsUat8zZ9hUm5V+6mD70ARpGTkj0qVYwKA7NwPWpkTA3Oc0AN2AKOtQsevFTu4biothIoAgOd4xyDQU4z0qcrxion+VaAKdwdqbgcY7VkfbXlmKxEkLyT2rQuj5jbQeKrJbCNCyjhjk0AV2VzksxY/Wm7X5GenrVnZxSlcUAVG3d+aYwYkjGKubPamFcHBzQBTMeckgZHNNEeWFXGTnApmzJ54oAr7AOozmoXx9fpVpgQc4/CmeSS2cHjnNAGc6/MVxnH8qi2EfeBxWjKoHHNVnTcSCOnegCIkGIgrWf8AdPPStNRhO3uKqTx4JUdaAKcmGU8YJ9qpXMIZCrqCKvshx7fzqOSMbST2oA5e7tjC5U9Ox9apPEM9OtdJqMIaDpypz+FZEkfGKAMiaHg8VQnh65rdlj5qlPFkGgDnbiHnpWTeW/J4rqLiL1rLuYc9qAONv7fGTiswjB5rrL63yDxzXOXcJRicUAQwf6+P/eH86KIP9fH/ALw/nRQB9/3MpLEA1UyeeTUsinee9RlDweaAG+YyngkE0hnkH8RzQyHjORTWQnnt6mgBTcA/eUGmkx5JK4+nIpoVVHLDOO1I0iA8KT+OKAFMUbjhup9Kelrj/louPrUTTNjAwo9qhJY9SaAL3kIuSWLfSp4mVDlEJPvWYhK9CRipkndV5J9qANyKYMAGXb/KllgYjKkkGsZLuQEEmtC3vyCAwyvrmgAMeDymTUirH/ErE1aYpKgP5VE8Yx14oAYSqj5AKbksMmnrGAcn+VPK0AQBOc0pUdcVMEwO1RuMHPegCIgVTumJGwY561ZlcAcdfeqpXjPBNAFLb6VYMalMGlKgN05qTHPJoAz3j2HB6dsU3bzn9KuzJke/aq4TnnigCPbn6CmlPT8KnAGfUe1KVJPsO9AFN14Hrmo9vzVcZADzUTK38Ix75oAi8rAyRznpUMhJB5OKsDgEHrioXGCTn8aAKsqZxmq7AAdhg1ekX5c5rn9d1M28q2FjCt1qk65SE52ovTzJD/Cg/M9BQBy3iL4h6XYXa6fpIOralI4jSG3PybjwAX6dewz74rqVS4+xW7Xvlm5KjzfKBCg+gz2HSuY8LfDez0HxC2rNMJ5jH8kflhVjkOd7KB0GOAO2Tya7hkV1x6+tAGXtGDUTJnK1daMrwfpUTJlu9AGdew/6MePxrDkT0rq5o90Dj8awWi6jHWgDMkj4qlNFx04rZliyM1Uli46UAYc0Wcgis25iHIroJYsZ4qhcRUAcxdwdeK57UbbGSBxXaXEXWsO+t8ggigDjQhS6jHbcP50VoXVvieP13D+dFAH3YyZY4J61HJ8o55+lTynqB/8ArqpJkjB/OgCN5QOFWq0jFuuamZRnofwpm3tQBGDxwMUhxT+AT7UhxzyaAGH8aOvSg07HfPNAAq/LzSjGOaFPtmg+9ADgo7/pUiZBwORUakYPenAgetAGhazlTgjir5IYAgde1Y0bYPtWhay5GD1FAE547HIpNwxzxTyN35VEy4z35oAlRs+9IwzUS5AGMCnbqAKUwJlIPQUhXC4qZhls5601hwaAKjDLDJp+OPcUrjnIpw55oAiIxUEkeTkGrLdaYQTgYoAgXKt+tI5wAOnenkbSQKhkJJGOlADCcjOajzjPHTtUpHUDpTGHHt3oAhPJ6DPrUbrknNWMdB1qPGeDQBRvVne0mW0eNLgqRG0i7lVscZAIzVDRtHh0qGTa7z3MzB57mU5kmb1J7D0A4A6VslcH2pjrwMcUAVmXn6VGVIP05q0V5/WmMpxkj6UAU3Unr1NVnRQ7KCCwAOM8gH/9R/Kr0pWNGkdgqKCxZjgADqa80+GviJ/Evi/xRdg5tSsKQKeojUuB+eST7mgDvIky2D0PFYtxFtlcehrowgUj61j3cY+1S+maAMx4+Kqyx5B9a1CnB9qqyoCST0oAyZo85rOni4rclj68VRnT24oA5+4i6msm9h6jGcV0lxHyeKzbqLI6UAcfc2+Zk453D+dFa08GJlPP3h/OigD7EuoSrsV5FU3Axz2rWc4JB5FVLi3z8yfXFAGcwqNxxxzVl17d6iZT1oArMM5OeRSYOPc9qlK8H0pqjHHY0AR444pcCpcHH0oAOevHpQBGVOOPzoweOOtS7ec0baAGAdPTvSN1z60/HGKXb6igAQ5x+lWoCR1qugxU0Z+fA6UAaKP8oob1/SoYjge1TAkjpzQBG2QRzz7Ug4Jwae4J6moz70ANbJNB5BNB+lKOR7UAQsO1NHTFSstRlfzoARhxwOaao4+lSexpNvJ9OtAFade4qEAccGrUoyORxVcdSaAI3XrTWHp6VK4yDkc0zg96AIcc1G4x06VMRg5qNxkGgBhHXmmFcjHWnsM4zSAc0ARFSenamkDjg1MRnoOKaR60AZ+oWsF7aTW12ge3lQpIpJAKkcjj2rjPhv4Y03S9OTVtPhkhl1CMyFS5KiNnLIMH0UqP5113iaK6k0DUI9PTfePA6RDOPmIwD+Gc1PaWqWtrDbxDEUKBFHoAMCgBiKC3Sse6ANzL/vV0MSfvBn06Vh3S/vpDjuaAKbLnpVaReSKv7c5qCReKAMyWPg+9U54xitaVexzVSZMjmgDEni5NZ1xH1OK3Z46z548544oA52eHMi8fxCitGWP96vpkUUAfVsq5Yj9Ki5Bq58lwNy/K46iq7LhiG4oAqzwhxkcNVB1IOGGCK1WXmopIlcc9ex9KAMwpn6Uxk6irbxFGIPX+dMYcUAVwvHFKF71Io7ilC9OOKAIivpRtqUrxRj8+9AEe3pRipNo70ADv1oAjPApyDB560AZJJo9c0AWoTgn3qwKqxHGKsryO2aAFK5A9aYwxnips4FNPt+dAEOPxozzgGpCtRgY60ADLk8CoiMVOMYJpjgUAV3HQUkT4Yo3TsT2qRhzUMgxyDQA5068cj3qqy43HtVoNuXr8wFVyck0AMxxg96aQPT2qQqCc9MUwg4NAELjr6VGRntVhhnp19KjYZHfmgCIjg5pp4J44p5FIfzoAZ1PSmsOlPPQ4z1oI5FAEbD6c1DgH1zVgD3qMr2xQA2Nf3mMViXS/v5Pqa34x8wrIvU/0hx70AZ+CAaikFWduajce1AFKReKqSJxWjItVZFoAzJkyMVQmjwDiteZCRyKpTJz2oAxnj/erx3FFW3jzIP8AeFFAH0erfNuQ4Iq0siXK7W+WUdP9qqp2liejfzoYHg5x7igB8iEHkdO1MAq3G32lMH/Wr39ahKHP9KAIpIwy4I47H0qnLEUYgjjsavgED2pGUMuCOKAMwr+NAXJFWHi2nBpmz0oAjA5pNvNS7ec0mOlAEW360cYqQrx60m3igBhFNK8+1S7aNuKAETjmrSAY6VAq1YjoAeOnNIfenetNxgUAJSFefal/i4oBGOaAGYxmkPJx6VNxTCBQBA6+1QsPyq23NVZ3AH9KAK0jeWCRjNMR1c4P3qbMd3JFQ98igC0y03GOmaWCUONrdelSunFAFfofSo3GSMipmGQRTWGefWgCuw5z3qNhx9KnK8de9RmgCPHOPSkHOSOtPxTQegoAQjk5ppHBp9GOMdqAEjGGHv3rL1JNtyT6961l4YelUdXTDKw+lAGSRk89aikXmrJHNRyA/hQBTdefwqs6+30q9Iufeq7ryeTQBnyLyeKqSqTWjKvfFVJU9aAMxkzIp9xRVl0/eJx3FFAHuwbL++eKnSTjpVMct75qZSB1oAtoCjCSMkgdRVqRRIocdT+tUoJNpyDxWjEgeIlOo7UAUyDSbevvVllz7GoyhGTQBXlj3D37VVK89Kv7euaglTDZHfmgCsF+XmgjJPAqTBFGOTnrQBDjFIVxUzD1pCvXigCLbk0Bc1Lto24oAaq4PSpFGMY6UBeRUigkcUAAFNPBqQjmmMOaAG0mPwpDnHHrTsZxmgBpBFNLdKkYEfWoJeKAI5HJqlPISSB24NTytwaqNnHFADGx60w9aew+YU09B7UANJPBHbpVy1lDrhutVG+lIpKNlaAL0qY5FQN1wOnWrULCWPjrUMqY+lAFdjx7ioz07c1JJ144FRE4zQAxvrzTe44pSabu5oAfjmkzzijtx1o9+pNACjGR/Oq+qpmIEDoasZ9KLpd0B4zxQBhMPmGOaY3p2qQ8nsKawzigCrIDUEgHerbjg1Xk6HGM0AU5Bx7VVlXir0oqrIvGKAKW0F1HfdRUm394p9xRQB7DHcBj8+AT/EKtY4GTx61z8EhIYZzk4rTtLggYzle4oA0UznitCxc5Ycc1nIwb5kOR6dxVuyJ3kntQBpPHu5HWoSmOCKmhbcvNSFQwOaAKJXg+vrUE65HXmrrrg4IqCRcqfpQBQKmgDNTMhwKbjHHagBm3ik2nipQBmjHcCgCEijbzUhHB65oA5oAaF596kUcH1pVFOHHB6UAMxmmkZ9alwc8U0j60AV9vPSnlePU1JjnOKQigCJ/Sqlw+AAOtW5OhwKoy8uTQBXcc89ajZasMB+NRFfTrQBCR1pjLU5UCmFc+n40AREHHX2phHFSn9femEUAOtZfLkwfumr0qhl3Ac+1ZbcVoWUpdArfeFAFaRTnmomTmr06YPAx9KquMeoNAFZk/Oo9pFWmGRmoyOaAIMkHvmng+/wCtK468U3bj6UAPHFP6xEVHj2qWLnI9aAMORdszL6GojmruoJtuNwGAapsO9AELj0qB168VaaoXGTxQBVdTiqsi9quvx9KryLmgCiV+cDjrRUxH7xec80UAdpbHazDPetKEkDnoe9ZjKySHIPU1egchOD1oAvR3DI24ZGD1rb06VZlYjAaucXl+DnNatn+7j4GCeeKANyJirDNXe2RWZbTCXCyHDdj61fgJGVPUUASMoYY71WlTbnNWqHUMhB60AZhTnjvUbLVp0IOCKYUGaAK+Of5UuKkK4+lNI9jigCMilC0/HOKcoGRxQA0LS7fapAM8UpHT1oAi53c00j0FSEfKKQigCL2pp4HvUhGelMbANAEEnQntVJhljVyfAHAxVUjFAEO0800jipiKY3FAEDr6VGRVkrUTL19KAIGHPQVEwxzn8qsMtQsOTxzQBERx1p0LGOQN+dOIO48/lSEY4PSgDTYb0GO4qnIpFWLKTKbT1HFOuE74oAo4G7jpUbrjkirBHtUcg9B0oArkDtik6ZxUjD2phx3oATBzkUsZ+YUelKAN2aAK2qRny9w/hNZfO0n+Vb86h4SD3GKxGXHB7UAQEY6VE44qZhhqiYccUAV2FQOKstwahdaAKrL+8H1oqQr86/WigDtsksRjjPerTQKUzH8px07VWLlWbuM+lXrU7lAxkmgCOCJy43DCj9a0FYk9eDUw8ry9gGT3pggIx5YOPSgCaPsTWpZ3BOFc/RqyYjz83arsJPXigDa6gUh96itZcDY3TsfSp5Fx3zQAx4wy4xzVVhgkEVcHNJKm4HHWgCgRk/0ppWrLKeaYyfL0oAg2/gKeg4x3p23jjrTwuOgoAYFoINSbe9BTpQBBgge9IR7VKV5pCMCgCEjnpUbD1qwwJB9agk4+lAFKbk896hIqduSfSmYoAhYc9aYRUxWmEe/FAEWOfemNnGRUxphHBoArsMjpioymTVkjBpm3uP1oAg2DvTSuanZabt/MUAMhYxyK34GtF1DJnFZxHFXrRy0eOpHFAFaROT6iomXPBq5cJjrVcjBwaAKjgDNRHmrLr1NQEZoAb9OtHf2pM8inDmgCWMZQjtism9i2Tk9M81qw8MM9+KrajFlMjtQBkuOCe4qF149Ks9fpUbLj6elAFRgahccVZkX/AOvUL+npQBXIG8H3FFSD76/WigDs0Ri7cZGelXII9q7SfmNLC6qpBIL1MqhsMp5oAI8rye1W4W4qEJ8uGzzU0aleAaALARXX3PcVIiFW5HHrSL8qj1qxCwfg9KAJYj0Oau28u75W6Hoap+WVHyjI9PSpIT2oAuMu046UoPp1p0LeYoUn5uxpCCD0NAEUqY+YdKgKVeAyCCBiq7rtbFAEG33pwUcipCOKMUAMxTCOnHFS4xSYoAjK8Uxl7CpmWmkdx1FAFcgDtUE/CmrJFVpzk4oAqEHvTSKmZcnAPWmkZ+tAELD8KYy8GpyM9aYRQBBt9elNK++anI61G65P4UAQMOKaR+dTEfjTdvGKAIiOMnrUZGOMcVOVphHTH60AQEdfSnW7bJR2BpSBg/nimMMHigDQkXcmRVV19qs20nmRj1qOVcMaAKMi+2KrNV2RaqSA96AIjmgYwKRsA+tKvHSgB4x1qSdfMj9qjWp05Ug0Ac+6lHZfQ01gD35q7qMW2UN2PFVCOlAEDiq8icZ71ccdeOahdfb3oApgYdfr1oqUp+8Bx3FFAHZ2dtLNuJOEJPOOa2bfT/LUErJtHc1a05YxdLkDaMkD1xVkalKzblAI/u4oAqNaggbeR+tCRBRzVy4PlzNtGAeQPSqMsmyUg/dPNAEgPPTNTR4XkgCiIK43AA554pWXJGBxQBPC54JqcIDyvBqtGDirSEUASRnBweKtlfMG4fjVYKG+tTwEqwBPB60AJyDQyB19xUjrg0IMEUAVSvBpmKtSphsgcGoSuKAI6B1pxFJj3oAYRSEU8jim/WgCJxwaoyZLE/lV+XhTmqZXj3oAhYU3GalximkfnQBEQPpTCPyqYjt2phHPWgCIjn1phHrUpGPpTWHbtQBCVppHtipiOBimkcUAVyMGmMKnYYHY1GwyKAICBUbcVOw4qJx3FAC2jbZCM8GrsihlrLPBB9DmtOFxIgPr2oApyjiqkg4z0rRlTBIqi68mgCo4zSLUko4FRj6UAPHap4u2RzUA61LGenGKAI76LdEQOTWOB2I56V0TKGXNYV3H5czehoAgIpjKKmx0NNZeCaAKoHzrx3oqXb86+uaKAPQY2aNgynBBzVpbjDbljRT61mQuyDDqWUHg9xUklwirkBz9BQBcDFn3MclveqNzJvuTt6DioheecSsYZFPGT1NRt8gwDQBehuNoGOncitKFxKoycGsaDPWrUUhQ/LQBtIuODg1IgqvbSBwMn5sVaXp70ASRdvWrKcj3qqBVhD0oAsAZTnqOtN28DtUsR3AjvQwoAjI3JjvVdhVvvUUi/N7UAViKae9SlaaR+VAEeKY361Lg/hTD0oArzD5TVcirUoytRbeKAKpAJppB61O6d6iK470AM600r+dO4HakIwRQBEw7dKaVGRUpHtTcd6AI2HWmNU7Dg1GRQBAQDUTA47VZYAVGw/zigCsy1Gy5qwRjjFRkcUAU2HJ4qazk2ybTkDtUcg+brVcuUcOD0oA2JgGQkVnyDmr0EgkQEd6gnj2saAKEi5HA4qv3q66+lVGAyQKAFWpU6j0qIfWpFxQBZhOQRWfqcGV3AcirsfBzUk8YdMY6igDm1449aUMRnPI96knj8uUrTDjFAEIHzAe9FPA+dc+tFAHUrMyOc9KkEoJ44BqtxvPX6Ux5QCFTr/KgC9tRiCAA3qKRl2nd1HTNVVdieDmrkOWBwcEdqAHo5IOBxVmABh9KbFGCD0U/pTlUockc0AWoSRznnNaUMgOAxrLibPSpwWPsRQBrqCaenWqlrNnCuaujigCzbZ3VMygioLf71WvftQBDjBpJBleOtTFe9MYZBoArFewqMirJFRupx2oArEU0gVMRxTGHNAFeQHFRsKsOvBqLFAEDKMGoGX2q4RULKcmgCqwOabipmXkYqNl9M0AREcn9KCMc4p7A85ocelAEeKYakxzSEUAQkY6VGw61M3H1phH6+tAFdhUTCrDgVCxH40AUrniqLHmrt90FUmBoAt6ZLg7D9RWlKm9OnNYKsY5AwPSt+3cPGrA5BFAFB0x2qnIpDnA4rWuI8etZ9wvPvQBXA71KBkimL+VSr05oAevWp1+ZdveoAOanTjHrQBm6lDn5sdKzguMjFdFcRh0Ix1rDki2MVPagCDHzD60VIFy4xxyKKANaWTMhRTzkg5oEY+UkYxVeMgyY68/nWhFtY4HIoAjh+U/1rQt0PB70y3ijB45NWoyFbigBy8deKsxMGUq44NNKKeufWlUY6c/WgB5gYHCHK+vpThgNgcmpYnOwA1I0Ctgrwf50ACcDJ/Kr9tL0V+hqkFI4Ix+FToMUAa0S7ST2qyvK84qraMQiq5/GrcYxwetAChcU1l646VJRigCqRxTWGamZcGmMKAKzrz9KYwqwy8VGw4NAFaQfLiomFWZFqIr7UAQkVE656VZZfaomFAFV09elMZcHrVll9BUTL7UAQkfSmHoAamZcUwrjrQBFj6UhGelOHXJpSOOlAEDDNRP71YYcVGw60AVX4HvUT8Zqw45qCQGgChefdqmeuBV+4GVaqHSgBjjPNXtImwTCx6ciqmOOabGTHIHHUHNAHRuu9Ky7lPz6Vp2ziRAQeCKr38WKAMvGCeTTh0x2p5XkHpQB/wDroAcvSpUHA74piCpF65xQBKBuTp0rL1KHHzgfWtWIc1HdRblYHoaAMALytFS7NsgVuoPeigB6qyk7f71WbctksRyO1FFAF63Mm75xx7VpLEQobFFFAEyoxXnrUiKcjIFFFAE6KSucYNWIwdwx2oooAn2buDUkURD/ADdqKKALaDoRV2BsjB6iiigCWiiigBrDIqJh6UUUAMIqNl4oooAhcEtUZFFFACFTUTKcdKKKAGFeKjZT3FFFADGQ5zjNQuhPTpRRQBGUPSm7SfyoooAYykGo2Vs8dKKKAIXU/nUToTkYoooAqSRttORWYEYnFFFACmNsjijyzjBFFFAGhpLtzE2eORWlcRmSE8dBRRQBlGFuc0gjYEZH60UUAPETA8U8I2OlFFAEixtnOOfrU8kRIBxzRRQBkXtuVlDgdTg0UUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A Hill-Sachs deformity is a cortical depression (black arrows) in the humeral head made by the glenoid rim with dislocation. They occur in 35 to 40 percent of anterior dislocations and are seen on the AP radiograph with the arm in internal rotation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mary Hochman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42142=[""].join("\n");
var outline_f41_9_42142=null;
var title_f41_9_42143="Removal of nasal foreign body using a nasal speculum";
var content_f41_9_42143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Removal of nasal foreign body using a nasal speculum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 404px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Insert the speculum as shown in the figure to avoid injury to the nasal septum with epistaxis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bennett JE. Nasal foreign body removal. In: Textbook of Pediatric Emergency Procedures, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_9_42143=[""].join("\n");
var outline_f41_9_42143=null;
